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emographics of the world’s population show that the number of individuals 
aged 60 years and over will increase from 600 million in 2000 to more than 
2 billion by 2050 (1). Specifically, elderly people aged 80 years and over are 
presently the fasted growing subpopulation in the developed countries. As a con-
sequence of this global aging, our healthcare system will face serious challenges 
because of increased morbidity and greater need for hospitalization and institu-
tionalization. Good health is essential for older people to remain independent and 
to continue with actively taking part in family and community life. One of the 
factors that plays an important role in the ability to maintain a healthy active life-
style is the preservation of skeletal muscle mass (2). However, after the fifth dec-
ade of life, a progressive loss of skeletal muscle mass is observed with increasing 
age (3). Therefore, interventional strategies are needed to attenuate the age-
related decline in skeletal muscle mass and, as such, promote healthy aging. 
Muscle loss with aging 
Skeletal muscle mass generally contributes up to 50% of total body weight in young 
adults but declines with aging to 25% when reaching an age of 75-80 years (3). This 
loss of muscle mass is typically offset by gains in fat mass and is most notable in the 
lower limb muscles (Figure 1). In addition, the loss of skeletal muscle mass is ac-
companied by the loss of muscle strength and a decline in physical performance (4-
6). These progressive muscular changes are termed sarcopenia, with sarcos mean-
ing ‘flesh’ and penia meaning ‘lack of’ (7). Primarily, sarcopenia is considered a 
process with no other cause evident except for the aging process itself (8). With 
normal human growth and development, skeletal muscle mass increases until the 
third decade and then remains relatively stable until the age of 40-50 years. There-
after, a gradual but progressive loss is generally observed (3). 
The consequences of sarcopenia on health status are numerous and include in-
creased risk of falls and fractures, impaired ability to perform activities of daily 
living, and loss of independence (4-6). Apart from these, more obvious, conse-
quences of reduced muscle strength and physical performance, sarcopenia also 
induces a greater risk of developing chronic metabolic diseases. Skeletal muscle 
tissue comprises ~70% of body cell mass and therefore plays a major role in glu-
cose, fat, and protein metabolism. A decline in muscle mass reduces the capacity 
for postprandial blood glucose disposal thereby impairing glycemic control. Also, a 
decline in muscle mass and the subsequent greater relative fat mass increase the 
likelihood of ectopic lipid deposition in liver and skeletal muscle tissue. The latter 
will further impair insulin sensitivity and contributes to the development of hyper-
glycemia, hyperlipidemia, hypertension and, eventually, type 2 diabetes and/or 
cardiovascular co-morbidities. 
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Figure 1. CT-scan of the upper leg (mid-thigh level) in a young (25 years; left panel) and elderly (81 
years; right panel) male subject, matched for body mass and height. Note the reduced muscle area (in 
grey) surrounding the bone (in white), increased subcutaneous fat (dark area surrounding the muscles), 
and increased fat and connective infiltration (dark areas within the muscles) in the upper leg of the 
elderly subject compared with the young control subject (9). 
Muscle protein turnover 
Proteins serve as the main building blocks of our body and consist of amino acids 
linked together via peptide-bonds. Muscle proteins account for about 40% of total 
body proteins and serve as the principal reservoir of amino acids. The body’s free 
amino acid pool is small compared with the body’s protein-bound amino acid pool, 
e.g. 200 g versus 12 kg for a 70-kg adult man, and is greatly influenced by daily 
cycles of feeding and fasting (10). Both amino acid pools are closely related through 
the process of whole-body protein turnover, which is crucial for maintaining the 
quality and quantity of body protein. Through the process of whole-body protein 
turnover, proteins are constantly being broken down and re-synthesized (Figure 2). 
On a whole-body level this occurs with a rate of approximately 3-4% per day. How-
ever, our body contains numerous different proteins, each with a specific amino 
acid sequence, structure, function and turnover rate. For example, the turnover 
rate of intestinal protein is 30-40% per day, whereas the turnover rate of muscle 
protein is just 1-2% per day (10). These turnover rates indicate that our intestinal 
surface of 100 m
2
 is renewed every 3 days, whereas it takes 3 months to renew our 
skeletal muscle tissue. Nevertheless, taking into account its mass, skeletal muscle 
protein is responsible for up to 50% of whole-body protein turnover. 
In the absence of food intake, i.e. during fasting conditions, muscle protein break-
down exceeds muscle protein synthesis which creates a negative muscle protein 
balance and, as such, a continuous flow of amino acids into the body’s free amino 
acid pool (11). While the majority of amino acids that are released through muscle 
protein breakdown are reincorporated into newly synthesized protein, a small 
proportion is consumed for energy or lost otherwise and must therefore be re-
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placed. Amino acid losses can be replaced by consuming dietary protein (12). 
Following food intake, i.e. in the postprandial phase, digestion and absorption of 
dietary protein will result in an increased availability of plasma amino acids (13). A 
rapid increase in postprandial plasma amino acid concentrations strongly increases 
muscle protein synthesis rates, while moderately inhibiting muscle protein break-
down rates via a concomitant rise in plasma insulin concentrations (14). These 
changes will result in a shift from a negative muscle protein balance to a positive 
muscle protein balance and, as such, will replace the loss of muscle protein that 
occurred in the post-absorptive phase. Consequently, daily fluctuations in muscle 
protein balance in the normal fed and fasted state allow for muscle mass preserva-
tion.  
 
Figure 2. General model of whole-body protein turnover. The consumption of dietary protein is instru-
mental to replace amino acid losses and maintain protein balance. 
Anabolic resistance 
The decline in skeletal muscle mass with aging must be attributed to a disruption in 
the regulation of skeletal muscle protein turnover, leading to a structural imbal-
ance between muscle protein synthesis and breakdown rates. As basal (fasting) 
muscle protein synthesis and breakdown rates do not seem to differ substantially 
between young and older adults (15), many research groups have since refocused 
on the muscle protein synthetic response to food intake. It has well been estab-
lished that protein synthesis in skeletal muscle tissue is highly responsive to food 
intake (12). Recent work suggests that the muscle protein synthetic response to 
food intake is impaired in older persons (16-18). Such an impaired muscle protein 
synthetic response would not allow for the complete replacement of muscle pro-
teins lost during the fasted state. On a daily basis, this would result in a net loss of 
muscle protein. Daily net muscle protein losses could result into severe losses of 
muscle mass over the course of many years. Although, the reported impairments in 
muscle protein synthesis in older adults have only been observed under non-
physiological conditions, i.e. following ingestion (16) or infusion (17) of free amino 
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acids while plasma insulin levels were kept constant, the proposed anabolic re-
sistance to food intake is now being regarded as a possible key-factor in the etiolo-
gy of sarcopenia (18).  
The mechanisms that might be responsible for the proposed anabolic resistance to 
food intake in the elderly remain to be elucidated. Impaired digestion and absorp-
tion kinetics of dietary protein might attenuate or reduce the appearance rate of 
amino acids in the circulation, thereby lowering the postprandial muscle protein 
synthetic rate. Furthermore, amino acid uptake in the splanchnic area has been 
shown to be elevated in the elderly, which implies that less of the ingested amino 
acids would be available for muscle protein synthesis (19, 20). Postprandial 
hyperinsulinemia can increase skeletal muscle perfusion and, as such, allow for a 
greater amino acid delivery to the muscle (21). However, the role of insulin in the 
regulation of the postprandial muscle protein anabolic response is still controver-
sial. Some propose that insulin is rather permissive instead of modulatory, and that 
plasma insulin levels of ~10–15 µU·mL
-1
 are already sufficient to allow a maximal 
muscle protein synthetic response (22, 23). In contrast, others suggested that 
muscle protein synthesis is resistant to the anabolic action of physiological 
hyperinsulinemia in older adults (24, 25). On an extracellular level, the sensing of 
amino acids and/or insulin might be a limiting factor for senescent muscle tissue. 
The extracellular increase in essential amino acid (EAA) concentrations, with 
leucine in particular (26), seems to represent the main anabolic signal responsible 
for stimulating postprandial muscle protein synthesis rates (22, 27). In accordance, 
the attenuated muscle protein synthetic response to food intake in the elderly can 
be, at least partly, compensated for by increasing the leucine content of a meal (28, 
29). The intracellular mechanisms that regulate (muscle) protein synthesis are in 
part mediated through downstream signaling of the insulin/insulin-like growth 
factor I (IGF-I) receptor via the mammalian target of rapamycin (mTOR) pathway 
(30). Cuthbertson et al. (16) reported that signaling protein concentrations differed 
between old and young muscle and showed an attenuated rise in the activation of 
key-signaling proteins of the mTOR pathway after ingesting 10 g essential amino 
acids (EAAs) in the elderly versus the young. These findings seem to be in line with 
observations by Guillet et al. (17) and suggest that an anabolic signal might not be 
sensed and/or transduced as well in senescent muscle.  
The aforementioned mechanisms are all interrelated; yet, the focus of this thesis 
will be on the role of digestion and absorption kinetics of dietary protein and the 
subsequent muscle protein synthetic response. 
Protein digestion and absorption kinetics 
The postprandial availability of dietary protein-derived amino acids is largely de-
termined by the digestion and absorption kinetics of the specific proteins in a meal 
(13). Dietary proteins are often classified as either fast or slow digestible proteins 
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(31). Interestingly are the observations that ingestion of slow digestible protein 
leads to a more positive protein balance compared with the ingestion of fast d
gestible protein in healthy young subjects (32). However, in the elderly, the pos
prandial protein anabolic response turned out to be the opposite; ingestion of fast 
digestible protein was shown to result in greater net protein retention compared 
with slow digestible protein when provided in healthy elderly men (33). The latter 
might be attributed to the proposed anabolic resistance of the muscle protein 
synthetic machinery to become activated in elderly muscle. In accordance, it has 
been reported that protein pulse feeding (providing up to 80% of daily protein 
intake in one meal) leads to greater protein retention than ingesting the same 
amount of protein provided over four meals throughout the day (spread
elderly women (34). In agreement, pulse feeding did not lead to greater
retention than spread feeding when applied 
The findings on fast vs slow digestible protein and pulse
indicate that the threshold of plasma amino acid(s) concentration that needs to be 
reached to allow an adequate muscle protein synthetic
elevated in the elderly. This concept has been illustrated in 
young adults might benefit more from a
in plasma amino acid availability, older adults may require higher peak levels
plasma amino acid concentrations to allow for an optimal muscle protein synth
response to food intake. 
 
Figure 3. Suggested concept of an elevated anabolic threshold with increasing age.
sent the (elevated) anabolic threshold and the curves represent typical amino acid concentrations 
following ingestion of fast and slow digestible protein. Note how the anabolic response can be impaired 
with the slow/spread curve compared with the fast/pulse curve when the threshold has been increased.
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Besides choosing specific fast digestible protein sources and/or changing the com-
position of the macronutrients in the diet, also the structure of a (slow) protein can 
be modified to resemble a fast digestible protein. By enzymatic hydrolysation of 
slow digestible intact micellar casein, a casein hydrolysate can be obtained consist-
ing of >90% di- and tripeptides, while retaining its original amino acid composition. 
Koopman et al. (36) performed a study in which elderly men consumed a single 
bolus of intact casein and casein hydrolysate in a cross-over design. The results 
showed that the casein hydrolysate resembled a faster digestible protein, which 
resulted in a greater availability of dietary amino acids in the circulation during the 
6 h postprandial period and tended to further increase muscle protein synthesis 
rates when compared with the slower digestible intact casein (36).  
In summary, modulating protein digestion and absorption kinetics represents a 
powerful tool to promote postprandial muscle protein synthesis rates in older 
adults. While some proteins have the right chemical properties, others could be 
made more anabolic with some structural changes without affecting their unique 
amino acid composition. 
Stable isotope methodology: intrinsically labeled protein 
For many years, stable isotopes have been applied in human research because they 
are effective, safe, and non-toxic (37). Molecules labeled with a stable isotope can 
be used to ‘trace’ the metabolism of this molecule in vivo in the human body. The 
molecule of interest is then referred to as the ‘tracee’, whereas the labeled mole-
cule is referred to as the ‘tracer’ (38). In general, the turnover of a specific amino 
acid (tracee) is investigated through isotope dilution via continuous intravenous 
administration of a labeled amino acid (tracer). When studying protein metabolism, 
the use of labeled EAAs is warranted as by definition EAAs can only appear in the 
plasma via food intake or protein breakdown. However, when investigating the 
impact of feeding on protein metabolism, most groups generally apply a research 
design in which labeled leucine or phenylalanine is co-ingested, with or without 
continuous infusion of an intravenous amino acid tracer (39). The fact that the oral 
tracer is being administered as a free amino acid and the bulk of amino acids are 
provided as intact dietary protein introduces substantial methodological limita-
tions.  
Free amino acids and protein-derived amino acids exhibit an entirely different 
timing and efficiency of intestinal absorption (13, 33, 40). Therefore, dietary pro-
tein with a labeled amino acid incorporated within its protein matrix is warranted 
to directly assess the appearance rate of dietary protein-derived amino acids from 
the gut into the circulation. However, such intrinsically labeled dietary protein is 
not commercially available and only few reports describe the production of stable 
isotope-labeled proteins for more specific purposes (41-43). Previously, intrinsically 
labeled milk protein has been produced by intravenous infusion of L-[1-
13
C]leucine 
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in lactating dairy cows, collection of the milk, and purification of the milk protein 
fractions (Figure 4). This method allows for the producti
protein to be used on a larger scale in human nutrition research (44). Specifically, 
the impact of protein digestion and absorption kinetics on whole
metabolism was investigated, which led to the development of the 
tein concept (31). However, the enrichment level of the labeled proteins previously 
used was not high enough (≤10%) to measure the subsequent incorporation of 
labeled amino acids in skeletal muscle tissue following
amounts of dietary protein. Therefore, the impact of protein digestion and absor
tion kinetics on postprandial muscle protein synth
 
Figure 4. The production of intrinsically labeled milk protein (44).
 
Our lab extended on the work by Boirie 
[1-
13
C]phenylalanine in lactating dairy cows and pooling the milk
peak plateau enrichment levels (45). As a result,
ments in the collected milk protein as high as 29.4% were achieved. Such high 
enrichment levels are necessary when aiming to assess both protein digestion and 
absorption kinetics as well as subsequent skeletal muscle protein synthesis rates 
following the ingestion of a meal-like amount of protein. The experimental work 
presented in this thesis includes the use of these highly enriched, intrinsically 
labeled proteins to allow for the in vivo
synthesis in young and older adults. 
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-body protein 
fast-slow pro-
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Thesis outline 
This thesis describes a series of dietary interventions that were aimed to effectively 
increase the postprandial muscle protein synthetic response to food intake in older 
adults. In Chapter 2, we first compared dietary protein digestion and absorption 
kinetics and subsequent postprandial muscle protein synthesis rates following 
ingestion of a meal-like amount of protein between young and older adults. Be-
cause some level of physical activity generally precedes food intake in normal daily 
life, we assessed the postprandial muscle protein synthetic response both at rest 
and following physical activity. In Chapter 3, we determined to what extent dietary 
protein digestion and absorption kinetics as well as amino acid composition modu-
late postprandial muscle protein synthesis rates in elderly males. Therefore, we 
compared protein digestion and absorption kinetics and subsequent postprandial 
muscle protein accretion following the ingestion of whey, casein, and casein 
hydrolysate. In Chapter 4, we determined the impact of the amount of (whey) 
protein ingested on protein digestion and absorption kinetics, whole-body protein 
balance, and subsequent postprandial muscle protein accretion in elderly men. In 
Chapter 5, we describe the production of intrinsically labeled milk protein with an 
enrichment level that allows the assessment of both dietary protein digestion and 
absorption kinetics as well as subsequent de novo muscle protein accretion. Fur-
thermore, we tested the feasibility to produce intrinsically labeled meat protein 
that would allow the in vivo assessment of protein digestion and absorption kinet-
ics following beef consumption in humans. In Chapter 6, we determined the effect 
of meat texture on digestion and absorption kinetics and subsequent postprandial 
protein retention in older adults. Therefore, older men were randomly assigned to 
a cross-over experiment in which they consumed intrinsically L-[1-
13
C]phenylalanine-labeled beef, provided as a steak or as minced beef. Finally, 
Chapter 7 combines the results and conclusions from the previous chapters and 
places them in a broader perspective. In addition, we present future research aims 
that extend on the present knowledge and will allow for the development of more 
effective dietary interventions to attenuate the loss of muscle mass with aging. 
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Abstract 
The aim of this study was to compare in vivo dietary protein digestion and absorp-
tion kinetics and subsequent postprandial muscle protein synthesis rates at rest 
and following exercise between young and elderly men. Twenty-four young (21±1 
y) and 24 elderly (74±1 y) men consumed a 20 g bolus of intrinsically L-[1-
13
C]phenylalanine-labeled protein at rest (REST) or following exercise (EXC). Con-
tinuous infusions with L-[ring-
2
H5]phenylalanine were applied, with blood and 
muscle samples collected, to assess in vivo protein digestion and absorption kinet-
ics and subsequent postprandial muscle protein synthesis rates. Exogenous phenyl-
alanine appearance rates expressed over time did not differ between groups. No 
differences were observed in plasma phenylalanine availability between the young 
and elderly (51±2 vs 51±1%) or between REST and EXC (52±1 vs 49±1%). Muscle 
protein synthesis rates calculated from the oral tracer were 0.0620±0.0065 and 
0.0560±0.0039 %·h
-1
 at REST and 0.0719±0.0057 and 0.0727±0.0040 %·h
-1
 following 
EXC in young and elderly men, respectively (age effect, P=0.62; exercise effect, 
P<0.05; interaction of age and exercise, P=0.52).  
In conclusion, dietary protein digestion and absorption kinetics are not impaired 
following exercise or at older age. Exercising before protein intake allows for a 
greater use of dietary protein-derived amino acids for de novo muscle protein 
synthesis in both young and elderly men. 
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Introduction 
Aging is accompanied by a progressive decline in skeletal muscle mass, termed 
sarcopenia (1). This age-related loss of skeletal muscle mass is attributed to an 
imbalance between mixed muscle protein synthesis and breakdown rates. Whereas 
some have reported significant differences in basal muscle protein synthesis rates 
between the young and elderly (2, 3), others have failed to observe such differ-
ences (4, 5). Recently, various research groups have started to focus on potential 
impairments in the muscle protein synthetic response to the main anabolic stimuli, 
i.e. food intake and exercise. Skeletal muscle protein synthesis is highly responsive 
to both food intake (5-7) and exercise (8-11) in healthy, young adults. Recent data 
indicate that the muscle protein synthetic response to food intake (5, 12) and 
exercise (11) may be blunted in the elderly. This proposed anabolic resistance is 
now being regarded as a possible key-factor in the etiology of sarcopenia. As some 
level of physical activity generally precedes food intake in normal daily life, it seems 
evident that the concept of anabolic resistance should be studied in a postprandial 
state both at rest as well as in post-exercise conditions.  
There is much speculation on the mechanisms responsible for the proposed blunt-
ed muscle protein synthetic response to food intake in the elderly (13). One of the 
mechanisms that has been suggested includes an impairment in dietary protein 
digestion and absorption kinetics (14). Impaired protein digestion and absorption 
kinetics might reduce the appearance rate of dietary protein-derived amino acids in 
the circulation, thereby lowering postprandial muscle protein synthesis rates. 
Evidence to support the existence of in vivo differences in protein digestion and 
absorption kinetics and subsequent muscle protein synthesis between young and 
elderly humans has not been provided due to methodological limitations (15). To 
allow the in vivo assessment of dietary protein digestion and absorption kinetics 
and postprandial muscle protein synthesis we specifically produced intrinsically L-
[1-
13
C]phenylalanine labeled protein by collecting milk protein from lactating cows 
that were infused with large amounts of L-[1-
13
C]phenylalanine (16). Recently, we 
showed that dietary protein digestion and absorption kinetics following the inges-
tion of a large bolus of intrinsically labeled protein (35 g) were not substantially 
impaired in healthy, elderly men (17). In accordance, anabolic resistance has only 
been observed in studies applying smaller, meal-like amounts of amino acids (5, 7). 
In the present study, young and elderly subjects were studied following the inges-
tion of 20 g intrinsically L-[1-
13
C]phenylalanine-labeled casein protein at rest or 
following a single bout of exercise. An equivalent of 20 g protein (or 10 g EAA) has 
been shown to maximize the muscle protein anabolic response in the young (5, 18), 
whereas suboptimal muscle protein synthesis rates have been reported in the 
elderly (5). In addition, 20 g dietary protein represents a normal, meal-like amount 
of protein consumed by healthy elderly men in the Netherlands (19). Ingestion of 
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the bolus intrinsically labeled casein was combined with continuous intravenous L-
[ring-
2
H5]-phenylalanine infusion to allow simultaneous assessment of both exoge-
nous and endogenous phenylalanine appearance and disappearance rates and 
fractional mixed muscle protein synthetic rates (FSR) in vivo in humans. 
Methods 
Subjects 
Twenty-four elderly men (74±1 y) and 24 body-weight matched, young controls 
(21±1 y) participated in the present study. Within each age-group subjects were 
randomly assigned to either the rest (REST) or exercise (EXC) experiment. Subjects’ 
characteristics are presented in Table 1. None of the subjects had a history of 
participating in any regular exercise program. All subjects were informed on the 
nature and possible risks of the experimental procedures before their written 
informed consent was obtained. This study was approved by the Medical Ethics 
Committee of the Academic Hospital Maastricht. 
Pretesting 
Before selection in the study, all subjects participated in 2 pretesting sessions. 
These sessions were performed to exclude subjects with type 2 diabetes and/or 
increased risk of heart failure and to determine the subject’s maximal strength 
(one-repetition maximum, 1RM). In the first session, an oral glucose tolerance test 
(OGTT) was performed to assess glucose tolerance and screen for type 2 diabetes 
prevalence according to World Health Organization criteria (20). Body weight and 
height were assessed prior to the OGTT. Body composition was determined by a 
dual-energy X-ray absorptiometry scan (DXA, Discovery A, Hologic Corporate, 
Bedford, MA, USA) and leg volume was measured as described previously (19). 
After the OGTT, an electrocardiogram (both at rest and during exercise) was per-
formed to screen for heart failure. All eligible subjects were then familiarized with 
the physical activity protocol and the equipment. Proper lifting technique was 
demonstrated and practiced for each of the 2 lower-limb exercises (leg press and 
leg extension). In addition, 1RM was estimated using the multiple repetitions 
testing procedure (21). During the second screening session, the subjects’ true 1RM 
was determined. After warming-up, the load was set at 90-95% of the estimated 
1RM and increased after each successful lift. A 5-min resting period between sub-
sequent attempts was allowed. A repetition was valid if the subject was able to 
complete the entire lift in a controlled manner without assistance. There was at 
least a 7-day interval between the 2 sessions and the experiment. 
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Diet and activity before testing  
All subjects consumed a standardized meal (33±2 kJ·kg
-1
 body weight, consisting of 
55 energy% (E%) carbohydrate, 15 E% protein and 30 E% fat) the evening prior to 
the experiment. All volunteers were instructed to refrain from any sort of exhaus-
tive physical activity and to keep their diet as constant as possible for 3 days prior 
to the experiment.  
Protocol 
At 8.00 am, after an overnight fast, subjects arrived at the laboratory by car or 
public transportation. A Teflon catheter was inserted into an antecubital vein for 
stable isotope infusion. A second Teflon catheter was inserted in a heated dorsal 
hand vein of the contralateral arm and placed in a hot-box (60°C) for arterialized 
blood sampling (22). Following basal blood sample collection (t=-120 min), the 
plasma phenylalanine pool was primed with a single intravenous dose of the amino 
acid tracer L-[ring-
2
H5]phenylalanine (2 µmol·kg
-1
), after which continuous tracer 
infusion was started with an infusion rate of 0.044±0.001 µmol·kg-1·min-1. Thereaf-
ter, subjects rested in a supine position for 90 min, after which they either re-
mained in that position for another 30 min (REST) or performed a 30 min standard-
ized exercise protocol (EXC). 
 
Immediately thereafter, an arterialized blood sample was drawn and a muscle 
tissue sample was collected from the vastus lateralis muscle (t=0 min). Subjects 
then received a single bolus (250 mL) of test drink containing 20 g intrinsically L-[1-
13
C]phenylalanine-labeled casein protein. Arterialized blood samples were collected 
at t= 15, 30, 45, 60, 75, 90, 105, 120, 150, 180, 210, 240, 270, 300, 330 and 360 min 
with a second muscle biopsy collected at t=360 min from the vastus lateralis in the 
contralateral limb. Blood samples were collected in EDTA containing tubes and 
centrifuged at 1000 g for 5 min at 4°C. Aliquots of plasma were frozen in liquid 
nitrogen and stored at –80°C. Muscle biopsies were obtained from the middle 
region of the vastus lateralis, 15 cm above the patella and approximately 3 cm 
below entry through the fascia, using the percutaneous needle biopsy technique 
(23). Muscle samples were dissected carefully and freed from any visible non-
muscle material. The muscle samples were immediately frozen in liquid nitrogen 
and stored at –80°C until further analysis. 
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Table 1. Subjects’ characteristics. 
 Young 
REST 
(n=12) 
Young 
EXC 
(n=12) 
Elderly 
REST 
(n=12) 
Elderly 
EXC 
(n=12) 
P-value 
age 
P-value 
exercise 
P-value 
age x 
exercise 
Age (yrs) 21 ± 1 21 ± 1 75 ± 1 73 ± 1 <0.001 0.22 0.29 
Weight (kg) 76.2 ± 3.6 77.0 ± 2.1 74.4 ± 2.3 73.5 ± 2.1 0.32 0.98 0.75 
BMI (kg·m
-2
) 23.4 ± 1.0 22.8 ± 0.5 24.9 ± 0.8 23.6 ± 0.6 0.13 0.23 0.65 
Fat % 15.2 ± 0.9 15.9 ± 0.9 20.1 ± 1.0 17.3 ± 1.0 <0.05 0.29 0.07 
Lean body mass (kg) 64.5 ± 2.8 64.7 ± 1.6 59.4 ± 1.7 60.6 ± 1.4 <0.05 0.71 0.79 
Leg volume (L) 8.7 ± 0.5 9.1 ± 0.3 7.4 ± 0.3 7.5 ± 0.3 <0.001 0.51 0.70 
HbA1c (%) 5.4 ± 0.1 5.3 ± 0.1 6.1 ± 0.1 6.0 ± 0.1 <0.001 0.17 0.89 
Basal glucose (mmol·L
-1
) 5.1 ± 0.1 5.2 ± 0.1 5.9 ± 0.2 5.5 ± 0.1 <0.001 0.25 0.13 
Basal insulin (mU·L
-1
) 10.4 ± 0.7 9.7 ± 1.0 9.6 ± 1.0 10.8 ± 1.9 0.89 0.85 0.46 
HOMA-IR 2.4 ± 0.2 2.2 ± 0.2 2.5 ± 0.3 2.7 ± 0.5 0.35 0.97 0.64 
1RM leg press (kg) 254 ± 17 243 ± 8 168 ± 9 176 ± 8 <0.001 0.91 0.39 
1RM leg extension (kg) 122 ± 6 121 ± 5 74 ± 3 77 ± 2 <0.001 0.85 0.77 
Values are expressed as means±SEM. Data were analyzed with ANOVA (age x exercise).  
Exercise regimen 
The exercise protocol consisted of 30 min moderate intensity exercise, combining 
both low-intensity cycling and resistance-type exercise tasks. After 5 min of self-
paced cycling at 1.4±0.1 W·kg
-1
 body weight with a cadence of 70-90 rpm, subjects 
performed 6 sets of 10 repetitions on the horizontal leg press machine (Technogym 
BV, Rotterdam, Netherlands) and 6 sets of 10 repetitions on the leg extension 
machine (Technogym BV). The first 2 sets of both exercises were performed at 40% 
of the subjects’ 1RM. Sets 3-4, and 5-6 were performed at 55% and 75% of 1RM, 
respectively, with 2 min rest intervals between sets. The young and elderly men 
performed exercise at the same relative intensity. 
Preparation of intrinsically labeled protein and beverage composition 
Intrinsically L-[1-
13
C]phenylalanine-labeled casein protein was obtained by infusing 
a Holstein cow with large quantities of L-[1-
13
C]phenylalanine, collecting milk, and 
purifying the casein fraction as described previously (16). The L-[1-
13
C]phenylalanine enrichment in the casein fraction averaged 29.2 mole percent 
excess (MPE). The casein protein met all chemical and bacteriological specifications 
for human consumption. Subjects received a beverage volume of 250 mL providing 
a dose of 20 g micellar casein protein. Drinks were flavored by adding 5 mL vanilla 
flavor (Givaudan, Naarden, The Netherlands) per liter beverage. 
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Plasma analyses 
Plasma glucose (Uni Kit III, 07367204, Roche, Basel, Switzerland) concentrations 
were analyzed with the COBAS-FARA semi-automatic analyzer (Roche). Insulin was 
analyzed by radio-immunoassay (Insulin RIA kit, LINCO Research Inc., St. Charles, 
MO, USA). Plasma (100 µL) for amino acid analyses was deproteinized on ice with 
10 mg dry 5-sulphosalicylic acid, mixed and the clear supernatant was collected 
after centrifugation. Plasma amino acid concentrations were determined by HPLC, 
after precolumn derivatization with o-phthaldialdehyde (24). For plasma phenylal-
anine enrichment measurements, plasma phenylalanine was derivatized to its t-
butyldimethylsilyl (TBDMS) derivative and its 
13
C and 
2
H enrichments were deter-
mined by electron ionization gas chromatography-mass spectrometry (GC-MS, 
Agilent 6890N GC/5973N MSD Little Falls, DE, USA) using selected ion monitoring of 
masses 336, 337 and 341 for unlabeled and labeled (1-
13
C and ring-
2
H5) phenylala-
nine, respectively (25). We applied standard regression curves in all isotopic en-
richment analysis to assess linearity of the mass spectrometer and to control for 
the loss of tracer. Enrichments (MPE) were calculated according to Biolo et al. (26) 
to correct for the presence of both the 
13
C and 
2
H5 phenylalanine isotopes. 
Muscle analyses 
For measurement of L-[1-
13
C]phenylalanine and L-[ring-
2
H5]phenylalanine enrich-
ment in the free amino acid pool and mixed muscle protein, 55 mg of wet muscle 
was freeze-dried. Collagen, blood, and other non-muscle fiber material were re-
moved from the muscle fibers under a light microscope. The isolated muscle fiber 
mass (10-15 mg) was weighed and 8 volumes (8x dry weight of isolated muscle 
fibers x wet/dry ratio) of ice-cold 2% perchloric acid (PCA) were added. The tissue 
was then homogenized and centrifuged. The supernatant was collected and pro-
cessed in the same manner as the plasma samples, such that tissue-free L-[1-
13
C]phenylalanine and L-[ring-
2
H5]-phenylalanine enrichments could be measured 
using their TBDMS derivatives on a GC-MS.  
The protein pellet was washed with 3 additional 1.5 mL washes of 2% PCA, dried 
and hydrolyzed in 6M HCl at 120°C for 15-18 h. The hydrolyzed protein fraction was 
dried under a nitrogen stream while heated to 120°C, then 50% acetic acid solution 
was added, and the hydrolyzed protein was passed over a Dowex exchange resin 
(AG 50W-X8, 100-200 mesh hydrogen form, Biorad, Hercules, CA, USA) using 2M 
NH4OH. The eluate was divided over 2 vials for separate measurement of L-[1-
13
C]phenylalanine and L-[ring-
2
H5]phenylalanine enrichment in mixed muscle pro-
tein. The latter was determined by derivatizing L-[ring-
2
H5]phenylalanine to its 
MTBSTFA-phenylethylamine (27). Thereafter, the ratios labeled/unlabeled deriva-
tives were determined by GC-MS. The L-[1-
13
C]phenylalanine enrichment was 
determined by derivatization to its N(O,S)-ethoxycarbonyl ethyl ester. The deriva-
tive was measured by GC-C-IRMS (Finnigan MAT 252, Bremen, FRG), using HP Ultra 
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I GC-column (#19091A-112, Hewlett-Packard, Palo. Alto, CA), combustion interface 
II, and monitoring of ion masses 44 and 45. By establishing the relationship be-
tween the enrichment of a series of L-[1-
13
C]phenylalanine standards of variable 
enrichment and the enrichment of the N(O,S)-ethoxycarbonyl ethyl esters of these 
standards, the muscle protein-bound enrichment of phenylalanine was deter-
mined. Standard regression curves were applied to assess linearity of the mass 
spectrometer and to control for loss of tracer. The coefficient of variance (CV) for 
the measurement of L-[1-
13
C]phenylalanine and L-[ring-
2
H5]phenylalanine enrich-
ment in mixed muscle protein averaged 1.1±0.1% and 1.0±0.1%, respectively. 
Calculations 
Ingestion of L-[1-
13
C]phenylalanine labeled protein, intravenous infusion of L-[ring-
2
H5]phenylalanine, and arterialized blood sampling were used to assess whole-body 
amino acid kinetics in non-steady state conditions. Total, exogenous, and endoge-
nous rate of appearance (Ra) and plasma availability of dietary phenylalanine (i.e., 
fraction of dietary phenylalanine that appeared in the systemic circulation, 
Pheplasma) were calculated using modified Steele’s equations (15, 28). These param-
eters were calculated as follows. 
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where F is the intravenous tracer infusion rate, pV (0.125) is the distribution vol-
ume for phenylalanine (15), C(t) is the mean plasma phenylalanine concentration 
between 2 time points, dEiv/dt represents the time-dependent variations of plasma 
phenylalanine enrichment derived from the intravenous tracer, and Eiv(t) is the 
mean plasma phenylalanine enrichment from the intravenous tracer between 2 
consecutive time points. Exo Ra represents the plasma entry rate of dietary phenyl-
alanine, Epo(t) is the mean plasma phenylalanine enrichment for the oral tracer, 
dEpo/dt represents the time-dependent variations of plasma phenylalanine enrich-
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ment derived from the oral tracer, and Eprot is the L-[1-
13
C]phenylalanine enrich-
ment in the dietary protein. PheProt is the amount of dietary phenylalanine ingest-
ed, AUCExoRa represents the area under the curve (AUC) of Exo Ra, which corre-
sponds to the amount of dietary phenylalanine that appeared in the circulation 
over the 6 h period following drink intake. BW represents the subjects’ body weight 
in kg.  
Total rate of disappearance (Total Rd) of phenylalanine equals the rate of phenylal-
anine hydroxylation (first step in phenylalanine oxidation) and utilization for pro-
tein synthesis. This parameter is calculated as follows: 
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Fractional rate of mixed muscle protein synthesis (FSR) was calculated by dividing 
the increment in enrichment in the product, i.e. mixed muscle protein-bound L-[1-
13
C]phenylalanine or L-[ring-
2
H5]phenylalanine, by the enrichment of the precursor. 
Plasma L-[1-
13
C]phenylalanine and plasma L-[ring-
2
H5]phenylalanine enrichments 
were used as precursor pools to provide an estimate for the true fractional synthe-
sis rate of mixed muscle proteins. Plasma L-[ring-
2
H5]phenylalanine enrichments 
were significantly correlated with muscle tissue-free enrichments (r=0.54, P<0.001) 
and were, as such, corrected to reflect the true precursor pool. Muscle FSR’s were 
calculated as follows (29): 
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where ∆Ep is the delta increment of protein bound L-[1-
13
C]phenylalanine or L-
[ring-
2
H5]phenylalanine, during incorporation periods. Eprecursor is the average plas-
ma L-[1-
13
C]phenylalanine or plasma L-[ring-
2
H5]phenylalanine enrichment during 
the time period for determination of amino acid incorporation. t indicates the time 
interval (h) between biopsies. 
Statistics 
All data are expressed as means±SEM. A two-factor repeated measures mixed 
model ANOVA with age and exercise as factors was used to compare differences 
between treatments (REST and EXC) and age-groups (young and elderly) over time. 
For non-time dependent variables, a two-factor ANOVA with age and exercise as 
factors was used to compare differences between treatments and age-groups. In 
case of a significant interaction between age and exercise, a Bonferroni post-hoc 
test was applied to locate these differences. Statistical significance was set at 
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P<0.05. All calculations were performed using SAS (version 6.11; SAS Institute Inc, 
Cary, NC, USA). 
Results 
Plasma analyses 
Plasma insulin concentrations rapidly increased following protein ingestion in all 
groups (Figure 1). Plasma insulin concentrations averaged 9.8±0.5, 9.5±0.7, 
12.6±1.7, and 8.7±1.0 mU·L
-1
 in the young at rest, young after exercise, elderly at 
rest, and elderly after exercise, respectively. Plasma insulin concentrations were 
higher in the elderly at rest compared with the other groups (P<0.05). Plasma 
glucose concentrations did not change following protein ingestion and averaged 
5.2±0.1, 5.0±0.1, 5.4±0.1, and 5.3±0.1 mmol·L
-1
, respectively. 
 
 
Figure 1. Plasma insulin concentrations (mU·L
-1
) following protein ingestion in young (n=24) and elderly 
(n=24) men at rest (REST) and following exercise (EXC). Values represent means±SEM. Data were 
analyzed with mixed model repeated measures ANOVA. In case of a significant interaction between age 
and exercise, a Bonferroni post-hoc test was applied to locate these differences. Time effect, P<0.01; 
age x exercise effect, P<0.05. Plasma insulin levels in the elderly at rest were significantly greater when 
compared with the other groups: P<0.05. 
 
Plasma phenylalanine (A), tyrosine (B), isoleucine (C), leucine (D), and valine (E) 
concentrations over time are illustrated in Figure 2. In general, plasma amino acid 
concentrations increased over time and remained elevated throughout the 6 h 
postprandial phase. Plasma phenylalanine concentrations were significantly higher 
in the elderly compared with the young, irrespective of treatment (P<0.05). Plasma 
leucine concentrations were significantly higher in the elderly at rest compared 
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with the other groups (P<0.05). Additionally, plasma leucine concentrations were 
significantly lower in the young after exercise compared with the young at rest and 
the elderly after exercise (P<0.05). 
 
 
Figure 2. Postprandial plasma phenylalanine (A), tyrosine (B), isoleucine (C), leucine (D), and valine (E) 
concentrations (μmol·L
-1
) following protein ingestion in young (n=24) and elderly (n=24) men at rest 
(REST) and following exercise (EXC). Values represent means±SEM. Data were analyzed with mixed 
model repeated measures ANOVA. In case of a significant interaction between age and exercise, a 
Bonferroni post-hoc test was applied to locate these differences. Phenylalanine: time effect, P<0.01; age 
x exercise effect, P<0.01; Elderly EXC vs Young EXC, P<0.01; Elderly EXC vs Young REST, P<0.05; Elderly 
REST vs Young EXC, P<0.01; Elderly REST vs Young REST, P<0.01. Tyrosine: time effect, P<0.01; age x 
exercise effect, P<0.01; Elderly EXC vs Young EXC, P<0.01; Elderly REST vs Young EXC, P<0.01; Elderly 
REST vs Young REST, P<0.05; Young EXC vs Young REST, P<0.01. Isoleucine: time effect, P<0.01; age x 
exercise effect, P<0.01; Elderly EXC vs Young EXC, P<0.01; Elderly REST vs Young EXC, P<0.01; Elderly 
REST vs Young REST, P<0.01. Leucine: time effect, P<0.01; age x exercise effect, P<0.01; Elderly EXC vs 
Elderly REST, P<0.05; Elderly EXC vs Young EXC, P<0.01; Elderly REST vs Young EXC, P<0.01; Elderly REST 
vs Young REST, P<0.01; Young EXC vs Young REST, P<0.05. Valine: time effect, P<0.01; age x exercise 
effect, P<0.01; Elderly EXC vs Elderly REST, P<0.01; Elderly EXC vs Young EXC, P<0.05; Elderly REST vs 
Young EXC, P<0.01; Elderly REST vs Young REST, P<0.01. 
 
The time course of plasma L-[1-
13
C]phenylalanine (ingested tracer) and L-[ring-
2
H5]phenylalanine (infused tracer) enrichments are shown in Figure 3. Plasma L-[1-
13
C]phenylalanine enrichments increased immediately following protein ingestion 
in all subjects, with no significant differences between groups. Plasma L-[ring-
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2
H5]phenylalanine enrichments were significantly higher in the elderly compared 
with the young, irrespective of treatment (P<0.01). This was expected as isotope 
tracers were administered based on body weight and not lean body mass, the 
latter of which differs significantly between the young and elderly subjects (Table 1: 
P<0.05). 
 
 
Figure 3. Plasma and tissue-free L-[1-
13
C]phenylalanine (A) and L-[ring-
2
H5]phenylalanine (B) enrich-
ments (MPE) following protein ingestion in young (n=24) and elderly (n=24) men at rest (REST) and 
following exercise (EXC). Values represent means±SEM. Data were analyzed with mixed model repeated 
measures ANOVA. In case of a significant interaction between age and exercise, a Bonferroni post-hoc 
test was applied to locate these differences. Plasma L-[1-
13
C]phenylalanine enrichment: time effect, 
P<0.01; age x exercise effect, P=0.24. Tissue-free L-[1-
13
C]phenylalanine enrichment: time effect, 
P<0.001; age effect, P=0.64; exercise effect, P<0.05; age x exercise effect, P=0.24. Plasma L-[ring-
2
H5]phenylalanine enrichment: time effect, P<0.01; age x exercise effect, P<0.01; Elderly EXC vs Young 
EXC, P<0.01; Elderly EXC vs Young REST, P<0.01; Elderly REST vs Young EXC, P<0.01; Elderly REST vs 
Young REST, P<0.01. Tissue-free L-[ring-
2
H5]phenylalanine: time effect, P=0.80; age effect, P<0.05; 
exercise effect, P<0.01; age x exercise effect, P=0.47. 
Whole-body plasma tracer kinetics 
Whole-body plasma tracer kinetics, expressed per kg lean body mass (LBM), are 
presented in Figure 4. Total phenylalanine rates of appearance decreased (Figure 
4A) and total phenylalanine rates of disappearance increased (Figure 4B) during the 
6 h postprandial period in the young and elderly, both at rest and following exer-
cise. Total phenylalanine rates of appearance and disappearance were lower in the 
elderly when compared with the young, irrespective of treatment (P<0.05). The 
plasma rates of appearance of exogenous phenylalanine rapidly increased following 
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protein ingestion and slowly returned to baseline values during the 6 h postprandi-
al period (Figure 4C). This response over time was similar for all groups.  
 
 
Figure 4. Whole-body plasma phenylalanine (PHE) kinetics expressed per kg lean body mass. (A) Total 
PHE rate of appearance (Ra), (B) total PHE rate of disappearance (Rd), (C) exogenous PHE Ra, and (D) 
endogenous PHE Ra in μmol·kg lean body mass
-1
·min
-1
 following protein ingestion in young (n=24) and 
elderly (n=24) men at rest (REST) and following exercise (EXC). Values represent means±SEM. Data were 
analyzed with mixed model repeated measures ANOVA. In case of a significant interaction between age 
and exercise, a Bonferroni post-hoc test was applied to locate these differences. Total PHE Ra: time 
effect, P<0.01; age x exercise effect, P<0.05; Elderly EXC vs Young EXC, P<0.05; Elderly EXC vs Young 
REST, P<0.05; Elderly REST vs Young EXC, P<0.05; Elderly REST vs Young REST, P<0.05. Total PHE Rd: time 
effect, P<0.01; age x exercise effect, P<0.05; Elderly EXC vs Young EXC, P<0.05; Elderly EXC vs Young 
REST, P<0.05; Elderly REST vs Young EXC, P<0.05; Elderly REST vs Young REST, P<0.05. Exogenous Ra: 
time effect, P<0.01; age x exercise effect, P=0.87. Endogenous Ra: time effect, P<0.01; age x exercise 
effect, P<0.05; Elderly EXC vs Young EXC, P<0.05; Elderly EXC vs Young REST, P<0.05; Elderly REST vs 
Young EXC, P<0.05; Elderly REST vs Young REST, P<0.05. 
 
The calculated percentage of ingested phenylalanine that appeared in the circula-
tion during the 6 h postprandial period, was 52±2 and 50±2% in the young and 
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52±2 and 49±2% in the elderly group, at rest and following exercise, respectively. 
No differences were observed between groups (P=0.87). Total endogenous rates of 
phenylalanine appearance declined following protein ingestion and remained 
below baseline values during the 6 h postprandial period (Figure 4D). The average 
endogenous phenylalanine appearance rates were lower in the elderly compared 
with the young, irrespective of treatment (P<0.05). 
Muscle tracer analysis 
Tissue-free enrichments (MPE), determined in the muscle samples collected at 0 
and 6 h following dietary protein ingestion, are presented in Table 2 and included 
in Figure 3. Tissue-free enrichments were higher following EXC compared with REST 
for both L-[1-
13
C]phenylalanine (P<0.05) and L-[ring-
2
H5]phenylalanine (P<0.01). 
Tissue-free L-[ring-
2
H5]phenylalanine enrichments showed a significant age effect 
(P<0.05). No significant differences in L-[ring-
2
H5]phenylalanine enrichments over 
time were observed (P=0.80). 
 
Table 2. Muscle tissue-free enrichments. 
 
Young 
REST 
(n=12) 
Young 
EXC 
(n=12) 
Elderly 
REST 
(n=12) 
Elderly 
EXC 
(n=12) 
0 h L-[1-
13
C]phenylalanine (MPE) 0.06 ± 0.05 0.05 ± 0.02 0.01 ± 0.05 0.07 ± 0.03 
6 h L-[1-
13
C]phenylalanine (MPE) 1.22 ± 0.20 1.91 ± 0.19 1.28 ± 0.15 1.67 ± 0.25 
0 h L-[ring-
2
H5]phenylalanine (MPE) 4.02 ± 0.18 5.49 ± 0.22 5.28 ± 0.61 6.39 ± 0.29 
6 h L-[ring-
2
H5]phenylalanine (MPE) 4.46 ± 0.34 5.54 ± 0.23 5.46 ± 0.33 5.87 ± 0.23 
Values are expressed as means±SEM. Data were analyzed with repeated measures mixed model ANOVA 
(age x exercise). L-[1-
13
C]phenylalanine: time effect, P<0.001; age effect, P=0.64; exercise effect, P<0.05; 
interaction age x exercise, P=0.24. L-[ring-
2
H5]phenylalanine: time effect, P=0.80; age effect, P<0.05; 
exercise effect, P<0.01; interaction age x exercise, P=0.47. 
 
Protein-bound labeled phenylalanine enrichments during the 6 h post-prandial 
period are presented as pooled data for either young and elderly or REST and EXC. 
The protein-bound enrichments were higher following EXC compared with REST for 
both L-[1-
13
C]phenylalanine (0.022±0.005 vs 0.019±0.005 MPE; P<0.05) and L-[ring-
2
H5]phenylalanine (0.024±0.004 vs 0.020±0.005 MPE; P<0.01). No significant differ-
ences were observed between age-groups. 
Mixed muscle protein synthesis rates 
Mixed muscle protein synthesis rates, expressed as fractional synthetic rates (FSR), 
are presented in Figure 5. Statistical testing was performed using ANOVA (age x 
exercise). As such, mean values (±SEM) presented below represent pooled data for 
either the young and elderly or REST and EXC. 
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Figure 5. Mixed muscle protein fractional synthetic rates (FSR) following protein ingestion in young 
(n=24) and elderly (n=24) men at rest (REST) and following exercise (EXC) based on (A) L-[1-
13
C]phenylalanine (ingested tracer) enrichment and (B) L-[ring-
2
H5]phenylalanine (infused tracer) 
enrichment. Values represent means±SEM. Data were analyzed with ANOVA (age x exercise). L-[1-
13
C]phenylalanine enrichment: age effect, P=0.62; exercise effect, P<0.05; age x exercise effect, P=0.52. 
L-[ring-
2
H5]phenylalanine enrichment: age effect, P=0.32; exercise effect, P<0.001; age x exercise effect, 
P=0.70. 
 
Mixed muscle protein FSR based on L-[1-
13
C]phenylalanine, with the mean plasma 
L-[1-
13
C]phenylalanine enrichment as precursor, were significantly higher with EXC 
compared with REST (0.0723±0.0034 vs 0.0590±0.0037 %·h
-1
, respectively; P<0.05) 
in both the young (+16%) and elderly (+30%). In agreement, using the L-[ring-
2
H5]phenylalanine tracer, FSR values also showed significantly higher values follow-
ing EXC compared with REST (0.0750±0.0020 vs 0.0602±0.0025 %·h
-1
, respectively; 
P<0.001) in both the young (+22%) and elderly (+28%). No significant differences 
were observed between age-groups. 
Discussion 
In the present study, dietary protein digestion and absorption kinetics and subse-
quent postprandial muscle protein synthesis rates were compared at rest and 
following exercise between healthy, young and elderly males. The appearance of 
phenylalanine from the ingested protein into the circulation (~50%) did not differ 
between rest and exercise or between the young and elderly. Postprandial muscle 
protein synthesis rates calculated from both the ingested and infused tracer were 
higher following exercise when compared with resting conditions and were inde-
pendent of age.  
It has recently been reported that the acute muscle protein synthetic response to 
the main anabolic stimuli, i.e. food intake (5, 7, 12) and exercise (11), is blunted in 
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the elderly. This blunted anabolic response has been suggested to represent a key-
factor in the etiology of sarcopenia. Following protein ingestion, a rapid increase in 
plasma amino acid concentrations was observed in both age-groups, with higher 
concentrations in the elderly compared with the young (Figure 2). These differ-
ences are, at least partly, attributed to the fact that dietary protein was adminis-
tered based on body weight and not lean body mass, which was significantly lower 
in the elderly (Table 1). However, even when corrected for differences in lean body 
mass, whole-body phenylalanine turnover rates remained lower in the elderly 
when compared with the young (Figure 4AB). These observations are consistent 
with previous work applying phenylalanine as tracer (17, 30-32). 
To allow true insight into in vivo dietary protein digestion and absorption kinetics, 
we combined the use of specifically produced intrinsically L-[1-
13
C]phenylalanine-
labeled protein with continuous intravenous infusion of L-[ring-
2
H5]phenylalanine. 
We observed that approximately half of the dietary protein-derived amino acids 
became available in the circulation over the 6 h postprandial period in all groups. 
This is in line with previous work in humans (26) and pigs (33), showing that the 
splanchnic area extracts about 50% of the ingested amino acids to sustain its func-
tional mass. Consequently, our data show that dietary protein digestion and ab-
sorption kinetics are not impaired at a more advanced age and remain unchanged 
when exercise is performed prior to protein ingestion. 
Following dietary protein ingestion, changes in protein metabolism became directly 
apparent on a whole-body level. Exogenous phenylalanine appearance rates in-
creased immediately (Figure 4C), whereas endogenous phenylalanine appearance 
rates (i.e. whole-body protein breakdown) were rapidly reduced (Figure 4D). These 
findings are consistent with previous work (17, 28, 34) and are indicative of a more 
anabolic situation. Endogenous phenylalanine appearance rates were lower in the 
elderly when compared with the young (Figure 4D). However, this does not indi-
cate that postprandial inhibition of whole-body protein breakdown was attenuated 
in the elderly, as basal whole-body protein turnover rates are generally ~20% lower 
in the elderly when compared with the young (30, 31). As changes in protein me-
tabolism on a whole-body level do not necessarily represent changes on a muscle 
level (35), we determined the incorporation of L-[1-
13
C]phenylalanine into mixed 
muscle protein. The fact that tracer incorporation did not differ between the young 
and the elderly demonstrated that a similar amount of dietary protein-derived 
amino acids was incorporated in newly synthesized skeletal muscle protein in both 
age-groups over the 6 h postprandial period. Though no differences were observed 
between the young and the elderly, substantial differences in the incorporation of 
L-[1-
13
C]phenylalanine in newly synthesized skeletal muscle protein were observed 
between resting and post-exercise conditions (P<0.05). We extend on previous 
findings (6, 29, 36, 37) with the observation that significantly more of the ingested 
protein-derived amino acids were incorporated in newly synthesized skeletal mus-
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cle protein over the 6 h postprandial period when exercise was performed before 
food intake. Postprandial muscle protein fractional synthetic rates (FSR) based on 
the oral L-[1-
13
C]phenylalanine tracer were higher following exercise when com-
pared with rest (Figure 5A; P<0.05). Similar findings were obtained when FSR were 
calculated based on the intravenous L-[ring-
2
H5]-phenylalanine tracer (Figure 5B; 
P<0.001). The reported FSR values may seem relatively small (Figure 5), but are 
attributed to the fact that we applied a relatively long incorporation period, re-
quired to accurately assess in vivo casein digestion and absorption kinetics, and 
used plasma phenylalanine enrichments as precursor to calculate muscle protein 
synthesis rates (38). Though we observed a significant correlation between plasma 
and muscle tissue-free precursor enrichments at 6 h after dietary protein ingestion, 
there are no data available on the relationship between plasma and muscle precur-
sor enrichments throughout the entire postprandial period. Therefore, we can only 
speculate on potential differences in tracer equilibration in plasma and muscle 
tissue between the young and elderly. As such, we cannot exclude the presence of 
diversities in tracer equilibration in plasma and muscle tissue between age-groups. 
Nonetheless, it should be noted that all subjects ingested the same amount of 
intrinsically labeled protein and that more of the ingested tracer had been incorpo-
rated in mixed muscle protein following 6 h of post-exercise recovery when com-
pared with resting conditions, with no significant differences between age-groups. 
Our findings seem to be in contrast with studies suggesting that the muscle protein 
synthetic response to amino acid administration (5, 12) and exercise (11) may be 
blunted in the elderly. Those authors measured postprandial muscle protein syn-
thesis with insulin levels clamped (5, 12) or assessed post-exercise muscle protein 
synthesis in the absence of amino acid administration (11). In contrast, we assessed 
the muscle protein synthetic response under normal living conditions, i.e. following 
ingestion of a single meal-like amount of protein. Ingestion of the protein bolus 
resulted in a rapid increase in plasma amino acid availability (Figures 2 and 4), 
accompanied by a rapid, but short-lived, postprandial peak in circulating insulin 
(Figure 1). The latter is relevant to facilitate nutritive blood flow which supports 
protein synthesis by increasing amino acid availability to the muscle (39).  
Though similar postprandial FSR values were reported, the elderly showed greater 
plasma insulin responses (Figure 1) and higher circulating plasma amino acid con-
centrations (Figure 2) compared with the younger controls. The greater plasma 
insulin response and more rapid rise in postprandial plasma amino acid concentra-
tions in the elderly may represent a compensatory mechanism to maintain a proper 
postprandial muscle protein synthetic response and, as such, could be regarded as 
an early stage of anabolic resistance. However, the higher plasma amino acid 
concentrations can be, at least partly, attributed to the fact that all subjects were 
provided with the same amount of dietary protein. As subjects were matched for 
body weight, the lower lean body mass in the elderly might be accompanied by 
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lower whole-body insulin sensitivity and/or a reduced distribution volume for 
phenylalanine. Correcting the distribution volume for the lower lean body mass 
(~8%) did not result in significant changes in whole-body phenylalanine kinetics 
(data not shown). This is in line with previous observations by Boirie et al. (15). 
Effective dietary strategies are needed to prevent and/or attenuate the age-related 
loss of muscle mass. The present study provides novel data to show that 1) dietary 
protein digestion and absorption kinetics are not impaired following exercise or at 
older age; and 2) exercising before protein intake allows for a greater use of dietary 
protein-derived amino acids for de novo muscle protein synthesis in both young 
and elderly men. Clearly, exercise and/or physical activity should be considered an 
important tool to improve postprandial muscle protein accretion and, as such, to 
treat sarcopenia and support healthy aging. 
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Abstract 
Differences in digestion and absorption kinetics of dietary protein and/or its amino 
acid composition have been suggested to modulate postprandial muscle protein 
accretion. In the present study, we compared protein digestion and absorption 
kinetics and subsequent postprandial muscle protein accretion following ingestion 
of whey, casein, and casein hydrolysate in healthy, older adults. A total of 48 older 
men (74±1 y) were randomly assigned to ingest a meal-like amount (20 g) of intrin-
sically L-[1-
13
C]phenylalanine-labeled whey (WHEY), casein (CAS), or casein 
hydrolysate (CASH). Protein ingestion was combined with continuous intravenous 
L-[ring-
2
H5]phenylalanine infusion to assess in vivo digestion and absorption kinet-
ics of dietary protein. Postprandial mixed muscle protein fractional synthetic rates 
(FSR) were calculated from the ingested tracer. The peak appearance rate of die-
tary protein-derived phenylalanine in the circulation was greater with WHEY and 
CASH when compared with CAS (P<0.05). FSR values were higher following WHEY 
(0.15±0.02 %·h
-1
) compared with CAS (0.08±0.01 %·h
-1
; P<0.01) and CASH 
(0.10±0.01 %·h
-1
; P<0.05) ingestion. Peak plasma leucine concentrations and post-
prandial FSR values showed a strong positive correlation (r=0.66; P<0.01). 
In conclusion, whey protein stimulates postprandial muscle protein accretion more 
effectively than do casein and casein hydrolysate in older men. This effect can be 
attributed to a combination of whey’s faster digestion and absorption kinetics and 
higher leucine content. 
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Introduction 
Aging is accompanied by a progressive decline in skeletal muscle mass, termed 
sarcopenia (1). Recently, data have been obtained to suggest that the skeletal 
muscle protein synthetic response to food intake is impaired in older adults (2-5). 
This proposed anabolic resistance is now regarded a key-factor in the etiology of 
sarcopenia.  
Ingestion of a meal-like amount of protein in the form of free amino acids (6, 7), 
milk protein (8) or beef (9) strongly stimulates skeletal muscle protein synthesis 
rates. This postprandial muscle protein synthetic response depends on the quantity 
but, to some extent, also on the type of protein that is ingested (10). Previous work 
suggests that whey protein ingestion results in greater postprandial protein reten-
tion when compared with the ingestion of casein (11, 12). The greater anabolic 
properties of whey versus casein have been mainly attributed to the faster diges-
tion and absorption kinetics of whey, resulting in a greater increase in postprandial 
plasma amino acid availability, thereby further stimulating muscle protein synthesis 
(13-16). These findings have led to the development of the “fast” versus “slow” 
protein concept (13, 14, 17). 
Besides differences in protein digestion and absorption kinetics, whey and casein 
also markedly differ in their amino acid composition (13, 14, 16). Whereas both 
proteins contain all the amino acids required to effectively stimulate muscle pro-
tein synthesis (6), whey has a considerably higher leucine content (13, 14, 16). The 
latter may also contribute to the proposed greater anabolic properties of whey 
compared with casein, as leucine has been identified as the main nutritional signal 
responsible for stimulating postprandial muscle protein accretion (18-21). Conse-
quently, it remains to be elucidated whether the proposed greater anabolic proper-
ties of whey versus casein protein are attributed to faster digestion and absorption 
kinetics or simply due to differences in amino acid composition. 
Recently, we observed that when intact casein is hydrolyzed, in vivo protein diges-
tion and absorption kinetics can be modulated to resemble a fast protein while 
retaining its amino acid composition (17). This provides us with an important tool 
to define the characteristics responsible for the proposed anabolic properties of 
whey versus casein. Consequently, our objective was to compare protein digestion 
and absorption kinetics and subsequent postprandial muscle protein accretion 
following the ingestion of whey, intact casein, and hydrolyzed casein in older 
adults. As the metabolic fate of amino acids ingested as protein cannot be correctly 
assessed by oral or intravenous administration of labeled free amino acids (11, 22), 
we applied specifically produced intrinsically L-[1-
13
C]phenylalanine-labeled milk 
proteins. Labeled milk proteins were obtained by infusing cows with large quanti-
ties of L-[1-
13
C]phenylalanine, collecting milk, purifying the casein and whey frac-
tions, and hydrolyzing part of the casein (23). 
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This study provides insight in the characteristics that define the anabolic properties 
of different types of dietary protein under normal, physiological conditions in older 
adults by comparing dietary protein digestion and absorption kinetics and subse-
quent postprandial muscle protein accretion following the ingestion of 20 g whey, 
casein, and casein hydrolysate in vivo in 48 healthy, older men. 
Methods 
Subjects 
Forty-eight healthy older men (74±1 y) participated in this study. Subjects were 
randomly assigned to ingest a single bolus of whey (WHEY), casein (CAS), or casein 
hydrolysate (CASH). Subjects’ characteristics are presented in Table 1. None of the 
subjects participated in any regular exercise program or had a history of type 2 
diabetes, though average HbA1c levels of 6.1-6.2 % placed them in the pre-
diabetes category (24). All subjects were informed on the nature and possible risk 
of the experimental procedures before their written informed consent was ob-
tained. This study was approved by the Medical Ethics Committee of the Academic 
Hospital Maastricht. 
Pretesting 
Before selection in the study an oral glucose tolerance test (OGTT) was performed 
to assess glucose tolerance and screen for type 2 diabetes prevalence according to 
World Health Organization criteria (25). Prior to the OGTT, body weight and height 
were assessed and body composition was determined by dual-energy X-ray absorp-
tiometry (DXA, Discovery A, Hologic Corporate, Bedford, MA, USA). 
 
Table 1. Subjects’ characteristics 
 WHEY 
(n=16) 
CAS 
(n=16) 
CASH 
(n=16) 
Age (yrs) 73 ± 1 74 ± 1 74 ± 1 
Weight (kg) 75.9 ± 1.5 74.9 ± 2.8 76.4 ± 1.5 
BMI (kg·m
-2
) 25.4 ± 0.4 25.4 ± 0.6 25.0 ± 0.7 
Fat % 21.9 ± 0.9 20.6 ± 0.9 20.6 ± 0.7 
Lean body mass (kg) 59.2 ± 1.2 59.3 ± 1.9 60.7 ± 1.3 
HbA1c (%) 6.2 ± 0.1 6.1 ± 0.1 6.1 ± 0.1 
OGTT0 glucose (mmol·L
-1
) 5.7 ± 0.1 5.7 ± 0.1 5.8 ± 0.2 
OGTT120 glucose (mmol·L
-1
) 6.1 ± 0.3 6.2 ± 0.4 6.4 ± 0.4 
Values are expressed as means±SEM. Oral glucose tolerance test (OGTT). Plasma glucose concentrations 
during basal, fasting conditions (OGTT0) and 120 min after ingestion of a 75-g glucose load (OGTT120). 
Data were analyzed with ANOVA. No differences were observed between groups. 
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Diet and activity prior to testing  
All subjects consumed a standardized meal (32±2 kJ·kg
-1
 body weight, consisting of 
55 energy% (E%) carbohydrate, 15 E% protein and 30 E% fat) the evening prior to 
the experiment. All volunteers were instructed to refrain from any sort of exhaus-
tive physical activity and to keep their diet as constant as possible 3 d prior to the 
experiments.  
Experiments 
Each subject participated in a single 8 h experiment, in which a 20 g bolus of intrin-
sically L-[1-
13
C]phenylalanine-labeled protein was ingested. Subjects ingested either 
WHEY, CAS, or CASH protein. Following the ingestion of the dietary protein, plasma 
and muscle samples were collected during a 6 h postprandial period. Ingestion of 
labeled protein was combined with continuous intravenous L-[ring-
2
H5]phenylalanine infusion to simultaneously assess exogenous and endogenous 
phenylalanine rates of appearance, dietary phenylalanine availability, and mixed 
muscle protein fractional synthetic rates (FSR) in vivo in humans. 
Protocol 
At 8.00 am, following an overnight fast, subjects arrived at the laboratory by car or 
public transportation. A Teflon catheter was inserted into an antecubital vein for 
stable isotope infusion. A second Teflon catheter was inserted in a heated dorsal 
hand vein of the contralateral arm and placed in a hot-box (60°C) for arterialized 
blood sampling (26). Following basal blood collection (t=-120 min), the plasma 
phenylalanine pool was primed with a single intravenous dose L-[ring-
2
H5]phenylalanine (2 µmol·kg
-1
), after which continuous L-[ring-
2
H5]phenylalanine 
infusion was started (0.050±0.001 µmol·kg-1·min-1). After resting in a supine posi-
tion for 120 min, a second arterialized blood sample was drawn and a muscle 
biopsy was collected from the vastus lateralis muscle (t=0 min). Subjects then 
received a single bolus (250 mL) of test drink containing 20 g intrinsically L-[1-
13
C]-
phenylalanine-labeled WHEY, CAS, or CASH. Arterialized blood samples were col-
lected at t= 15, 30, 45, 60, 75, 90, 105, 120, 150, 180, 210, 240, 270, 300, 330 and 
360 min, with a second muscle biopsy taken from the same incision at t=180 min 
and a third muscle biopsy taken from the vastus lateralis of the contralateral limb 
at t=360 min. The biopsies from the same incision were taken in a distal and proxi-
mal direction, respectively. Blood samples were collected in EDTA containing tubes 
and centrifuged at 1000 g for 5 min at 4°C. Aliquots of plasma were frozen in liquid 
nitrogen and stored at –80°C. Muscle biopsies were obtained from the middle 
region of the vastus lateralis, 15 cm above the patella and approximately 3 cm 
below entry through the fascia, using the percutaneous needle biopsy technique 
(27). Muscle samples were dissected carefully and freed from any visible non-
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muscle material. The muscle samples were immediately frozen in liquid nitrogen 
and stored at –80°C until further analysis.  
 
Table 2. Amino acid composition of the proteins 
 WHEY CAS CASH 
Alanine, g 1.0 0.6 0.6 
Arginine, g 0.5 0.7 0.7 
Aspartic acid, g 2.3 1.3 1.3 
Cysteine, g 0.7 0.1 0.1 
Glutamic acid, g 3.2 4.1 4.1 
Glycine, g 0.4 0.3 0.3 
Histidine, g 0.4 0.5 0.5 
Isoleucine, g 1.2 1.1 1.1 
Leucine, g 2.5 1.7 1.7 
Lysine, g 2.1 1.4 1.4 
Methionine, g 0.4 0.5 0.5 
Phenylalanine, g 0.7 0.9 0.9 
Proline, g 0.7 2.1 2.1 
Serine, g 0.7 1.3 1.3 
Threonine, g 0.9 0.8 0.8 
Tryptophan, g 0.5 0.2 0.2 
Tyrosine, g 0.8 1.1 1.1 
Valine, g 1.0 1.3 1.3 
Total AA, g 20.0 20.0 20.0 
Total NEAA, g 10.7 12.1 12.1 
Total EAA, g 9.3 7.9 7.9 
Amount in g per 20 gram protein. WHEY = whey; CAS = casein; CASH = casein hydrolysate; AA = amino 
acids; EAA = essential AA; NEAA = non-EAA. 
Preparation of intrinsically labeled protein and beverage composition 
Intrinsically L-[1-
13
C]phenylalanine-labeled milk protein was obtained by infusing a 
Holstein cow with large quantities of L-[1-
13
C]phenylalanine, collecting milk, and 
purifying the casein and whey fractions as described previously (23). Part of the 
casein fraction was enzymatically hydrolyzed by specific endopeptidases and 
proline-specific endoprotease by DSM Food Specialties (Delft, Netherlands). The L-
[1-
13
C]phenylalanine enrichments in WHEY, CAS, and CASH, assessed by gas chro-
matography-mass spectrometry after hydrolysis, were 24.6, 29.4, and 29.4 mole 
percent excess (MPE), respectively. The proteins met all chemical and bacteriologic 
specifications for human consumption. Subjects received a beverage volume of 250 
mL to ensure a given dose of 20 g WHEY, CAS, or CASH (Table 2). The protein drinks 
provided 1.1, 1.7, and 1.7 mmol L-[1-
13
C]phenylalanine in WHEY, CAS, and CASH, 
respectively. Drinks were uniformly flavored by adding 5 mL vanilla flavor 
(Givaudan, Naarden, The Netherlands) per L beverage.  
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Plasma analyses 
Plasma glucose (Uni Kit III, 07367204, Roche, Basel, Switzerland) concentrations 
were analyzed with the COBAS-FARA semi-automatic analyzer (Roche). Insulin was 
analyzed by radio-immunoassay (Insulin RIA kit, LINCO Research Inc., St. Charles, 
MO, USA). Plasma (100 µL) for amino acid analyses was deproteinized on ice with 
10 mg dry 5-sulphosalicylic acid, mixed and the clear supernatant was collected 
after centrifugation. Plasma amino acid concentrations were determined by HPLC, 
after precolumn derivatization with o-phthaldialdehyde (28). For plasma phenylal-
anine enrichment measurements, plasma phenylalanine was derivatized to its t-
butyldimethyl-silyl (TBDMS) derivative and its 
13
C and 
2
H enrichments were deter-
mined by electron impact ionization gas chromatography-mass spectrometry (GC-
MS, Agilent 6890N GC/5973N MSD Little Falls, DE, USA) using selected ion monitor-
ing of masses 336, 337 and 341 for unlabeled and labeled (1-
13
C and ring-
2
H5) 
phenylalanine, respectively (29). We applied standard regression curves in all 
isotopic enrichment analyses to assess linearity of the mass spectrometer and to 
control for the loss of tracer. Enrichments were corrected for the presence of both 
the 
13
C and 
2
H5 phenylalanine isotopes (30). 
Muscle analyses 
For measurement of L-[1-
13
C]phenylalanine enrichment in the tissue-free amino 
acid pool and mixed muscle protein, 55 mg of wet muscle was freeze-dried. Colla-
gen, blood, and other non-muscle fiber material were removed from the muscle 
fibers under a light microscope. The isolated muscle fiber mass (10-15 mg) was 
weighed and 8 volumes (8x dry weight of isolated muscle fibers x wet/dry ratio) ice-
cold 2% perchloric acid (PCA) were added. The tissue was then homogenized and 
centrifuged. The supernatant was collected and processed in the same manner as 
the plasma samples, such that tissue-free L-[1-
13
C]phenylalanine enrichment could 
be measured using its TBDMS derivative on a GC-MS.  
The protein pellet was washed with 3 additional 1.5 mL washes of 2% PCA, dried 
and hydrolyzed in 6M HCl at 120°C for 15-18 h. The hydrolyzed protein fraction was 
dried under a nitrogen stream while heated to 120°C, then 50% acetic acid solution 
was added, and the hydrolyzed protein was passed over a Dowex exchange resin 
(AG 50W-X8, 100-200 mesh hydrogen form, Biorad, Hercules, CA, USA) using 2M 
NH4OH. The eluate was collected in a vial for the measurement of L-[1-
13
C]phenylalanine enrichment in mixed muscle protein as described previously (17). 
In short, L-[1-
13
C]phenylalanine was derivatized to its N(O,S)-ethoxycarbonyl ethyl 
esters (31). Thereafter, the ratios labeled/unlabeled derivatives were determined 
by GC-C-IRMS (Finnigan MAT 252, Bremen, Germany). Standard regression curves 
were applied to assess linearity of the mass spectrometer and to control for the 
loss of tracer. The coefficient of variance (CV) for the measurement of L-[1-
13
C]phenylalanine enrichment in mixed muscle protein averaged 1.1±0.1%. 
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Calculations 
Ingestion of L-[1-
13
C]phenylalanine-labeled protein, intravenous infusion of L-[ring-
2
H5]phenylalanine, and arterialized blood sampling were used to assess whole-body 
amino acid kinetics in non-steady state conditions. Total, exogenous, and endoge-
nous rate of appearance (Ra) and plasma availability of dietary phenylalanine (i.e., 
fraction of dietary phenylalanine that appeared in the systemic circulation, 
Pheplasma) were calculated using modified Steele’s equations (12, 22). These param-
eters were calculated as follows: 
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where F is the intravenous tracer infusion rate (µmol·kg
-1
·min
-1
), pV (0.125) is the 
distribution volume for phenylalanine (22). C(t) is the mean plasma phenylalanine 
concentration between two time points. dEiv/dt represents the time-dependent 
variations of plasma phenylalanine enrichment derived from the intravenous tracer 
and Eiv(t) is the mean plasma phenylalanine enrichment from the intravenous 
tracer between two consecutive time points. Exo Ra represents the plasma entry 
rate of dietary phenylalanine, Epo(t) is the mean plasma phenylalanine enrichment 
for the oral tracer, dEpo/dt represents the time-dependent variations of plasma 
phenylalanine enrichment derived from the oral tracer and Eprot is the L-[1-
13
C]phenylalanine enrichment in the dietary protein. PheProt is the amount of die-
tary phenylalanine ingested, AUCExoRa represents the area under the curve (AUC) of 
Exo Ra, which corresponds to the amount of dietary phenylalanine that appeared in 
the blood over a 6 h period following drink ingestion. BW represents the subjects’ 
body weight in kg. 
Total phenylalanine rate of disappearance (Total Rd) equals the rate of phenylala-
nine hydroxylation (first step in phenylalanine oxidation) and utilization for protein 
synthesis. This parameter is calculated as follows: 
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The FSR of mixed muscle protein synthesis was calculated by dividing the incre-
ment in enrichment in the product, i.e. mixed muscle protein-bound L-[1-
13
C]phenylalanine, by the enrichment of the precursor. Muscle tissue-free L-[1-
13
C]phenylalanine enrichments during the decay of enrichment levels were used as 
precursor to provide an estimate for the fractional synthesis rates of mixed muscle 
proteins during non-steady state conditions (32). Muscle FSR’s were calculated as 
follows: 
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where EB(t) - EB(0) is the delta increment of mixed muscle protein-bound L-[1-
13
C]phenylalanine during the 6 h incorporation period and EF is the mean muscle 
tissue-free L-[1-
13
C]phenylalanine enrichment obtained from muscle biopsies at 3 
and 6 h. 
Statistics 
All data are expressed as mean±SEM. A two-way repeated measures ANOVA with 
time and treatment as factors was used to compare differences between treat-
ments over time in older subjects. In case of a significant interaction between time 
and treatment, a Bonferroni post-hoc test was applied to locate these differences. 
For non-time dependent variables, a one-way ANOVA with treatment as factor was 
used to compare differences between treatments in older subjects. Statistical 
significance was set at P<0.05. All calculations were performed using the SPSS 
15.0.1.1 software package. 
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Results 
Plasma analyses  
Plasma insulin concentrations showed a rapid, but short-lived, increase following 
protein ingestion in all groups (Figure 1). Peak plasma insulin concentrations were 
higher following WHEY and CASH ingestion when compared with CAS (P<0.05). 
Plasma glucose concentrations did not change significantly following protein inges-
tion and averaged 5.3±0.1, 5.3±0.1, and 5.2±0.1 mmol·L
-1
, respectively. 
 
 
Figure 1. Plasma insulin concentrations (mU·L
-1
) following ingestion of CAS (n=16), CASH (n=16), and 
WHEY (n=16). Values represent means±SEM. Data were analyzed with repeated measures ANOVA (time 
x treatment). In case of a significant interaction, a Bonferroni post-hoc test was applied to locate these 
differences. time effect, P<0.001; treatment effect, P<0.01; time x treatment interaction, P<0.001. 
*WHEY significantly different from CAS, P<0.05; 
$
CASH significantly different from CAS, P<0.05.  
 
Plasma phenylalanine (A), leucine (B), and total essential amino acid (EAA; C) con-
centrations over time are illustrated in Figure 2. Following dietary protein inges-
tion, a rapid increase in plasma EAA concentrations was observed in all groups, 
with higher peak amino acid concentrations following WHEY and CASH compared 
with CAS ingestion (P<0.05). Peak plasma phenylalanine and leucine concentrations 
were significantly higher following CASH compared with CAS ingestion (P<0.05). In 
addition, peak plasma leucine concentrations were higher following WHEY com-
pared with CASH ingestion (P<0.01). 
The time courses of plasma L-[1-
13
C]phenylalanine and L-[ring-
2
H5]-phenylalanine 
enrichments are illustrated in Figure 3. Plasma L-[1-
13
C]-phenylalanine enrichment 
(ingested tracer) increased after ingestion of the test drink with higher peak values 
observed following ingestion of CASH compared with WHEY and CAS (P<0.01). 
However, plasma L-[1-
13
C]-phenylalanine enrichments were higher in CAS vs CASH 
and WHEY during the later stages of the experimental period (P<0.01). The plasma 
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L-[ring-
2
H5]phenylalanine enrichment (infused tracer) decreased during all treat-
ments after dietary protein ingestion, with lowest values observed during the early 
stages after CASH ingestion (P<0.05). Following the initial decrease, plasma L-[ring-
2
H5]phenylalanine enrichments increased over time, with higher values observed 
following WHEY and CASH compared with CAS ingestion (P<0.05). 
 
 
Figure 2. Plasma phenylalanine (A), leucine (B), and essential amino acids (C) concentrations (μmol·L
-1
) 
following ingestion of CAS (n=16), CASH (n=16), and WHEY (n=16). Values represent means±SEM. Data 
were analyzed with repeated measures ANOVA (time x treatment). In case of a significant interaction, a 
Bonferroni post-hoc test was applied to locate these differences. Plasma phenylalanine concentration: 
time effect, P<0.001; treatment effect, P=0.12; time x treatment interaction, P<0.05. Plasma leucine 
concentration: time effect, P<0.001; treatment effect, P<0.001; time x treatment interaction, P<0.001. 
Plasma EAA concentration: time effect, P<0.001; treatment effect, P<0.001; time x treatment interac-
tion, P<0.001. *WHEY significantly different from CAS, P<0.05; 
$
CASH significantly different from CAS, 
P<0.05; 
#
WHEY significantly different from CASH, P<0.05.  
Whole-body phenylalanine kinetics 
Whole-body phenylalanine kinetics are presented in Figure 4. Ingestion of the 
intrinsically labeled dietary protein resulted in a rapid rise in exogenous phenylala-
nine appearance rates (Figure 4A), with higher peak values observed following 
WHEY and CASH when compared with CAS ingestion (P<0.05). In contrast, during 
the later stages of the postprandial period exogenous phenylalanine appearance 
rates were higher following CAS compared with WHEY and CASH ingestion 
(P<0.01). Total exogenous phenylalanine appearance (expressed as AUC over 6 h) 
was expressed as a fraction of the total amount of phenylalanine that was ingested 
(Equation 4). The fraction of dietary phenylalanine that appeared in the systemic 
circulation during the 6 h postprandial period was higher following WHEY (58±1%) 
when compared with CAS (53±1%; P<0.01) and CASH (55±1%; P<0.05) ingestion. 
However, no differences were observed between WHEY and CASH ingestion during 
the first few hours (0-2 h) after protein ingestion (41±1 and 39±1%, respectively). 
Ingestion of WHEY and CASH resulted in a much higher plasma availability of die-
tary phenylalanine when compared with CAS (25±1%; P<0.001) during this early 
postprandial phase (0-2 h). 
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Endogenous phenylalanine appearance rates rapidly decreased following protein 
ingestion, with lower values observed following ingestion of WHEY compared with 
CAS (t=75-150 min; Figure 4B; P<0.05). Total phenylalanine appearance and disap-
pearance rates (Figures 4C and 4D) were higher during the initial stages after in-
gesting CASH vs CAS (P<0.05), whereas rates were higher during the later stages 
following CAS vs WHEY and CASH ingestion (P<0.05). 
 
 
Figure 3. Plasma L-[1-
13
C]phenylalanine (A) and L-[ring-
2
H5]phenylalanine (B) enrichment expressed as 
mole percent excess (MPE) following ingestion of CAS (n=16), CASH (n=16), and WHEY (n=16). Values 
represent means±SEM. Data were analyzed with repeated measures ANOVA (time x treatment). In case 
of a significant interaction, a Bonferroni post-hoc test was applied to locate these differences. Plasma L-
[1-
13
C]phenylalanine enrichment: time effect, P<0.001; treatment effect, P<0.001; time x treatment 
interaction, P<0.001. Plasma L-[ring-
2
H5]-phenylalanine enrichment: time effect, P<0.001; treatment 
effect, P<0.01; time x treatment interaction, P<0.001. *WHEY significantly different from CAS, P<0.05; 
$
CASH significantly different from CAS, P<0.05; 
#
WHEY significantly different from CASH, P<0.05. 
Muscle tracer analysis 
Tissue-free L-[1-
13
C]phenylalanine enrichments (MPE), determined in muscle sam-
ples collected at 0, 3, and 6 h following protein ingestion were 0.11±0.03, 
2.59±0.17, and 0.61±0.05 for WHEY; 0.15±0.07, 4.97±0.36, and 1.64±0.13 for CAS; 
and 0.13±0.08, 3.78±0.25, and 0.84±0.08 for CASH. Tissue-free enrichments 
changed significantly over time (P<0.001) and differed between treatments 
(P<0.001). 
Protein-bound L-[1-
13
C]phenylalanine enrichments at 3 and 6 h into the postpran-
dial period were 0.010±0.001 and 0.017±0.002 MPE following WHEY ingestion; 
0.012±0.001 and 0.019±0.002 MPE following CAS inges-tion; and 0.012±0.001 and 
0.017±0.002 MPE following CASH ingestion. Protein-bound phenylalanine enrich-
ments increased over time (P<0.001) and did not differ between treatments. 
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Figure 4. Whole-body phenylalanine (PHE) kinetics expressed per kg body-weight. (A) exogenous PHE 
rate of appearance (Ra), (B) endogenous PHE Ra, (C) total PHE Ra, and (D) total PHE rate of disappearance 
(Rd) in μmol·kg
-1
·min
-1
 following ingestion of CAS (n=16), CASH (n=16), and WHEY (n=16). Values repre-
sent means±SEM. Data were analyzed with repeated measures ANOVA (time x treatment). In case of a 
significant interaction, a Bonferroni post-hoc test was applied to locate these differences. Exogenous 
PHE Ra: time effect, P<0.001; treatment effect, P<0.001; time x treatment interaction, P<0.001. Endoge-
nous PHE Ra: time effect, P<0.001; treatment effect, P=0.07; time x treatment interaction, P<0.05. Total 
PHE Ra: time effect, P<0.001; treatment effect, P=0.30; time x treatment interaction, P<0.001. Total PHE 
Rd: time effect, P<0.001; treatment effect, P=0.26; time x treatment interaction, P<0.001. *WHEY 
significantly different from CAS, P<0.05; 
$
CASH significantly different from CAS, P<0.05; 
#
WHEY signifi-
cantly different from CASH, P<0.05. 
Mixed muscle protein synthesis rates 
Mixed muscle protein synthesis rates, expressed as fractional synthetic rates (FSR) 
with tissue-free L-[1-
13
C]phenylalanine enrichment as precursor, are presented in 
Figure 5. FSR values assessed following WHEY ingestion (0.15±0.02 %·h
-1
) were 
higher compared with both CAS (0.08±0.01 %·h
-1
; P<0.01) and CASH (0.10±0.01 
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%·h-1; P<0.05). When plasma L-[1-
13
C]phenylalanine enrichment was used as pre-
cursor, calculated FSR values were lower, but revealed a similar intervention effect 
(data not shown). 
 
 
Figure 5. Fractional mixed muscle protein synthetic rates (FSR), with tissue-free L-[1-
13
C]phenylalanine 
enrichments as precursor, following ingestion of CAS (n=16), CASH (n=16), and WHEY (n=16). Values 
represent means±SEM. Data were analyzed with ANOVA with Bonferroni correction. *WHEY significantly 
different from CAS, P<0.01; 
#
WHEY significantly different from CASH, P<0.05. 
Correlations 
Postprandial FSR values showed a significant positive correlation with the delta (∆) 
peak increase in plasma EAA concentrations (r=0.55: P<0.01). The postprandial rise 
in plasma leucine concentrations showed the strongest correlation with postpran-
dial FSR values (r=0.66; P<0.01). However, significant correlations were also ob-
served for the rise in plasma isoleucine (r=0.60; P<0.01), tryptophan (r=0.45; 
P<0.01), threonine (r=0.44; P<0.01), lysine (r=0.43; P<0.01), and valine (r=0.39; 
P<0.05) concentrations, whereas the rise in phenylalanine (r=0.26; P=0.10) and 
methionine (r=0.20; P=0.21) concentrations did not show a significant correlation. 
Correlations between postprandial FSR values and the ∆ peak increase in plasma 
EAA (A) and leucine (B) concentrations are illustrated in Figure 6.  
Discussion 
In the present study, we compared dietary protein digestion and absorption kinet-
ics and subsequent muscle protein accretion following the ingestion of 20 g whey 
(WHEY), casein (CAS), and casein hydrolysate (CASH) in healthy, older men. Intrinsi-
cally L-[1-
13
C]phenylalanine-labeled milk proteins were ingested, in combination 
with continuous intravenous infusion of L-[ring-
2
H5]phenylalanine, to allow insight 
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into the metabolic fate of dietary protein-derived amino acids following protein 
ingestion. Protein-derived phenylalanine appeared more rapidly in the circulation 
following WHEY and CASH when compared with CAS ingestion. WHEY protein 
ingestion resulted in greater mixed muscle protein fractional synthetic rates (FSR) 
when compared with CAS and CASH administration. Postprandial FSR values corre-
lated strongly with the rise in plasma leucine concentration. 
 
 
Figure 6. Correlations between postprandial FSR values and delta (∆) peak plasma EAA (A) and leucine 
(B) concentrations: EAA (r=0.55; P<0.01) and leucine (r=0.66; P<0.01). Data were analyzed with two-
tailed tests of significance using Pearson’s correlation coefficients (n=48). 
 
In older adults, ingestion of whey protein has been suggested to effectively in-
crease postprandial protein retention when compared with casein ingestion (11, 
12). Much of this effect can be attributed to apparent differences in digestion and 
absorption kinetics between these proteins (13, 14). Following ingestion of whey 
and casein protein we observed a more rapid rise in plasma phenylalanine, leucine, 
as well as total essential amino acid concentrations in WHEY vs CAS (Figure 2). In 
addition, a more rapid rise in plasma L-[1-
13
C]phenylalanine enrichment was ob-
served following WHEY compared with CAS ingestion (Figure 3). In agreement, 
whole-body tracer kinetics showed a much greater appearance rate of protein-
derived phenylalanine in the circulation during the first 2 h after WHEY vs CAS 
ingestion (Figure 4A). These findings are in line with previous work that identified 
whey as a fast and casein as a slow digestible protein (13, 14).  
Besides differences in digestion and absorption kinetics, whey and casein also differ 
markedly in their amino acid composition (Table 2). Consequently, the proposed 
greater anabolic properties of whey versus casein could be attributed to differ-
ences in digestion and absorption kinetics as well as differences in amino acid 
composition between these proteins. In trying to define the characteristics respon-
sible for the proposed greater anabolic properties of whey versus casein admin-
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istration, we hydrolysed part of the intrinsically labeled casein to obtain a casein 
hydrolysate. The latter provided us with an important tool to investigate the impact 
of differences in amino acid composition and digestion and absorption kinetics on 
postprandial muscle protein synthesis, because a casein hydrolysate shows similar 
digestion and absorption kinetics when compared with a whey protein (13, 17) 
while retaining its unique amino acid composition (Table 2). In accordance, we 
observed similar dietary protein-derived phenylalanine appearance rates following 
ingestion of WHEY and CASH (Figure 4A). Furthermore, the amount of dietary 
phenylalanine that appeared in the circulation directly following protein intake (0-2 
h) did not differ between WHEY and CASH ingestion and was higher when com-
pared with CAS. However, plasma dietary phenylalanine availability over the total 6 
h postprandial period was higher for WHEY (58±1%) when compared with CASH 
(55±1%; P<0.05) and CAS (53±1%; P<0.01) ingestion. The latter implies that more 
dietary amino acids became available following WHEY compared with CASH and 
CAS ingestion. 
In the postprandial phase, a rapid increase in plasma essential amino acid (EAA) 
concentrations was observed in all groups, with peak EAA concentrations reaching 
higher plasma levels following WHEY and CASH compared with CAS ingestion 
(Figure 2C). Specific differences in plasma EAA concentrations following protein 
ingestion were observed when looking at individual EAA. In particular peak plasma 
leucine concentrations differed significantly between treatments, with the highest 
and lowest peak concentrations observed following WHEY and CAS ingestion, 
respectively (Figure 2B). As the dietary amino acid rate of appearance from the gut 
was greater following CASH compared with CAS ingestion (Figure 4A), it is evident 
that the greater rise in plasma leucine concentration following CASH administration 
(Figure 2B) is entirely attributed to its accelerated digestion and absorption kinet-
ics. However, despite similar protein digestion and absorption kinetics following 
WHEY and CASH ingestion, a greater rise in plasma leucine concentration was 
observed following WHEY compared with CASH. The latter is largely attributed to 
the greater leucine content of WHEY (12.5%) versus CASH (8.5%). This difference 
might be of substantial relevance, as the postprandial rise in plasma leucine con-
centration has been proposed to be responsible for the increase in mixed muscle 
protein synthetic rate (18-21). 
To study the postprandial muscle protein synthetic response to the ingestion of the 
different proteins sources, mixed muscle protein fractional synthetic rates (FSR) 
were calculated based on the ingested L-[1-
13
C]phenylalanine tracer. This allowed 
us to compare the capacity of the different protein sources to stimulate de novo 
postprandial muscle protein accretion. Mixed muscle protein FSR values assessed 
following WHEY ingestion were higher when compared with CAS (P<0.01) and CASH 
(P<0.05; Figure 5). These FSR values clearly demonstrate that WHEY ingestion 
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stimulates postprandial muscle protein accretion more effectively than do CAS and 
CASH in older men. 
In this study, we report significant correlations between the postprandial rise (∆ 
peak) in plasma EAA concentrations and FSR values (Figure 6A). The postprandial 
rise in plasma leucine concentrations showed the strongest positive correlation 
(r=0.66; P<0.01) with postprandial FSR values (Figure 6B). This seems to be in line 
with the suggestion that leucine forms a key-factor regulating postprandial muscle 
protein synthesis (18-21). We speculate that the postprandial rise in plasma EAA 
concentration, with leucine in particular, defines the subsequent postprandial rate 
of muscle protein synthesis. In the present study, we observed a greater rise in 
plasma leucine concentration following WHEY versus CAS and CASH ingestion. This 
difference was attributed to faster digestion and absorption kinetics as well as a 
higher leucine content of the protein and also resulted in peak plasma leucine 
concentrations that were considerably higher following WHEY when compared 
with CAS and CASH ingestion (526±21, 282±13, and 381±14 µmol·L
-1
, respectively). 
The present study is the first to compare in vivo dietary protein digestion and 
absorption kinetics and subsequent postprandial muscle protein accretion follow-
ing the ingestion of a meal-like amount of whey, intact casein, and hydrolysed 
casein in healthy, older men. Whey protein is more effective than casein and casein 
hydrolysate in promoting postprandial muscle protein accretion in healthy, older 
men. The greater muscle protein synthetic response to whey ingestion is likely 
attributed to both its faster digestion and absorption kinetics and higher leucine 
content, thereby further increasing the postprandial rise in plasma leucine concen-
tration. These data are of great clinical relevance to define more effective nutri-
tional strategies to attenuate the age-related loss of muscle mass. 
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Abstract 
Whey protein ingestion has been shown to effectively stimulate postprandial 
muscle protein accretion in older adults. However, the impact of the amount of 
whey protein ingested on protein digestion and absorption kinetics, whole-body 
protein balance, and postprandial muscle protein accretion remains to be estab-
lished. We aimed to fill this gap by including 33 healthy, older men (73±2 y) which 
were randomly assigned to ingest 10, 20, or 35 g of intrinsically L-[1-
13
C]phenylalanine-labeled whey protein; n=11 per treatment. Ingestion of labeled 
whey protein was combined with continuous intravenous L-[ring-
2
H5]phenylalanine 
and L-[ring-
2
H2]tyrosine infusion to assess the metabolic fate of whey protein-
derived amino acids. Dietary protein digestion and absorption rapidly increased 
following ingestion of 10, 20, and 35 g whey protein, with the lowest and highest 
(peak) values observed following 10 and 35 g, respectively (P<0.05). Whole-body 
net protein balance was positive in all groups (19±1, 37±2, and 58±2 µmol·kg
-1
), 
with the lowest and highest values observed following ingestion of 10 and 35 g, 
respectively (P<0.05). Postprandial muscle protein accretion, assessed by L-[1-
13
C]phenylalanine incorporation in muscle protein, was higher following ingestion 
of 35 g when compared with 10 (P<0.01) or 20 g (P<0.05). We conclude that inges-
tion of 35 g whey protein results in greater amino acid absorption and subsequent 
stimulation of de novo muscle protein synthesis when compared with the ingestion 
of 10 or 20 g whey protein in healthy, older men. 
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Introduction 
Aging is accompanied by a progressive decline in skeletal muscle mass, termed 
sarcopenia (1). Data have been obtained to suggest that the skeletal muscle protein 
synthetic response to food intake is impaired in older adults (2, 3). This proposed 
anabolic resistance is now regarded a key-factor in the etiology of sarcopenia. 
Consequently, we as well as other labs have been trying to define effective inter-
ventional strategies to compensate for this anabolic resistance by improving post-
prandial muscle protein accretion in older adults (4-7). Recently, we assessed the 
impact of protein digestion and absorption kinetics as well as amino acid composi-
tion on postprandial muscle protein synthesis rates in older men. The results 
showed that whey protein was more effective than either casein or casein 
hydrolysate protein in stimulating postprandial muscle protein accretion (8).  
Besides the quality of dietary protein, i.e. its amino acid composition and digestion 
and absorption kinetics, also the amount of dietary protein ingested likely modu-
lates postprandial muscle protein synthesis rates (5, 8). So far, no study has as-
sessed the impact of ingesting different amounts of whey protein on protein diges-
tion and absorption kinetics, whole-body protein balance, and postprandial muscle 
protein synthesis rates in older adults. As the metabolic fate of amino acids ingest-
ed as dietary protein cannot be assessed by oral or intravenous administration of 
labeled free amino acids (9, 10), we specifically produced intrinsically labeled whey 
protein by infusing cows with large quantities of L-[1-
13
C]phenylalanine, collecting 
milk, and purifying the whey protein fraction (11). The use of intrinsically labeled 
whey protein allowed us to assess the impact of ingesting different amounts of 
whey protein on in vivo protein digestion and absorption kinetics and subsequent 
muscle protein accretion without the need for extensive assumptions and extrapo-
lations. 
In the present study, 33 elderly men ingested a single bolus of 10, 20, or 35 g intrin-
sically L-[1-
13
C]phenylalanine-labeled whey protein. Ingestion of labeled whey 
protein was combined with continuous intravenous L-[ring-
2
H5]phenylalanine and 
L-[ring-
2
H2]tyrosine infusion, during which blood and muscle tissue samples were 
collected. This study is the first to describe the impact of the amount of whey 
protein ingested on subsequent protein digestion and absorption kinetics, splanch-
nic sequestration, whole-body protein metabolism, and postprandial muscle pro-
tein accretion in vivo in older males. 
Methods 
Subjects 
Thirty-three healthy, older men (73±2 y) participated in this study. Subjects were 
randomly assigned to ingest a single bolus of 10, 20, or 35 g intrinsically L-[1-
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C]phenylalanine-labeled whey protein; n=11 per treatment. Subjects’ characteris-
tics are presented in Table 1. None of the subjects had a history of participating in 
any regular exercise program. All subjects were informed on the nature and possi-
ble risk of the experimental procedures before their written informed consent was 
obtained. This study was approved by the Medical Ethics Committee of the Aca-
demic Hospital Maastricht. 
 
Table 1. Subjects’ characteristics 
 10 g 
whey protein 
(n=11) 
20 g 
whey protein 
(n=11) 
35 g 
whey protein 
(n=11) 
Age (y) 73 ± 2 73 ± 2 73 ± 1 
Weight (kg) 77.2 ± 1.6 78.0 ± 1.7 77.2 ± 1.3 
BMI (kg·m
-2
) 25.2 ± 0.5 25.6 ± 0.5 25.4 ± 0.6 
Fat % 21.1 ± 0.9 21.1 ± 1.0 20.8 ± 1.3 
Lean body mass (kg) 60.9 ± 1.3 61.4 ± 1.0 61.1 ± 1.2 
HbA1c (%) 5.7 ± 0.1 5.9 ± 0.1 5.6 ± 0.1 
Basal glucose (mmol·L
-1
) 5.5 ± 0.1 5.6 ± 0.1 5.5 ± 0.1 
Basal insulin (mU·L
-1
) 17.1 ± 1.6 19.1 ± 2.8 16.3 ± 1.1 
Values are expressed as means±SEM. Data were analyzed with ANOVA. No differences were observed 
between groups. 
Pretesting 
Before selection in the study, an oral glucose tolerance test (OGTT) was performed 
to assess glucose tolerance and screen for type 2 diabetes prevalence according to 
World Health Organization criteria (12). Prior to the OGTT, body weight and height 
were assessed and body composition was determined by DXA (Discovery A, Hologic 
Corporate, Bedford, MA, USA). 
Diet and activity prior to testing 
All subjects consumed a standardized meal (32±2 kJ·kg
-1
 body weight, providing 55 
E% carbohydrate, 15 E% protein and 30 E% fat) the evening prior to the experi-
ment. All volunteers were instructed to refrain from any sort of exhaustive physical 
activity and to keep their diet as constant as possible 3 d before the experiments. 
Protocol 
At 8.00 am, following an overnight fast, subjects arrived at the laboratory by car or 
public transportation. A Teflon catheter was inserted into an antecubital vein for 
stable isotope infusion. A second Teflon catheter was inserted in a heated dorsal 
hand vein of the contralateral arm and placed in a hot-box (60°C) for arterialized 
blood sampling (13). Following basal blood collection (t=-240 min), the plasma 
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phenylalanine and tyrosine pools were primed with a single intravenous dose L-
[ring-
2
H5]phenylalanine (2 µmol·kg
-1
) and L-[ring-
2
H2]tyrosine (0.775 µmol·kg
-1
), 
after which continuous L-[ring-
2
H5]-phenylalanine and L-[ring-
2
H2]tyrosine infusion 
was started (0.050 ±0.001 and 0.019±0.001 µmol·kg-1·min-1, respectively). After 
resting in a supine position for 120 min, a second arterialized blood sample was 
drawn and the first muscle biopsy was collected from the vastus lateralis muscle 
(t=-120 min), marking the start of a fasted, baseline period. During this period, 
additional blood samples were drawn every 30 min and a second muscle biopsy 
was taken at t=0 min. Directly following the second biopsy, subjects ingested a 
single bolus of 10, 20, or 35 g intrinsically L-[1-
13
C]phenylalanine-labeled whey 
protein dissolved in 400 mL water, which was uniformly flavored by adding 5 mL 
vanilla flavor (Givaudan, Naarden, The Netherlands) per Liter beverage. Arterialized 
blood samples were collected at t= 15, 30, 45, 60, 90, 120, 180, and 240 min with a 
third muscle biopsy taken from the contralateral limb at t= 240 min. Blood samples 
were collected in EDTA containing tubes and centrifuged at 1000 g for 5 min at 4°C. 
Aliquots of plasma were frozen in liquid nitrogen and stored at –80°C. Muscle 
biopsies were obtained from the middle region of the vastus lateralis. Biopsies 
from the same incision were taken in a distal and proximal direction, respectively. 
Muscle samples were dissected carefully and freed from any visible non-muscle 
material. The muscle samples were immediately frozen in liquid nitrogen and 
stored at –80°C until further analysis.  
Preparation of intrinsically labeled whey protein 
Intrinsically L-[1-
13
C]phenylalanine-labeled whey protein was obtained by infusing a 
Holstein cow with large quantities of L-[1-
13
C]phenylalanine, collecting milk, and 
purifying the whey protein fraction as described previously (11). The whey protein 
fraction consisted of 93% native whey protein and 7% casein and denatured whey 
protein and did not provide other sources of nutrients, i.e. during processing, milk 
fat and lactose were removed to ~1% of original milk content. The L-[1-
13
C]phenylalanine enrichment of labeled whey protein, which was assessed by gas 
chromatography-mass spectrometry after hydrolysis, was 31.3 mole percent excess 
(MPE). The labeled protein met all chemical and bacteriologic specifications for 
human consumption. 
Plasma analyses 
Plasma glucose (Uni Kit III, 07367204, Roche, Basel, Switzerland) concentrations 
were analyzed with the COBAS-FARA semi-automatic analyzer (Roche). Insulin was 
analyzed by radio-immunoassay (Insulin RIA kit, LINCO Research Inc., St. Charles, 
MO, USA). Plasma (100 µL) for amino acid analyses was deproteinized on ice with 
10 mg dry 5-sulphosalicylic acid, mixed and the clear supernatant was collected 
after centrifugation. Plasma amino acid concentrations were determined by HPLC, 
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after precolumn derivatization with o-phthaldialdehyde (14). For plasma phenylal-
anine and tyrosine enrichment measurements, plasma phenylalanine and tyrosine 
were derivatized to their t-butyldimethylsilyl (TBDMS) derivatives and their 
13
C and 
2
H enrichments were determined by electron ionization GC-MS (Agilent 6890N 
GC/5973N MSD Little Falls, DE, USA) using selected ion monitoring of masses 336, 
337 and 341 for unlabeled and labeled (1-
13
C and ring-
2
H5) phenylalanine, respec-
tively; and masses 466, 467, 468 and 470 for unlabeled and labeled (1-
13
C, ring-
2
H2 
and ring-
2
H4) tyrosine, respectively (15). Standard regression curves were applied in 
all isotopic enrichment analysis to assess linearity of the mass spectrometer and to 
control for the loss of tracer. Phenylalanine and tyrosine enrichments were cor-
rected for the presence of both the 
13
C and 
2
H isotopes (16). 
Muscle tissue analyses 
For measurement of L-[1-
13
C]phenylalanine and L-[ring-
2
H5]phenylalanine enrich-
ment in mixed muscle protein, 55 mg of wet muscle was freeze-dried. Collagen, 
blood, and other non-muscle fiber material were removed from the muscle fibers 
under a light microscope. The isolated muscle fiber mass (10-15 mg) was weighed 
and 8 volumes (8x dry weight of isolated muscle fibers x wet/dry ratio) ice-cold 2% 
perchloric acid (PCA) were added. The tissue was then homogenized and centri-
fuged. The protein pellet was washed with 3 additional 1.5 mL washes of 2% PCA, 
dried and hydrolyzed in 6M HCl at 120°C for 15-18 h. The hydrolyzed protein frac-
tion was dried under a nitrogen stream while heated to 120°C, then 50% acetic acid 
solution was added and the hydrolyzed protein was passed over a Dowex exchange 
resin (AG 50W-X8, 100-200 mesh hydrogen form, Biorad, Hercules, CA, USA) using 
2M NH4OH. The eluate was divided over 2 vials for separate measurement of both 
L-[1-
13
C]phenylalanine and L-[ring-
2
H5]phenylalanine enrichment in mixed muscle 
protein as described previously (5). In short, L-[1-
13
C]phenylalanine and L-[ring-
2
H5]phenylalanine were derivatized to their N(O,S)-ethoxycarbonyl ethyl esters and 
MTBSTFA-phenylethylamines, respectively (17). Thereafter, the ratios la-
beled/unlabeled derivatives were determined by GC-C-IRMS (Finnigan MAT 252, 
Bremen, Germany) and GC-MS, respectively. Standard regression curves were 
applied to assess linearity of the mass spectrometer and to control for loss of 
tracer. 
Calculations 
Ingestion of L-[1-
13
C]phenylalanine-labeled protein, intravenous infusion of L-[ring-
2
H5]phenylalanine and L-[ring-
2
H2]tyrosine, and arterialized blood sampling were 
used to assess whole-body protein metabolism in non-steady state conditions. 
Total, exogenous, and endogenous phenylalanine rate of appearance (Ra) and 
plasma availability of dietary phenylalanine (i.e., fraction of dietary phenylalanine 
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that appeared in the systemic circulation, Pheplasma) were calculated using modified 
Steele’s equations (9, 18). These parameters were calculated as follows: 
 
)(
/dd)(
 Total
tE
tEtCpVF
R
iv
iv
a
⋅⋅−
=
 
(1) 
prot
popo
a
E
tEpVtE
R
/dd  )(R Total
 Exo
a ⋅+⋅=
 
(2) 
 
F - R Exo - R Total Endo aa=aR  (3) 
 
(4) 
 
where F is the intravenous tracer infusion rate (µmol·kg
-1
·min
-1
), pV (0.125) is the 
distribution volume for phenylalanine (9). C(t) is the mean plasma phenylalanine 
concentration between two time points. dEiv/dt represents the time-dependent 
variations of plasma phenylalanine enrichment derived from the intravenous tracer 
and Eiv(t) is the mean plasma phenylalanine enrichment from the intravenous 
tracer between two consecutive time points. Exo Ra represents the plasma entry 
rate of dietary phenylalanine, Epo(t) is the mean plasma phenylalanine enrichment 
for the oral tracer, dEpo/dt represents the time-dependent variations of plasma 
phenylalanine enrichment derived from the oral tracer and Eprot is the L-[1-
13
C]phenylalanine enrichment in the dietary protein. PheProt is the amount of die-
tary phenylalanine ingested, AUCExoRa represents the area under the curve (AUC) of 
Exo Ra, which corresponds to the amount of dietary phenylalanine that appeared in 
the blood over the 4 h period following drink intake. BW represents the subjects’ 
body weight in kg. 
Total rate of disappearance of phenylalanine (Total Rd) equals the rate of phenylal-
anine (PHE) to tyrosine (TYR) conversion by hydroxylation (first step in phenylala-
nine oxidation) and utilization for protein synthesis. These parameters can be 
calculated as follows: 
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 Protein synthesis = Total Rd– PHE to TYR conversion (7) 
 PHE net balance = Protein synthesis – Endo Ra (8) 
where Phe Rd and Tyr Ra are the flux rates for phenylalanine and tyrosine, respec-
tively, Et(t) and Ep(t) are the mean plasma enrichments of L-[ring-
2
H4]tyrosine and L-
[ring-
2
H5]phenylalanine, respectively, and Fp is the infusion rate of the phenylala-
nine tracer. 
The fractional rate of mixed muscle protein synthesis (FSR) was calculated in %·h
-1
 
by the precursor-product method (15): 
 
100⋅
⋅
∆
=
tE
E
FSR
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p
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where ∆Ep is the delta increment of muscle protein-bound L-[ring-
2
H5]phenylalanine during the incorporation period. Eprecursor is the average plasma L-
[ring-
2
H5]phenylalanine enrichment during the time period for determination of 
amino acid incorporation. t indicates the time interval (h) between biopsies. 
Statistics 
All data are expressed as means±SEM. A two-way repeated measures ANOVA with 
time and treatment as factors was used to compare differences between treat-
ments over time. In case of a significant interaction between time and treatment, a 
Bonferroni post-hoc test was applied to locate these differences. For non-time 
dependent variables, one-way ANOVA with treatment as factor was used to com-
pare differences between treatments. Statistical significance was set at P<0.05. All 
calculations were performed using the SPSS 15.0.1.1 software package. 
Results 
Plasma analyses 
Plasma insulin concentrations showed a rapid, but short-lived, increase following 
whey protein ingestion in all groups (Figure 1A). Peak plasma insulin concentra-
tions were higher following ingestion of 35 g when compared with 10 and 20 g 
whey protein (P<0.05). Plasma glucose concentrations did not change over time or 
between treatments and averaged 5.2±0.1, 5.1±0.1, and 5.1±0.1 mmol·L
-1
 in the 10, 
20, and 35 g experiment, respectively (Figure 1B). 
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Figure 1. Plasma insulin (A; mU·L
-1
) and glucose (B; mmol·L
-1
) concentrations following ingestion of 10 
(n=11), 20 (n=11), and 35 g (n=11) whey protein. Values represent means±SEM. Data were analyzed 
with repeated measures ANOVA (time x treatment). In case of a significant interaction, a Bonferroni 
post-hoc test was applied to locate these differences. Time effect, P<0.001; treatment effect, P<0.05; 
time x treatment interaction, P<0.01. *35 g significantly higher when compared with 10 g, P<0.05. 
 
Plasma phenylalanine, leucine, and essential amino acid (EAA) concentrations over 
time are illustrated in Figure 2.  
 
 
Figure 2. Plasma phenylalanine (A), leucine (B), and essential amino acid (EAA; C), concentrations 
(μmol·L
-1
) following ingestion of 10 (n=11), 20 (n=11), and 35 g (n=11) whey protein. Values represent 
means±SEM. Data were analyzed with repeated measures ANOVA (time x treatment). In case of a 
significant interaction, a Bonferroni post-hoc test was applied to locate these differences. Plasma EAA 
concentrations: time effect, P<0.001; treatment effect, P<0.001; time x treatment interaction, P<0.001. 
Plasma phenylalanine concentrations: time effect, P<0.001; treatment effect, P<0.01; time x treatment 
interaction, P<0.001. Plasma leucine concentrations: time effect, P<0.001; treatment effect, P<0.001; 
time x treatment interaction, P<0.001. *35 g significantly different when compared with 10 g, P<0.05; 
$
35 g significantly different when compared with 20 g, P<0.05; 
#
20 g significantly different when com-
pared with 10 g, P<0.05. 
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Following whey protein ingestion, a rapid increase in plasma EAA concentrations 
was observed in all groups, with the lowest and highest concentrations following 
ingestion of 10 and 35 g whey protein, respectively (P<0.01). Plasma phenylalanine 
concentrations were significantly higher following ingestion of 20 and 35 g com-
pared with the ingestion of 10 g whey protein (P<0.05). The lowest and highest 
(peak) plasma leucine concentrations were observed in the 10 and 35 g experi-
ment, respectively (P<0.01). 
The time course of plasma L-[1-
13
C]phenylalanine and L-[ring-
2
H5]-phenylalanine 
enrichments are illustrated in Figure 3. Plasma L-[1-
13
C]-phenylalanine enrichments 
(ingested tracer) rapidly increased after ingestion of the test drinks, with the lowest 
and highest enrichments following ingestion of 10 and 35 g whey protein, respec-
tively (P<0.01). The plasma L-[ring-
2
H5]phenylalanine enrichment (infused tracer) 
decreased following whey protein ingestion in all groups, with lower values ob-
served during the early stages following ingestion of 20 and 35 g when compared 
with 10 g whey protein (P<0.05). Following this initial decrease, plasma L-[ring-
2
H5]phenylalanine enrichments slowly returned to baseline levels, with higher 
values following ingestion of 10 g compared with 20 and 35 g whey protein 
(P<0.05).  
 
 
Figure 3. Plasma L-[1-
13
C]phenylalanine (A) and L-[ring-
2
H5]phenylalanine (B) enrichments expressed as 
mole percent excess (MPE) following ingestion of 10 (n=11), 20 (n=11), and 35 g (n=11) whey protein. 
Values represent means±SEM. Data were analyzed with repeated measures ANOVA (time x treatment). 
In case of a significant interaction, a Bonferroni post-hoc test was applied to locate these differences. 
Plasma L-[1-
13
C]phenylalanine enrichments: time effect, P<0.001; treatment effect, P<0.001; time x 
treatment interaction, P<0.001. Plasma L-[ring-
2
H5]phenylalanine enrichments: time effect, P<0.001; 
treatment effect, P<0.001; time x treatment interaction, P<0.001. *35 g significantly different when 
compared with 10 g, P<0.05; 
$
35 g significantly different when compared with 20 g, P<0.05; 
#
20 g 
significantly different when compared with 10 g, P<0.05. 
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Whole-body protein metabolism 
Whole-body protein metabolism over time is presented in Figure 4. Ingestion of the 
labeled whey protein resulted in a rapid rise in exogenous phenylalanine appear-
ance rate (Figure 4A), with the lowest and highest (peak) values observed following 
ingestion of 10 and 35 g whey protein, respectively (P<0.05).  
 
 
Figure 4. Whole-body phenylalanine kinetics over time following ingestion of 10 (n=11), 20 (n=11), and 
35 g (n=11) whey protein (µmol phenylalanine·kg
-1
·min
-1
). Exogenous phenylalanine (PHE) appearance 
rates (A), endogenous phenylalanine (PHE) appearance rates (B), Total phenylalanine (PHE) disappear-
ance rates (C), and phenylalanine (PHE) to tyrosine (TYR) conversion rates (D). Values represent 
means±SEM and are expressed as μmol·kg
-1
·min
-1
. Data were analyzed with repeated measures ANOVA 
(time x treatment). In case of a significant interaction, a Bonferroni post-hoc test was applied to locate 
these differences. Exogenous PHE Ra: time effect, P<0.001; treatment effect, P<0.001; time x treatment 
interaction, P<0.001. Endogenous PHE Ra: time effect, P<0.001; treatment effect, P=0.34; time x treat-
ment interaction, P<0.05. Total PHE Rd: time effect, P<0.001; treatment effect, P<0.001; time x treat-
ment interaction, P<0.001. PHE to TYR conversion rates: time effect, P<0.001; treatment effect, P<0.001; 
time x treatment interaction, P<0.001. *35 g significantly different when compared with 10 g, P<0.05; 
$
35 g significantly different when compared with 20 g, P<0.05; 
#
20 g significantly different when com-
pared with 10 g, P<0.05. 
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Total exogenous phenylalanine appearance, expressed as AUC over 4 h, was calcu-
lated as a fraction of the total amount of phenylalanine that was ingested (Equa-
tion 4). The fraction of dietary phenylalanine that appeared in the systemic circula-
tion during the 4 h postprandial period was 61±1, 63±3, and 59±2% following 
ingestion of 10, 20, and 35 g whey protein and did not differ among treatments.  
Endogenous phenylalanine appearance rates decreased following whey protein 
ingestion and did not differ among treatments, though a trend (P=0.08) towards 
lower values following 35 g compared with 10 g was observed at t=180-240 min 
(Figure 4B). Total phenylalanine disappearance rate (Figure 4C) equals the rate of 
phenylalanine to tyrosine conversion, which is the first step in phenylalanine oxida-
tion (Figure 4D), and the utilization for protein synthesis. Phenylalanine to tyrosine 
conversion rates directly increased following whey protein ingestion in all treat-
ments and returned to baseline values by the end of the 4 h period. The highest 
amount (35 g) showed greater values at t=45-120 and t=90-120 min compared with 
the ingestion of 10 and 20 g whey protein (P<0.01), respectively.  
 
 
Figure 5. Whole-body protein metabolism expressed as area under the curve (AUC; µmol phenylala-
nine·kg
-1
) following ingestion of 10 (n=11), 20 (n=11), and 35 g (n=11) whey protein. Values represent 
means±SEM. Data were analyzed with ANOVA with Bonferroni correction. *35 g significantly different 
when compared with 10 g, P<0.05; 
$
35 g significantly different when compared with 20 g, P<0.05; 
#
20 g 
significantly different when compared with 10 g, P<0.05; 
‡
significantly different when compared with 
baseline (0 g). 
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Whole-body protein metabolism expressed as AUC in the basal and postprandial 
period is presented in Figure 5. Phenylalanine released into the circulation from 
whole-body protein breakdown, expressed as AUC of Endo Ra, decreased in all 
groups to the same extent following protein ingestion when compared with basal 
values (P<0.01). Phenylalanine utilized for whole-body protein synthesis, expressed 
as AUC of total Rd minus phenylalanine to tyrosine conversion rate, increased in all 
groups following protein ingestion when compared with basal values (P<0.05). 
Whole-body protein synthesis was higher following ingestion of 20 and 35 g when 
compared with 10 g whey protein (P<0.01). Protein oxidation, expressed as AUC of 
phenylalanine to tyrosine conversion rate, increased in all groups following protein 
ingestion when compared with basal values (P<0.01). Protein oxidation was higher 
following ingestion of 35 g compared with 10 g (P<0.01). Whole-body net protein 
balance increased in all groups following protein ingestion when compared with 
basal values (P<0.01), with the lowest and highest values observed following inges-
tion of 10 and 35 g, respectively (P<0.01). 
 
 
Figure 6. Muscle protein-bound L-[1-
13
C]phenylalanine enrichments (MPE) following ingestion of 10 
(n=11), 20 (n=11), and 35 g (n=11) whey protein. Values represent means±SEM. Data were analyzed 
with ANOVA with Bonferroni correction. *35 g significantly different when compared with 10 g, P<0.01; 
$
35 g significantly different when compared with 20 g, P<0.05 
Muscle tracer analysis 
The increment in muscle protein-bound L-[ring-
2
H5]phenylalanine enrichment 
during the basal period (between the first and the second biopsy) was 
0.0059±0.0005, 0.0059±0.0005, and 0.0065±0.0006 MPE in the groups that ingest-
ed 10, 20, and 35 g whey protein, respectively, and did not differ among treat-
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ments. The increment in muscle protein-bound L-[ring-
2
H5]-phenylalanine enrich-
ments in the postprandial period (between the second and third biopsy) was 
0.0102±0.0010, 0.0119±0.0012, and 0.0136±0.0009 MPE in the 10, 20, and 35 g 
experiment, respectively (P=0.08). The increment in muscle protein-bound L-[1-
13
C]phenylalanine enrichments in the postprandial period differed substantially 
among experiments (P<0.01; Figure 6) and was higher following ingestion of 35 g 
when compared with 10 (P<0.01) or 20 g (P<0.05) whey protein. 
Mixed muscle protein synthesis rates 
Mixed muscle protein synthesis rates are expressed as fractional synthetic rates 
(FSR) and presented in Table 2. In the basal period, FSR values did not differ among 
treatments. In contrast, FSR values were significantly different among treatments 
in the postprandial period (P<0.01). Ingestion of 35 g resulted in significantly higher 
FSR values when compared with basal values (P<.0.05) or ingestion of 10 g whey 
protein (P<0.05). 
 
Table 2. Mixed muscle protein FSR 
 10 g 
whey protein 
(n=11) 
20 g 
whey protein 
(n=11) 
35 g 
whey protein 
(n=11) 
Basal FSR (%·h
-1
) 0.035±0.002 0.037±0.003 0.039±0.003 
Postprandial FSR (%·h
-1
) 0.029±0.004 0.041±0.004 0.052±0.004*‡ 
Difference from basal (%) -1±14 16±13 44±16* 
Mixed muscle protein fractional synthetic rates (FSR) in the fasted, basal period and following ingestion 
of 10 (n=11), 20 (n=11), and 35 g (n=11) whey protein. Values are expressed as means±SEM. Data were 
analyzed with ANOVA. *35 g significantly different when compared with 10 g, P<0.05; 
‡
significantly 
different when compared with basal, P<0.05. 
Discussion 
In the present study, intrinsically L-[1-
13
C]phenylalanine-labeled whey protein was 
used to assess digestion and absorption kinetics of whey protein and its subse-
quent incorporation in newly synthesized muscle protein in vivo in older males. The 
present study shows that ingestion of 35 g whey protein results in greater amino 
acid absorption and subsequent stimulation of de novo muscle protein synthesis 
when compared with the ingestion of 10 or 20 g whey protein in healthy, older 
men. 
Whey protein ingestion has been shown to effectively promote postprandial mus-
cle protein accretion in older adults (8). However, information on the impact of the 
amount of whey protein ingested by older adults on protein digestion, amino acid 
absorption, and postprandial muscle protein accretion has not been established. 
Following the ingestion of 10, 20, and 35 g intrinsically L-[1-
13
C]phenylalanine-
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labeled whey protein, a rapid increase in plasma insulin concentrations (Figure 1A), 
plasma amino acid concentrations (Figure 2), and plasma L-[1-
13
C]phenylalanine 
enrichments (Figure 3A) was found, with the lowest and highest values observed 
following ingestion of 10 and 35 g, respectively. By combining plasma phenylala-
nine concentrations and tracer enrichments, the fraction of dietary phenylalanine 
that appeared in the circulation was calculated (Equation 4). These fractions were 
61±1, 63±3, and 59±2% in the groups that received 10, 20, and 35 g whey protein, 
respectively, and did not differ among treatments. Previous work has suggested 
that first pass clearance of amino acids by visceral tissues increases with increasing 
amounts of protein consumed (19). In agreement, when expressed as absolute 
amounts, 4±1, 8±1 and 14±1 g of whey-protein derived amino acids were retained 
in the gut and did not appear in the circulation during the 4 h postprandial period 
after ingesting 10, 20, and 35 g of whey protein, respectively. Despite greater 
retention in the gut, more amino acids became available in the circulation following 
ingestion of 35 g whey protein when compared with the ingestion of 10 or 20 g 
whey protein in older men. 
Exogenous phenylalanine rates of appearance increased rapidly following whey 
protein ingestion in all groups, with peak values being reached within 30-60 min 
(Figure 4A). No other macronutrients were included because we aimed to assess 
the postprandial response of different amounts of whey protein without possible 
confounding effects of carbohydrate and/or fat intake on protein digestion and 
absorption kinetics (20, 21). Consequently, non-isocaloric protein drinks were 
compared and, as a result, different insulin responses were observed between 
experiments (Figure 1A). Differences in the insulin response are unlikely to have 
modulated the observed muscle protein synthetic response because increases in 
plasma EAA concentrations, and not insulin per se, are responsible for stimulating 
postprandial muscle protein synthesis (22, 23). Circulating insulin levels are regard-
ed permissive rather than modulatory with concentrations of ~10-15 mU·mL
-1
 
being required to allow a maximal muscle protein synthetic response (2, 22-24). In 
the present study, plasma insulin levels exceeded these concentrations in all 
treatments (Figure 1A). In agreement, the observed plasma insulin levels were also 
sufficient to maximize the inhibition of protein breakdown in all treatments (Figure 
5). 
Muscle protein fractional synthetic rates (FSR) following whey protein ingestion 
were calculated under non-steady state conditions which may underestimate 
(peak) postprandial muscle protein synthesis rates (Table 2). As we more interested 
in an aggregated 4 h postprandial response, we also assessed the metabolic fate of 
whey protein-derived amino acids in de novo muscle protein (Figure 6). Only inges-
tion of 35 g whey protein significantly increased muscle protein synthesis rates 
when compared with baseline values. The latter seems to be at odds with the 
whole-body kinetics (Figure 5), showing a positive whole-body protein balance in 
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all treatments. However, whole-body protein kinetics do not necessarily represent 
skeletal muscle tissue, as splanchnic tissues and other organs contribute largely to 
postprandial protein metabolism (19).  
The present study shows that ingestion of 35 g whey protein results in greater 
amino acid absorption and subsequent use for de novo muscle protein synthesis 
when compared with the ingestion of 10 or 20 g whey protein. With habitual pro-
tein ingestion in a single meal varying between 10 g (breakfast) and 35 g (dinner) in 
institutionalized and independently living elderly (25), it has been suggested that 
increasing the amount of protein at breakfast and/or lunch may represent an 
effective dietary strategy to stimulate postprandial muscle protein accretion and, 
as such, improve muscle mass preservation in older adults. It should be noted that 
the dose-response relationship is likely specific for more rapidly digestible protein 
sources. Previous work from our lab suggests that ingesting greater amounts of 
more slowly digestible protein does not result in greater amino acid absorption (5, 
8). In agreement, we observed a dose-response effect between the amount of 
protein ingested and subsequent amino acid absorption rates following ingestion of 
a casein hydrolysate but not intact casein. Besides protein digestion and absorption 
kinetics, amino acid composition as well as co-ingestion of other macronutrients 
are likely to modulate the muscle protein synthetic response following meal inges-
tion. Nonetheless, the presented work clearly underlines the impact of the amount 
of protein ingested on subsequent amino acid availability and muscle protein 
synthesis.  
In conclusion, the ingestion of 35 g whey protein results in more amino acids being 
absorbed and subsequently used for de novo muscle protein synthesis when com-
pared with the ingestion of 10 or 20 g whey protein. These observations imply that 
anabolic resistance to food intake in older adults can, at least partly, be compen-
sated for by ingesting a greater amount of whey protein. 
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Abstract 
Administration of labeled, free amino acids does not allow direct assessment of in 
vivo dietary protein digestion and absorption kinetics. Consequently, dietary pro-
tein sources with labeled amino acids incorporated within their protein matrix are 
required. The aim of the present study was to produce intrinsically L-[1-
13
C]phenylalanine-labeled milk and meat protein that would allow the in vivo as-
sessment of postprandial protein digestion and absorption kinetics in humans. One 
lactating dairy cow was continuously infused with 420 µmol L-[1-
13
C]phenylalanine·min
-1
 for 96 h, with plasma and milk being collected before, 
during, and after isotope infusion. Twenty-four h after infusion, the cow was 
slaughtered to produce intrinsically labeled meat. Levels of L-[1-
13
C]phenylalanine 
enrichment as high as 40 mole percent excess (MPE) in milk and 1.5 MPE in meat 
protein were achieved. In a subsequent human proof-of-principle experiment, 2 
healthy young males (25±1 y; 66.2±5.2 kg) each ingested 135 g intrinsically L-[1-
13
C]phenyl-alanine-labeled minced beef, after which plasma samples were collect-
ed at regular time-intervals. Plasma L-[1-
13
C]phenylalanine enrichments increased 
during the first 90 min following beef ingestion reaching peak plasma enrichment 
levels of 0.61±0.04 MPE. Whole-body net protein balance, assessed by continuous 
infusion of L-[ring-
2
H5]phenylalanine and L-[ring-
2
H2]tyrosine, was higher in the 
postprandial period when compared with basal values (6.4±0.1 vs -4.5±0.1 µmol·kg
-
1
·h
-1
). In conclusion, the production of intrinsically L-[1-
13
C]phenylalanine labeled 
milk and meat protein is feasible and provides functional tools to investigate in vivo 
protein digestion and absorption kinetics in humans. 
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Introduction 
For many years, stable isotope labeled amino acids have been applied to study 
protein metabolism in vivo in humans (1). This work has led to important physiolog-
ical insights and has provided a wealth of practical information on the impact of 
nutrition in maintaining or increasing lean tissue mass in both health and disease 
(2). In general, the turnover of a specific amino acid is investigated through isotope 
dilution via continuous intravenous administration of a labeled amino acid. Howev-
er, when investigating the impact of feeding on protein metabolism, most groups 
generally apply a research design in which labeled leucine or phenylalanine is co-
ingested, with or without continuous infusion of an intravenous amino acid tracer. 
The fact that the oral tracer is being administered as a free amino acid and the bulk 
of amino acids are provided as intact dietary protein introduces substantial meth-
odological limitations (3). Free amino acids and protein-derived amino acids exhibit 
an entirely different timing and efficiency of intestinal absorption (4). Therefore, 
dietary protein with a labeled amino acid incorporated within its protein matrix is 
warranted to directly assess the digestion and absorption kinetics of dietary protein 
in vivo in humans. However, such intrinsically labeled dietary protein is not com-
mercially available and only few reports describe the production of stable isotope 
labeled proteins for more specific purposes (5-8). 
Previously, intrinsically labeled milk protein has been produced by intravenous 
infusion of L-[1-
13
C]leucine (6) or L-[1-
13
C]phenylalanine (9) in lactating dairy cows. 
In the latter experiment, L-[1-
13
C]phenylalanine enrichments in the collected milk 
protein as high as 29.4 mole percent excess (MPE) were achieved. Such high en-
richment levels are necessary when aiming to assess both in vivo protein digestion 
and absorption kinetics as well as the subsequent postprandial muscle protein 
synthetic response following ingestion of meal-like amounts (20-35 g) of protein 
(10, 11). As the latter becomes challenging with smaller amounts of dietary protein, 
we aimed to produce milk proteins with an even greater enrichment level. To allow 
maintenance of high plasma L-[1-
13
C]phenylalanine levels, a single Holstein-Friesian 
dairy cow was continuously infused with 400 g of L-[1-
13
C]phenylalanine for as 
much as 4 days (96 h). Furthermore, an isotonic glucose solution was infused simul-
taneously to increase the mean extraction rate of plasma L-[1-
13
C]phenylalanine by 
the mammary gland (12) and improve milk protein production by minimizing the 
loss of tracer due to hepatic amino acid oxidation (13). 
The maximal recovery rate of tracer in milk protein has been estimated to be 25-
28% (6, 9). We hypothesized that the current infusion protocol would also allow a 
large amount of L-[1-
13
C]phenylalanine to be incorporated in the skeletal muscle 
tissue of the animal. As a consequence we speculated whether the L-[1-
13
C]phenylalanine enrichment of meat protein would be detectable and potentially 
even allow subsequent application in human nutrition research. Therefore, the cow 
CHAPTER 5 
84 
was slaughtered 24 h after cessation of the stable isotope infusion procedure and 
the meat was subsequently used in a human proof-of-principle study to determine 
the potential of assessing beef protein digestion and absorption kinetics in vivo in 
humans. 
In the present study, we extend on our previous work (9) by investigating the 
potential to produce intrinsically L-[1-
13
C]phenylalanine-labeled milk protein with 
an enrichment level that is greater than any previously produced batch of labeled 
milk protein. Furthermore, we tested the applicability of this approach to produce 
intrinsically L-[1-
13
C]phenylalanine-labeled meat protein that would allow the in 
vivo assessment of protein digestion and absorption kinetics following beef inges-
tion in humans. 
Methods 
Production of intrinsically labeled protein 
Animal 
One lactating Holstein-Friesian dairy cow (5
th
 parity, 642 kg live weight, 40 days in 
milk at the start of the infusion period) was selected for the production of intrinsi-
cally L-[1-
13
C]phenylalanine-labeled milk and meat protein. During the infusion 
period, the cow produced 48.6±0.6 kg milk·day
-1
, with an equivalent amount of 
2.05±0.002 and 1.38±0.002 kg fat and protein·day
-1
, respectively. The animal was 
fed a mixed ratio of grass silage (50.8% w/w), maize silage (33.9% w/w), corn cob 
(11.3% w/w), soy-rape seed mix (3.4% w/w), lime (0.1% w/w), salt (0.1% w/w), and 
a mineral mix (0.3% w/w). During the experiment, the cow consumed 23.5±1.0 kg 
dry matter (DM)·day
-1
, which covered 82% of the net energy lactation (NEL) re-
quirements and 80% of the protein requirements (14, 15). The forage mixture was 
offered ad libitum 3 times daily allowing 10% orts. Equal portions of concentrate 
(7.1 kg DM·day
-1
) were given at 6:00, 14:00, and 22:00. The animal was housed in 
an individual tie stall and had free access to water. The experiment and animal 
handling procedures were approved by the Ethics Committee of the Wageningen 
University under the Dutch Law on Animal Experimentation. 
Stable isotope infusion 
The stable isotope L-[1-
13
C]phenylalanine (99% enriched) was purchased from 
Cambridge Isotopes Laboratories (Andover, MA, USA). A total of 400 g L-[1-
13
C]phenylalanine tracer was dissolved in 40 L of an isotonic glucose (5% w/v) 
solution (Braun Melsungen AG, Germany) with a final concentration of 278 mmol 
glucose·L
-1 
and 60.5 mmol L-[1-
13
C]phenyl-alanine·L
-1
. Infusates were stored at 4°C 
pending further use. Prior to use, the infusion bags were allowed to warm up to 
room temperature. 
An outline of the applied infusion protocol is shown in 
the start of the tracer infusion (d-5) th
14:00, and 22:00). Two days prior to tracer infusion
GA x 300 mm with 18 GA x 70 mm needle introducer; Becton Dickinson, BD, Net
erlands) were inserted percutaneously in the right and left jugular vein for intrav
nous infusion (6.94 mL·min
-1
) and blood sampling, 
ously (9). Directly following catheterization, glucose was infused at a rate of 116 
mmol·h
-1
. After 2 days, the milk from 22:00 (d
beled milk) and the continuous infusion of glucose 
started directly following the 6:00 milking at d0. This combined glucose and tracer 
infusion was continued for 96 h to 6:0
at a rate of 420 µmol·min
-1
. General health of the cow was monitored continuous
and all procedures were well-tolerated. 
 
 
Figure 1. Outline of the cow infusion protocol. 
Milk collection 
The cow was milked every 8 h until 24 h following cessation of the infusion (d5), 
with blood samples being obtained at each milking. Milk obtained
milking was separately collected in 25 L containers which were directly cooled to 
<7°C, frozen within 24 h and stored at 
The processing of the milk was performed at NIZO food research (Ede, The Nethe
lands) as previously described (9). In short, intrinsically L
labeled milk was fractionated into a casein 
the fractionation procedure, collected milk was thawed and pooled in a low and 
highly labeled batch. The highly labeled batch consisted of milk collected from 
22:00 at d0 to 06:00 at d4, i.e. from 16 to 96 h following
infusion, respectively. The lower labeled batch consisted of milk collected from 
22:00 at d-1 to 06:00 at d0 (unlabeled milk), milk collected at 14:00 at d0 (8 h 
following the start of the tracer infusion), and milk collected from 
06:00 at d5 (24 h following cessation of the tracer infusion).
Meat collection 
Twenty-four h following the infusion period, the cow was transported to a co
mercial abattoir (Henk Worst, Nijkerk, The Netherlands) and
carcass was refrigerated at 4ºC for 2 d postmortem. Thereafter, the carcass was 
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Figure 1. Five days before 
e cow was adapted to 3 milkings·day
-1
 (6:00, 
 (d-2), catheters (Careflow 16 
h-
e-
respectively, as described previ-
-1) and 6:00 (d0) was collected (unla-
and L[1-
13
C]phenylalanine was 
0 at d4, with L-[1-
13
C]phenylalanine infused 
ly 
 
 
 during each 
-40°C within 48 h until further processing. 
r-
-[1-
13
C]phenylalanine-
and a whey protein concentrate. Before 
 the onset of the tracer 
14:00 at d4 to 
 
m-
 slaughtered. The 
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deboned and meat cuts from the loin rib, shoulder and leg were weighted in por-
tions of 135 g and stored at -18ºC. Before packaging, part of the lean beef was 
minced. Slaughter and processing of the meat followed strict Food and Consumer 
Product Safety Authority regulations to assure that no contamination occurred 
during processing of the meat and that meat products were fully qualified for 
human consumption. 
Cow plasma and protein analyses 
Plasma phenylalanine and tyrosine were derivatized to their t-butyldimethylsilyl 
(TBDMS) derivatives and their 
13
C enrichments were determined by electron ioniza-
tion gas chromatography-mass spectrometry (GC-MS, Agilent 6890N GC/5973N 
MSD Little Falls, DE, USA) using selected ion monitoring of masses 336 and 337 for 
unlabeled and labeled L-[1-
13
C]phenylalanine, respectively; and masses 466, 467, 
for unlabeled and labeled L-[1-
13
C]tyrosine, respectively (16).  
For measurement of L-[1-
13
C]phenylalanine and L-[1-
13
C]tyrosine enrichments in 
the intrinsically labeled milk protein, 100 µL milk was added to 900 µL 2% ice-cold 
perchloric acid (PCA). The mixture was vortexed, kept on ice for 10 min and centri-
fuged.  
The protein pellet was washed with 3 additional 1.5 mL washes of 2% PCA, dried 
and hydrolyzed in 6M HCl at 120°C for 15-18 h. The hydrolyzed protein fraction was 
dried under a nitrogen stream while heated to 120°C, after which 50% acetic acid 
solution was added. The hydrolyzed protein was passed over a Dowex exchange 
resin (AG 50W-X8, 100-200 mesh hydrogen form, Biorad, Hercules, CA, USA) using 
2M NH4OH. Thereafter, the eluate was dried and the purified amino acids were 
derivatized to their N(O,S)-ethoxycarbonyl ethyl esters for the determination of 
13
C/
12
C ratios of milk protein-bound phenylalanine and tyrosine (17). Thereafter, 
the derivative was measured by GC-C-IRMS (Finnigan MAT 252, Bremen, FRG) using 
HP Ultra I GC-column (#19091A-112, Hewlett-Packard, Palo Alto, CA), combustion 
interface II and monitoring of ion masses 44 and 45.  
For measurement of L-[1-
13
C]phenylalanine enrichment in the intrinsically labeled 
meat protein, 55 mg meat was freeze-dried. Collagen, blood, and other non-muscle 
fiber material were removed from the meat under a light microscope. The isolated 
muscle fiber mass (10-15 mg) was weighed and 8 volumes (8x dry weight of isolat-
ed muscle fibers x wet/dry ratio) ice-cold 2% perchloric acid (PCA) were added. The 
tissue was then homogenized and centrifuged and the meat protein pellet was 
analyzed similarly as the milk protein pellet. 
The protein-bound enrichments of phenylalanine and tyrosine were determined by 
establishing the relationship between the enrichment of a series of L-[1-
13
C]phenylalanine and L-[1-
13
C]tyrosine standards of variable enrichment and the 
enrichment of the N(O,S)-ethoxycarbonyl ethyl esters of these standards. Standard 
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regression curves were applied in all isotopic enrichment analysis to assess for 
linearity of the mass spectrometer and to control for the loss of tracer.  
Human proof-of-principle study 
Subjects 
Two healthy young male volunteers (age: 25±1 y; weight: 66.2±5.2 kg; BMI: 
20.8±1.6 kg·m
-2
; basal glucose: 5.2±0.3 mmol·L
-1
; basal insulin: 8.5±1.8 mU·L
-1
) with 
no history of participating in any regular exercise program were selected to partici-
pate in the present study. Both subjects were informed on the nature and possible 
risks of the experimental procedures, before their written informed consent was 
obtained. This study was approved by the Medical Ethics Committee of the Aca-
demic Hospital Maastricht. 
Protocol 
At 8:00 am, following an overnight fast, subjects arrived at the laboratory by car. A 
Teflon catheter was inserted into an antecubital vein for stable isotope infusion. A 
second Teflon catheter was inserted in a heated dorsal hand vein of the contrala-
teral arm and placed in a hot-box (60°C) for arterialized blood sampling (18). Stable 
isotopes L-[ring-
2
H5]phenylalanine and L-[ring-
2
H2]-tyrosine were purchased from 
Cambridge Isotopes (Andover, MA) and dissolved in 0.9% saline before infusion. 
Tracer solutions were prepared by the pharmacy of the Academic Hospital Maas-
tricht (Maastricht, The Netherlands) following GMP-standards. Following basal 
blood collection, the plasma phenylalanine and tyrosine pools were primed with a 
single intravenous dose of 2 µmol·kg-1 L-[ring-2H5]phenylalanine and 0.775 µmol·kg
-
1 
L-[ring-
2
H2]tyrosine. Thereafter, continuous tracer infusion was started with an 
infusion rate of 0.050 and 0.019 µmol·kg-1·min-1 for L-[ring-2H5]phenylalanine and L-
[ring-
2
H2]tyrosine, respectively. After resting in a supine position for 60 min, a 
second arterialized blood sample was drawn (t=-90 min), marking the start of the 
post-absorptive period. During the post-absorptive period, arterialized blood sam-
ples were collected at t= -60, -30, and 0 min. Subjects then received 135 g minced 
beef (containing ~26 g protein). During the postprandial period, arterialized blood 
samples were collected at t= 30, 60, 90, 120, 150, 180, 240, 300, and 360 min.  
Beef preparation 
Subjects received a portion of 135 g minced lean beef. Meat was prepared in the 
kitchen of the department of Human Movement Sciences on the morning of the 
test day. In short, the minced beef (overnight-thawed in a refrigerator at 4ºC) was 
grilled until the inner temperature reached 65ºC. Subjects ingested the beef within 
15 min. Subjects were allowed to add salt (0.5 g) to the beef and drink a glass of 
water (200 mL).  
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Plasma Analyses 
Plasma (100 µL) for amino acid analyses was deproteinized on ice with 10 mg dry 5-
sulphosalicylic acid, mixed and the clear supernatant was collected after centrifuga-
tion. Plasma amino acid concentrations were determined by HPLC, after precolumn 
derivatization with o-phthaldialdehyde (19). For plasma ring-
2
H enrichment meas-
urements, phenylalanine and tyrosine were derivatized to their t-butyldimethylsilyl 
(TBDMS) derivatives and their 
2
H enrichments were determined by electron ioniza-
tion gas chromatography-mass spectrometry (GC-MS, Agilent 6890N GC/5973N 
MSD Little Falls,DE, USA) using selected ion monitoring of masses 336 and 341 for 
unlabeled and labeled (ring-
2
H5) phenylalanine, respectively, and masses 466, 468 
and 470 for unlabeled and labeled (ring-
2
H2 and ring-
2
H4) tyrosine, respectively 
(16). For plasma 1-
13
C enrichment measurements, phenylalanine was derivatized to 
its N(O,S)-ethoxycarbonyl ethyl esters (17). Thereafter, the ratios labeled/unlabeled 
derivatives were determined by GC-C-IRMS (Finnigan MAT 252, Bremen, Germany). 
Standard regression curves were applied in all isotopic enrichment analyses to 
assess for linearity of the mass spectrometer and to control for the loss of tracer. 
Enrichments were corrected for the presence of all isotopes of the same moiety 
(20). 
Calculations 
Ingestion of L-[1-
13
C]phenylalanine-labeled beef, intravenous infusion of L-[ring-
2
H5]phenylalanine and L-[ring-
2
H2]tyrosine, and arterialized blood sampling were 
used to assess whole-body phenylalanine kinetics in non-steady state conditions. 
Total, exogenous, and endogenous rate of appearance (Ra) and plasma availability 
of dietary phenylalanine (i.e., fraction of dietary phenylalanine that appeared in the 
systemic circulation, Pheplasma) were calculated using modified Steele’s equations 
(3, 21). These parameters were calculated as follows: 
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where F is the intravenous tracer infusion rate (µmol·kg
-1
·min
-1
), pV (0.125) is the 
distribution volume for phenylalanine (3). C(t) is the mean plasma phenylalanine 
concentration between two time points. dEiv/dt represents the time-dependent 
variations of plasma phenylalanine enrichment derived from the intravenous tracer 
and Eiv(t) is the mean plasma phenylalanine enrichment from the intravenous 
tracer between 2 consecutive time points. Exo Ra represents the plasma entry rate 
of dietary phenylalanine, Epo(t) is the mean plasma phenylalanine enrichment for 
the oral tracer, dEpo/dt represents the time-dependent variations of plasma phe-
nylalanine enrichment derived from the oral tracer and Eprot is the L-[1-
13
C]phenylalanine enrichment in the dietary protein. PheProt is the amount of die-
tary phenylalanine ingested, AUCExoRa represents the area under the curve (AUC) of 
Exo Ra, which corresponds to the amount of dietary phenylalanine that appeared in 
the blood over a 6 h period following beef ingestion. BW represents the subjects’ 
body weight in kg. 
Total rate of disappearance of phenylalanine (Total Rd) equals the rate of phenylal-
anine (PHE) to tyrosine (TYR) conversion by hydroxylation (first step in phenylala-
nine oxidation) and utilization for protein synthesis. These parameters can be 
calculated as follows: 
t
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 Protein synthesis = Total Rd– PHE to TYR conversion (7) 
 PHE net balance = Protein synthesis – Endo Ra (8) 
where Phe Rd and Tyr Ra are the flux rates for phenylalanine and tyrosine, respec-
tively, Et(t) and Ep(t) are the mean plasma enrichments of L-[ring-
2
H4]tyrosine and L-
[ring-
2
H5]phenylalanine, respectively, and Fp is the infusion rate of the phenylala-
nine tracer. 
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Results 
Production of intrinsically labeled protein 
Plasma analyses 
Infusion of L-[1-
13
C]phenylalanine in the cow substantially increased plasma L-[1-
13
C]phenylalanine enrichment (Figure 2). During the infusion period, mean plasma 
L-[1-
13
C]phenylalanine enrichment averaged 37.4±1.2 MPE. As a result of the L-[1-
13
C]phenylalanine infusion, plasma L-[1-
13
C]tyrosine enrichment also increased 
during the experiment and averaged 7.0±0.4 MPE. 
 
 
 
Figure 2. Cow plasma and milk enrichments of L-[1-
13
C]phenylalanine and L-[1-
13
C]tyrosine obtained 
before, during, and after the infusion protocol. Values are expressed as mole percent excess (MPE) 
 
Milk analyses 
L-[1-
13
C]phenylalanine and L-[1-
13
C]tyrosine enrichments over time are illustrated 
in Figure 2. Milk L-[1-
13
C]phenylalanine enrichment averaged 36.2±0.7 and 10.3±0.2 
MPE in the high and low labeled batches, respectively. Milk L-[1-
13
C]tyrosine en-
richment averaged 8.0±0.2 and 2.4±0.1 MPE, respectively. The labeled batches 
provided 178 and 86 kg milk, respectively. Both batches were successfully fraction-
ated into a high and low labeled casein protein concentrate (36 and 16 kg, respec-
tively) and high and low labeled whey protein concentrate (15 and 13 kg, respec-
tively). The composition of the milk protein concentrates are shown in Table 1. The 
total yield of intrinsically L-[1-
13
C]phenylalanine-labeled casein was 3.3 and 1.6 kg in 
the high and low labeled batch, respectively. A total of 0.6 and 0.3 kg of intrinsically 
L-[1-
13
C]phenylalanine-labeled whey protein was isolated from the high and low 
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labeled batch, respectively. The produced protein concentrates met all food-grade 
specifications and were subsequently released for human consumption. 
Of the 400 g L-[1-
13
C]phenylalanine that were infused in the cow, approximately 
105 g were recovered in the collected milk. Consequently, the recovery rate of 
tracer in milk protein was calculated to be 26% 
 
Table 1. Composition of the milk protein concentrates 
Protein concentrate 
Total  
protein (%) 
Casein and denatured 
whey protein
1
 (%) 
Native  
whey protein (%) 
High L-[1-
13
C]phe-labeled casein 9.03 8.75 (97%) 0.28 (3%) 
Low L-[1-
13
C]phe-labeled casein 10.40 10.10 (97%) 0.31 (3%) 
High L-[1-
13
C]phe-labeled whey 3.81 0.28 (7%) 3.53 (93%) 
Low L-[1-
13
C]phe-labeled whey 2.55 0.29 (11%) 2.26 (89%) 
The amounts of casein of whey protein in the protein concentrates are shown between brackets. 
1 
The 
presence of denatured whey proteins is regarded as nil as the temperature during processing was below 
the denaturation temperature of whey protein. 
Meat analyses 
The mean (±SEM) L-[1-
13
C]phenylalanine enrichment of the collected lean beef was 
1.38±0.05 MPE. The enrichment of the different meat cuts are shown in Table 2. 
Subjects in the human experiment ingested minced beef (from the leg) which had a 
L-[1-
13
C]phenylalanine enrichment of 1.47±0.02 MPE. 
 
Table 2. L-[1-
13
C]phenylalanine enrichment of different meat cuts (loin rib, shoulder and leg) after the 
labeling procedure. 
 Enrichment (MPE)
1
 
Loin rib 1.30±0.03 
Shoulder 1.37±0.12 
Leg 1.47±0.06 
1 
Enrichments are expressed as mole percent excess (MPE; mean ± SEM). 
 
Based on a total body mass of 642 kg, the estimated skeletal muscle mass of our 
cow was ~200 kg. As beef contains 7.5 g of phenylalanine·kg
-1
 (22), the recovery 
rate of tracer in the total skeletal muscle protein pool was approximately 6%. 
Human proof-of-principle study 
Plasma analyses 
The time course of the plasma L-[1-
13
C]phenylalanine and L-[ring-
2
H5]-
phenylalanine enrichments in the human experiment are illustrated in Figure 3A. 
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Plasma L-[1-
13
C]phenylalanine enrichment (derived from the intrinsically labeled 
meat) rapidly increased following beef ingestion, reaching peak levels after 90 min 
(0.61±0.04 MPE), after which they subsequently declined. The plasma L-[ring-
2
H5]phenylalanine enrichment decreased following the ingestion of the beef, after 
which levels returned towards basal values.  
Whole-body phenylalanine kinetics 
Ingestion of the intrinsically labeled beef resulted in a rapid increase in the appear-
ance rates of exogenous phenylalanine, reaching peak levels after 120 min 
(0.42±0.01 µmol·kg
-1
·h
1
), after which they subsequently declined over time (Figure 
3B). In contrast, appearance rates of endogenous phenylalanine decreased over 
time following ingestion of the beef (Figure 3C). The calculated percentage of 
ingested phenylalanine that appeared in the circulation was 79±1%. Whole-body 
net protein balance, calculated using plasma phenylalanine kinetics, was -4.5±0.1 
µmol·kg
-1
·h
1 
in the post-absorptive period and 6.4±0.1 µmol·kg
-1
·h
1 
in the postpran-
dial period. 
 
 
Figure 3. (A) Plasma L-[ring-
2
H5]phenylalanine and L-[1-
13
C]phenylalanine enrichments expressed as 
mole percent excess (MPE); and (B) Exogenous and (C) Endogenous rates of phenylalanine appearance 
expressed as µmol·kg
-1
·min
-1 
following beef ingestion in the human experiment (n=2). All values repre-
sent means±SEM. 
Discussion 
The present study shows that intrinsically L-[1-
13
C]phenylalanine-labeled milk and 
meat protein can be successfully produced by infusing a large amount of L-[1-
13
C]phenylalanine in a lactating dairy cow. Levels of L-[1-
13
C]phenylalanine enrich-
ment as high as 40 MPE in milk and 1.5 MPE in meat protein were achieved. This 
level of milk protein enrichment is greater than any previously produced batch of 
intrinsically labeled milk protein. In addition, this is the first study to report the 
production of intrinsically labeled meat protein and show its applicability as a 
functional tool to assess in vivo protein digestion and absorption kinetics following 
beef ingestion in humans. 
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In the present study, we extend on our previous work by investigating the potential 
to produce intrinsically L-[1-
13
C]phenylalanine-labeled milk protein with an enrich-
ment level that is greater than any previously produced batch of intrinsically la-
beled milk protein (6, 9, 23). Therefore, we applied a different regimen of L-[1-
13
C]phenylalanine isotope tracer administration to a lactating dairy cow. During 
tracer infusion, cow plasma L-[1-
13
C]phenyl-alanine enrichments reached levels as 
high as 37-44 MPE (Figure 2) which were considerably higher than the highest 
plasma enrichments that have been published previously (9). The high plasma 
enrichments were closely matched by a comparable rise in milk L-[1-
13
C]phenylalanine enrichment during tracer infusion (Figure 2). Consequently, the 
absolute L-[1-
13
C]-phenylalanine enrichment of the milk protein batches obtained 
in the current experiment were greater than previously reported, and averaged 
36.2 versus 29.4 and 10.3 versus 6.1 MPE, in the high and low labeled batches, 
respectively. The higher tracer enrichment could be attributed to both the longer 
tracer infusion (i.e. 96 vs 48 h) as well as the co-infusion of glucose. The latter 
should reduce plasma amino acid oxidation and, as such, maximize the tracer 
incorporation in endogenous protein (13). Of course, we can only speculate on the 
impact of glucose co-infusion on the proposed inhibition of amino acid oxidation. 
As the first step in phenylalanine oxidation is the hydroxylation to tyrosine, the 
magnitude of this process could be estimated from the accompanying increase in L-
[1-
13
C]tyrosine enrichment in both cow plasma and milk (Figure 2). The plasma L-[1-
13
C]tyrosine enrichments averaged 5.4±0.6 and 7.5±0.8 MPE in the previous and 
current experiment, respectively. The latter suggests that there were no large 
differences in plasma amino acid oxidation between both protocols. Therefore, the 
higher label enrichment of the milk batches in the present study is likely attributed 
to the longer tracer infusion protocol. This protocol allowed for a longer time 
period during which highly labeled milk could be collected, which is of particular 
relevance as L-[1-
13
C]phenylalanine milk enrichment takes about 32 h to reach peak 
enrichment levels (Figure 2). 
The recovery rate of tracer in milk protein was calculated to be 26%, which is in 
agreement with previous observations (6, 9). As only 26% of the infused tracer was 
retrieved in the labeled milk, 74% of the tracer had been directed to other tissues 
and metabolic processes. We speculated that with a 4 d infusion protocol a large 
amount of tracer would also have been incorporated in the muscle protein pool of 
the cow. Therefore, lean beef was harvested to evaluate whether this isotope 
tracer administration protocol would also allow the production of intrinsically 
labeled meat. As a result, labeled beef was obtained with a L-[1-
13
C]phenylalanine 
enrichment of 1.38±0.05 MPE. This is the first study to report the successful pro-
duction of intrinsically isotope labeled meat. The level of enrichment is much lower 
than that observed in the milk protein, which is not surprising considering the 
relatively low protein turnover rate of skeletal muscle protein when compared with 
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the rate of milk protein production in a lactating dairy cow. However, despite a 
total body mass of 642 kg and an estimated skeletal muscle mass of more than 200 
kg, we obtained a considerable level of muscle tissue L-[1-
13
C]phenylalanine en-
richment (Table 2). Theoretically, this level of enrichment should be sufficient to 
allow assessment of in vivo protein digestion and absorption kinetics following beef 
ingestion. To confirm the applicability of the intrinsically labeled meat in studying in 
vivo protein digestion and absorption kinetics, a subsequent proof-of-principle 
experiment was performed in humans. 
In the human experiment, 2 healthy young men were selected to ingest 135 g of L-
[1-
13
C]phenylalanine-labeled minced beef. Immediately after ingestion of the 
minced beef, plasma amino acid concentrations (data not shown) and plasma L-[1-
13
C]phenylalanine enrichments (Figure 3A) increased. Calculation of the exogenous 
phenylalanine appearance rate allowed for the direct assessment of dietary phe-
nylalanine that appeared in the circulation during the 6 h postprandial period 
(Figure 3B). The percentage of dietary phenylalanine that became available in the 
circulation was 79%. This percentage tends to be much higher when compared with 
label retention reported following the ingestion of milk protein (10). Future re-
search, therefore, should compare the bioavailability of dietary protein-derived 
amino acids between different protein sources. As plasma amino acid availability 
increased due to the digestion and absorption of the ingested meat, endogenous 
phenylalanine appearance rates decreased (Figure 3C). These changes were indica-
tive for a shift to a more anabolic situation. In fact, when subtracting whole-body 
protein synthesis rates from whole-body breakdown rates it became apparent that 
beef ingestion strongly increased whole-body net protein balance (-4.5±0.1 vs 
6.4±0.1 µmol·kg
-1
·h
-1
 in the post-absorptive and postprandial period, respectively). 
Such an increase is in line with previous work that assessed whole-body net protein 
balance following amino acid or milk protein ingestion (1, 3, 4, 11, 20, 21, 24). 
The present study shows that intrinsically L-[1-
13
C]phenylalanine-labeled milk and 
meat protein can be successfully produced by infusing a large amount of L-[1-
13
C]phenylalanine in a lactating dairy cow. Levels of L-[1-
13
C]phenylalanine enrich-
ment as high as 40 MPE in milk and 1.5 MPE in meat protein were achieved. This 
level of milk protein enrichment is greater than any previously produced batch of 
intrinsically labeled milk protein. In addition, this is the first study to report the 
production of intrinsically labeled meat protein and show its applicability as a 
functional tool to assess in vivo protein digestion and absorption kinetics following 
beef ingestion in humans. Because dairy and meat are considered high quality and 
widely consumed protein sources, the applicability of intrinsically labeled milk and 
meat protein will be instrumental to obtain further insight in human nutrition 
research. 
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Abstract 
Older individuals generally experience a reduced food chewing efficiency. As a 
consequence, food texture may represent an important factor that modulates 
dietary protein digestion and absorption kinetics and subsequent postprandial 
protein balance. The aim of the present study was assess the impact of meat tex-
ture on protein digestion and absorption kinetics, exogenous amino acid availabil-
ity, and subsequent postprandial protein balance in vivo in older men. Ten older 
men (74±2 y) were randomly assigned to a cross-over experiment that involved 2 
treatments in which they consumed 135 g specifically produced intrinsically L-[1-
13
C]phenylalanine-labeled beef, provided as beef steak or minced beef. Meat con-
sumption was combined with continuous intravenous L-[ring-
2
H5]phenylalanine and 
L-[ring-
2
H2]tyrosine infusion to assess beef protein digestion and absorption kinet-
ics as well as whole-body protein synthesis, breakdown, and oxidation rates. Meat 
protein-derived phenylalanine appeared more rapidly in the circulation following 
minced beef vs beef steak consumption (P<0.05). Furthermore, a greater amount 
of meat-derived phenylalanine became available in the systemic circulation during 
the 6 h postprandial period following consumption of minced beef vs beef steak 
(61±3 vs 49±3%, respectively; P<0.01). Whole-body protein balance was more 
positive following minced beef vs beef steak consumption (29±2 vs 19±3 µmol 
phenylalanine·kg
-1
, respectively; P<0.01).  
In conclusion, consumption of minced beef is followed by more rapid protein 
digestion and absorption kinetics when compared with the consumption of beef 
steak, resulting in increased amino acid availability and greater postprandial pro-
tein retention in older men. 
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Introduction 
Aging is accompanied by a progressive decline in skeletal muscle mass, termed 
sarcopenia (1). Recent work shows that the anabolic response to food intake is 
impaired in older adults (2-5). This proposed anabolic resistance is now regarded a 
key-factor in the etiology of sarcopenia.  
Dietary protein-derived amino acids serve as the main building blocks for de novo 
muscle protein synthesis (6). As such, the muscle protein synthetic response to 
food intake strongly depends on the quantity (7, 8) and quality (9, 10) of dietary 
protein consumed. Ingestion of dietary protein stimulates whole-body protein 
synthesis and inhibits protein breakdown rates, resulting in a positive net protein 
balance (11). However, the magnitude of this positive protein balance seems to 
depend on both the rate at which dietary proteins are digested as well as the age 
of the consumer (9, 12-14). Whereas young adults generally show a more positive 
whole-body protein balance after consumption of slowly digestible protein sources, 
older adults show a more positive whole-body protein balance after ingestion of 
more rapidly digestible protein sources (9, 12-14). 
Meat is considered a high quality and widely consumed protein source. The texture 
of the consumed meat plays a key-role in chewing efficiency and subsequent bolus 
formation during mastication (15). Aging has been associated with decreased 
chewing efficiency, leading to a lower disruption of swallowed meat pieces (16). 
The consequences of meat texture on dietary protein digestion rate, plasma amino 
acid availability, and subsequent postprandial protein retention, however, remain 
to be established.  
To directly and accurately assess the appearance rate of dietary protein-derived 
amino acids from the gut into the circulation, dietary protein with a labeled amino 
acid incorporated within its protein matrix is warranted (17). However, such intrin-
sically labeled dietary protein is not commercially available and only few reports 
describe the production of intrinsic stable isotope-labeled dietary proteins for the 
purpose of nutrition research (18-20). Recently, we succeeded in producing intrin-
sically labeled protein by infusing large amounts of L-[1-
13
C]phenylalanine in a 
Holstein cow. Besides collecting intrinsically L-[1-
13
C]phenylalanine-labeled milk, we 
also butchered the cow, thereby obtaining intrinsically labeled meat certified for 
human consumption (21). The latter is the unique feature of this study and allows 
us to directly assess meat protein digestion and absorption kinetics in vivo in hu-
mans.  
In the present study, 10 older men were randomly assigned to a cross-over experi-
ment in which they consumed 135-g intrinsically L-[1-
13
C]-phenylalanine-labeled 
beef, provided either as a minced beef paddy or as a beef steak. We hypothesized 
that minced beef is more rapidly digested and absorbed when compared with beef 
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steak, resulting in increased amino acid availability and greater postprandial pro-
tein retention in older males 
Methods 
Subjects 
Ten elderly men (age: 74±2 y; weight: 79.3±3.3 kg; BMI: 26.2±0.8 kg·m
-2
; basal 
glucose: 5.7±0.1 mmol·L
-1
; basal insulin: 16.0±1.2 mU·L
-1
) participated in this study. 
All subjects wore dentures for ≥6 months. None of the subjects had a history of 
participating in any regular exercise program. All subjects were informed on the 
nature and possible risk of the experimental procedures before their written in-
formed consent was obtained. This study was approved by the Medical Ethics 
Committee of the Academic Hospital Maastricht. 
Pretesting 
Before selection in the study an oral glucose tolerance test (OGTT) was performed 
to assess glucose tolerance and screen for type 2 diabetes prevalence according to 
World Health Organization criteria (22). Prior to the OGTT, body weight and height 
were assessed and body composition was determined by dual-energy X-ray absorp-
tiometry (DXA, Discovery A, Hologic Corporate, Bedford, MA, USA). 
Diet and activity prior to testing  
All subjects consumed a standardized meal (32±2 kJ·kg
-1
 body weight, consisting of 
55 energy% (E%) carbohydrate, 15 E% protein and 30 E% fat) the evening prior to 
the experiment. All volunteers were instructed to refrain from any sort of exhaus-
tive physical activity and to keep their diet as constant as possible 3 d prior to the 
experiments.  
Protocol 
All subjects were randomly assigned to a cross-over experiment that involved 2 
treatments in which they consumed a piece of 135 g intrinsically L-[1-
13
C]phenylalanine-labeled beef, either minced as a beef patty or intact as a steak. 
Both treatments were separated by at least 14 days. Each treatment started at 8.00 
am, when overnight-fasted subjects arrived at the laboratory by car or public 
transportation. A Teflon catheter was then inserted into an antecubital vein for 
stable isotope infusion. A second Teflon catheter was inserted in a heated dorsal 
hand vein of the contralateral arm and placed in a hot-box (60°C) for arterialized 
blood sampling (23). Following basal blood collection (t=-150 min), the plasma 
phenylalanine and tyrosine pools were primed with a single intravenous dose of L-
[ring-
2
H5]-phenylalanine (2 µmol·kg
-1
) and L-[ring-
2
H2]tyrosine (0.615 µmol·kg
-1
), 
after which continuous L-[ring-
2
H5]phenylalanine and L-[ring-
2
H2]-tyrosine infusion 
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was started (0.050±0.001 and 0.015±0.002 µmol·kg-1·min-1, respectively). After 
resting in a supine position for 60 min, a second arterialized blood sample was 
drawn and a muscle biopsy was collected from the vastus lateralis muscle (t=-90 
min). Additional arterialized blood samples (6 mL) were collected at t= -60, -30, and 
0 min with a second muscle biopsy taken at t=0 min, marking the end of the fasting, 
basal period. Subjects then received the meat meal to which they were allowed to 
add (the same amount of) salt and drink a glass of water. The time that the subjects 
needed to consume the entire meal was recorded. Following the consumption of 
the entire meal, subjects filled in a visual analogue scaled (VAS) questionnaire on 
the effort and time perceived of chewing the meat before swallowing. Arterialized 
blood samples were collected at t= 30, 60, 90, 120, 150, 180, 240, 300, and 360 min 
following the complete consumption of the meat meal. A third muscle biopsy taken 
from the vastus lateralis of the contra-lateral limb was obtained at 360 min to mark 
the end of the postprandial period. Blood samples were collected in EDTA contain-
ing tubes and centrifuged at 1000 g for 5 min at 4°C. Aliquots of plasma were fro-
zen in liquid nitrogen and stored at –80°C. Muscle biopsies were obtained from the 
middle region of the vastus lateralis, 15 cm above the patella and approximately 3 
cm below entry through the fascia, using the percutaneous needle biopsy tech-
nique. Muscle samples were dissected carefully and freed from any visible non-
muscle material. The muscle samples were immediately frozen in liquid nitrogen 
and stored at –80°C until further analysis.  
Preparation of intrinsically labeled meat 
Intrinsically L-[1-
13
C]phenylalanine-labeled meat was obtained by infusing a Hol-
stein cow with large quantities of L-[1-
13
C]phenylalanine as described previously 
(21). Twenty-four h following the infusion period, the cow was transported to a 
commercial abattoir (Henk Worst, Nijkerk, The Netherlands) and slaughtered. The 
carcass was refrigerated at 4ºC for 2 d postmortem. Thereafter, the carcass was 
deboned and meat cuts from the right leg were weighted in portions of 135 g and 
stored at -18ºC. Before packaging and storage, part of the lean beef was minced to 
guarantee that meat from the same cut could be provided as a minced beef paddy 
as well as a beef steak. On the morning of the test day, meat meals were prepared 
in the kitchen of the department of Human Movement Sciences. In short, the meat 
meals (overnight-thawed in a refrigerator at 4ºC) were grilled until the inner tem-
perature reached 65ºC. The meat met all chemical and bacteriologic specifications 
for human consumption. The L-[1-
13
C]phenylalanine enrichment, assessed by gas 
chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) after 
hydrolysis, was 1.47±0.03 mole percent excess (MPE). The protein content was ~19 
g protein per 100 g (raw) beef. As such, 135 g beef provided ~26 g protein and ~ 2 g 
leucine. 
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VAS questionnaire 
Following the consumption of the entire meal, subjects filled in a VAS questionnaire 
on the effort perceived of chewing the meat before swallowing. They specified 
their answer by indicating a position along a continuous 10-cm line between two 
end-points, i.e. not much effort (0 cm) and a lot of effort (10 cm). 
Plasma analyses 
Plasma glucose (Uni Kit III, 07367204, Roche, Basel, Switzerland) concentrations 
were analyzed with the COBAS-FARA semi-automatic analyzer (Roche). Insulin was 
analyzed by radio-immunoassay (Insulin RIA kit, LINCO Research Inc., St. Charles, 
MO, USA). Plasma (100 µL) for amino acid analyses was deproteinized on ice with 
10 mg dry 5-sulphosalicylic acid, mixed and the clear supernatant was collected 
after centrifugation. Plasma amino acid concentrations were determined by
 
HPLC, 
after precolumn derivatization with o-phthaldialdehyde (24). For plasma ring-
2
H 
enrichment measurements, plasma phenylalanine and tyrosine were derivatized to 
their t-butyldimethylsilyl (TBDMS) derivatives and analyzed by gas chromatography 
mass spectrometry (GC-MS, Agilent 6890N GC/5973N MSD Little Falls, DE, USA) 
using selected ion monitoring of masses 336 and 341 for unlabeled and labeled 
(ring-
2
H5) phenylalanine, respectively; and masses 466, 468 and 470 for unlabeled 
and labeled (ring-
2
H2 and ring-
2
H4) tyrosine, respectively (25). For plasma 1-
13
C 
enrichment measurements, phenylalanine was derivatized to its N(O,S)-
ethoxycarbonyl ethyl ester (26). Thereafter, the ratios labeled/unlabeled deriva-
tives were analyzed by gas chromatography combustion isotope ratio mass spec-
trometry (GC-C-IRMS, Finnigan MAT 252, Bremen, Germany). Standard regression 
curves were applied in all isotopic enrichment analyses to assess linearity of the 
mass spectrometer and to control for the loss of tracer. 
Muscle analyses 
For measurement of L-[ring-
2
H5]phenylalanine enrichment in the muscle tissue-free 
amino acid pool and mixed muscle protein, 55 mg of wet muscle was freeze-dried. 
Collagen, blood, and other non-muscle fiber material were removed from the 
muscle fibers under a light microscope. The isolated muscle fiber mass (10-15 mg) 
was weighed and 8 volumes (8x dry weight of isolated muscle fibers x wet/dry 
ratio) of ice-cold 2% perchloric acid (PCA) were added. The tissue was then homog-
enized and centrifuged. The supernatant was collected and processed in the same 
manner as the plasma samples, such that tissue-free L-[ring-
2
H5]phenylalanine 
enrichments could be measured using their TBDMS derivatives on a GC-MS.  
The protein pellet was washed with 3 additional 1.5 mL washes of 2% PCA, dried 
and hydrolyzed in 6M HCl at 120°C for 15-18 h. The hydrolyzed protein fraction was 
dried under a nitrogen stream while heated to 120°C, then 50% acetic acid solution 
was added, and the hydrolyzed protein was passed over a Dowex exchange resin 
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(AG 50W-X8, 100-200 mesh hydrogen form, Biorad, Hercules, CA, USA) using 2M 
NH4OH. The eluate was collected and L-[ring-
2
H5]phenylalanine was derivatized to 
MTBSTFA-phenylethylamine (26). Thereafter, the ratios labeled/unlabeled deriva-
tives were determined by GC-MS. Standard regression curves were applied to 
assess linearity of the mass spectrometer and to control for loss of tracer. 
Calculations 
Ingestion of L-[1-
13
C]phenylalanine-labeled meat, intravenous infusion of L-[ring-
2
H5]phenylalanine and L-[ring-
2
H2]tyrosine, and arterialized blood sampling were 
used to assess whole-body protein metabolism in non-steady state conditions. 
Total, exogenous, and endogenous phenylalanine rate of appearance (Ra) and 
plasma availability of dietary phenylalanine (i.e., fraction of dietary phenylalanine 
that appeared in the systemic circulation, Pheplasma) were calculated using modified 
Steele’s equations (13, 27). These parameters were calculated as follows: 
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where F is the intravenous tracer infusion rate (µmol·kg
-1
·min
-1
), pV (0.125) is the 
distribution volume for phenylalanine (27). C(t) is the mean plasma phenylalanine 
concentration between two time points. dEiv/dt represents the time-dependent 
variations of plasma phenylalanine enrichment derived from the intravenous tracer 
and Eiv(t) is the mean plasma phenylalanine enrichment from the intravenous 
tracer between two consecutive time points. Exo Ra represents the plasma entry 
rate of dietary phenylalanine, Epo(t) is the mean plasma phenylalanine enrichment 
for the oral tracer, dEpo/dt represents the time-dependent variations of plasma 
phenylalanine enrichment derived from the oral tracer and Eprot is the L-[1-
13
C]phenylalanine enrichment in the dietary protein. PheProt is the amount of die-
tary phenylalanine ingested, AUCExoRa represents the area under the curve (AUC) of 
Exo Ra, which corresponds to the amount of dietary phenylalanine that appeared in 
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the blood over the 6 h period following meat consumption. BW represents the 
subjects’ body weight in kg. 
Total rate of disappearance of phenylalanine (Total Rd) equals the rate of phenylal-
anine (PHE) to tyrosine (TYR) conversion by hydroxylation (first step in phenylala-
nine oxidation) and utilization for protein synthesis. These parameters can be 
calculated as follows: 
t
C
pVRR ad
d
d
 Total Total ⋅−=  (5) 
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 Protein synthesis = Total Rd– PHE to TYR conversion (7) 
 PHE net balance = Protein synthesis – Endo Ra (8) 
where Phe Rd and Tyr Ra are the flux rates for phenylalanine and tyrosine, respec-
tively, Et(t) and Ep(t) are the mean plasma enrichments of L-[ring-
2
H4]tyrosine and L-
[ring-
2
H5]phenylalanine, respectively, and Fp is the infusion rate of the phenylala-
nine tracer. 
The fractional rate of mixed muscle protein synthesis (FSR) was calculated in %·h
-1
 
by the precursor-product method (25): 
 
100⋅
⋅
∆
=
tE
E
FSR
precursor
p
 
(9) 
 
 
where ∆Ep is the delta increment of muscle protein-bound L-[ring-
2
H5]phenylalanine during the incorporation period. Eprecursor is the average plasma L-
[ring-
2
H5]phenylalanine enrichment during the time period for determination of 
amino acid incorporation. t indicates the time interval (h) between biopsies. 
Statistics 
A two-way repeated measures ANOVA with time and treatment as within-subject 
factors was used to assess differences between treatments over time (time x 
treatment interaction). In case of a significant time x treatment interaction, pair-
wise comparisons for individual time points were applied to locate differences 
between treatments. For non-time dependent variables, a paired t-test was used to 
compare differences between treatments. 
MEAT TEXTURE AND PROTEIN DIGESTION 
107 
We hypothesized that minced beef is more rapidly digested and absorbed when 
compared with beef steak, resulting in increased amino acid availability and greater 
postprandial protein retention in older males. As such, the primary outcomes for 
evaluating the study hypothesis were exogenous PHE Ra and whole-body net pro-
tein balance. 
The sample size calculation, with a two-sided significance level of 0.05 and a power 
of 0.8, was based on differences in protein digestion and absorption kinetics as 
described previously (14). Sample size was estimated at n=10. Statistical signifi-
cance was set at P<0.05. All calculations were performed using the SPSS 19.0.1.1 
software package. All data are expressed as means±SEM. 
Results  
Meal consumption time and VAS questionnaire 
The subjects required more time to consume the beef steak than the minced beef, 
14.4±2.6 and 5.1±0.4 min, respectively (P<0.01). In addition, the subjects reported 
via the VAS questionnaires that it took them more effort to chew the beef steak 
before swallowing when compared with the minced beef, 7.8±0.9 vs 1.0±0.4 cm 
(P<0.01). 
Plasma analyses 
Plasma insulin concentrations increased following meat consumption, peaking at 
90 min and returning back to baseline levels by 240 min with no differences be-
tween treatments (Figure 1). 
 
 
Figure 1. Plasma insulin concentrations (mU·L-1) after consumption of minced beef (minced) or beef 
steak (steak) in older adults (n=10). Values represent means+SEM. Data were analyzed with a two-way 
repeated measures ANOVA with time and treatment as within subject factors. 
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Plasma glucose concentrations did not change over time or between treatments 
and averaged 5.1±0.1 mmol·L
-1
 for both treatments. Plasma phenylalanine, leucine, 
and essential amino acid (EAA) concentrations over time are illustrated in Figure 2. 
Plasma EAA concentrations increased following meat consumption and peaked at 
120 min. No differences were observed between treatments. 
 
 
Figure 2. Plasma phenylalanine (A), leucine (B), and essential amino acid (EAA; C), concentrations 
(μmol·L
-1
) after consumption of minced beef (minced) or beef steak (steak) in older adults (n=10). Values 
represent means+SEM. Data were analyzed with a two-way repeated measures ANOVA with time and 
treatment as within subject factors. 
 
The time course of plasma L-[1-
13
C]phenylalanine and L-[ring-
2
H5]-phenylalanine 
enrichments are illustrated in Figure 3.  
 
 
Figure 3. Plasma L-[1-
13
C]phenylalanine (A) and L-[ring-
2
H5]phenylalanine (B) enrichments expressed as 
molar percent excess (MPE) after consumption of minced beef (minced) or beef steak (steak) in older 
adults (n=10). Values represent means+SEM. Data were analyzed with a two-way repeated measures 
ANOVA with time and treatment as within subject factors. 
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Plasma L-[1-
13
C]phenylalanine enrichments (intrinsically labeled meat protein-
derived phenylalanine) rapidly increased after consumption of the test meals, with 
a higher average enrichment observed after minced beef consumption when com-
pared with beef steak (P<0.01). The plasma L-[ring-
2
H5]-phenylalanine enrichments 
(from continuous L-[ring-
2
H5]phenylalanine infusion) initially decreased following 
beef consumption but slowly returned to baseline levels by the end of the post-
prandial period. No differences were observed in plasma L-[ring-
2
H5]phenylalanine 
enrichments between treatments. 
Whole-body protein kinetics 
Whole-body protein kinetics over time are presented in Figure 4. Total PHE Ra 
(Figure 4A) equals the rate of exogenous PHE Ra (Figure 4B) and endogenous PHE Ra 
(Figure 4C). Consumption of the labeled beef resulted in a rapid rise in exogenous 
PHE Ra, with higher (peak) values observed between 60 and 180 min for minced 
beef when compared with beef steak (P=0.03). 
 
 
Figure 4. Whole-body phenylalanine (PHE) kinetics over time after consumption of minced beef 
(minced) or beef steak (steak) in older adults (n=10). Total PHE appearance rates (Ra; A), exogenous PHE 
Ra (B), endogenous PHE Ra (C), total PHE disappearance rates (Rd; D), PHE to tyrosine (TYR) conversion 
rates (E), and PHE utilization rates for protein synthesis (F). Values represent means+SEM and are 
expressed as μmol phenylalanine·kg
-1
·min
-1
. Data were analyzed with a two-way repeated measures 
ANOVA with time and treatment as within subject factors. In case of a significant time x treatment 
interaction, pairwise comparisons for individual time points were applied to locate differences between 
treatments. *minced beef significantly different when compared with beef steak, P<0.05. 
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Total exogenous PHE appearance, expressed as AUC over the 6 h postprandial 
period, was calculated as the fraction of the total amount of phenylalanine that 
was ingested (Equation 4). The fraction of dietary phenylalanine that appeared in 
the systemic circulation during the 6 h postprandial period was 61±3 and 49±3% 
after minced beef and beef steak consumption, respectively (P<0.01). Endogenous 
PHE Ra decreased after beef consumption and did not differ between treatments. 
Total PHE Rd (Figure 4D) equals the rate of PHE to TYR conversion, which is the first 
step in phenylalanine oxidation (Figure 4E), and the utilization for protein synthesis 
(Figure 4F). PHE to TYR conversion rates directly increased after beef consumption 
in both treatments and returned to baseline values by the end of the 6 h postpran-
dial period. No differences were observed between treatments. Phenylalanine 
utilized for whole-body protein synthesis increased after beef consumption in both 
treatments with higher values observed between 60 and 90 min for minced beef 
when compared with beef steak (P=0.02). 
 
 
Figure 5. Whole-body protein metabolism expressed as area under the curve (AUC; µmol phenylala-
nine·kg
-1
) after consumption of minced beef (minced) or beef steak (steak) in older adults (n=10). Values 
represent means+SEM. Data were analyzed with a two-way repeated measures ANOVA with time (basal 
or postprandial) and treatment (minced or steak) as within subject factors. Synthesis: time effect, 
P=0.08; treatment effect, P=0.20; time x treatment interaction, P=0.38. Breakdown: time effect, P<0.01; 
treatment effect, P=0.55; time x treatment interaction, P=0.34. Oxidation: time effect, P<0.01; treat-
ment effect, P=0.66; time x treatment interaction, P=0.28. Net balance: time effect, P<0.01; treatment 
effect, P<0.05; time x treatment interaction, P<0.01. 
#
postprandial significantly different when com-
pared with basal, P<0.01; *minced beef significantly different when compared with beef steak, P<0.01. 
 
MEAT TEXTURE AND PROTEIN DIGESTION 
111 
Whole-body protein synthesis, breakdown, oxidation, and net balance in the basal 
and postprandial period are presented in Figure 5. Whole-body protein synthesis 
was expressed as AUC of PHE utilization rate for protein synthesis (Figure 4F), No 
differences were observed for whole-body protein synthesis, although there was a 
trend for greater protein synthesis after beef consumption when compared with 
basal values (P=0.08). Phenylalanine released into the circulation from whole-body 
protein breakdown, expressed as AUC of endogenous PHE Ra (Figure 4C), was lower 
after beef consumption when compared with basal values (P<0.01). No differences 
were observed between treatments. Whole-body protein oxidation, expressed as 
AUC of PHE to TYR conversion rate (Figure 4E), was higher after beef consumption 
when compared with basal values (P<0.01). No differences were observed between 
treatments. Whole-body net protein balance equals synthesis minus breakdown. 
The net protein balance was higher after beef consumption when compared with 
basal values (P<0.01), with a more positive net protein balance observed after 
minced beef consumption when compared with beef steak (P<0.01). 
Muscle tracer analysis and calculations 
Mixed muscle protein-bound L-[ring-
2
H5]phenylalanine enrichments and fractional 
synthetic rates (FSR) are presented in Table 1. One subject experienced the muscle 
biopsy procedure as highly unpleasant and continued the experiment without it, as 
such, muscle data are presented for n=9. Basal FSR values did not differ between 
treatments and are presented as group average for both treatments. No differ-
ences were observed between treatments or between basal and postprandial FSR. 
 
Table 1. Mixed muscle protein enrichments and FSR 
 Minced 
(n=9) 
Steak 
(n=9) 
Enrichment biopsy 2 (MPE) 0.0044±0.0007 0.0049±0.0008 
Enrichment biopsy 3 (MPE) 0.0211±0.0019 0.0192±0.0038 
Basal FSR (%·h
-1
) 0.035±0.005 0.035±0.005 
Postprandial FSR (%·h
-1
) 0.035±0.004 0.034±0.003 
Mixed muscle protein-bound L-[ring-
2
H5]phenylalanine enrichments in molar percent excess (MPE) and 
mixed muscle protein fractional synthetic rates (FSR) in the fasted, basal period and after consumption 
of minced beef (n=9) or beef steak (n=9). Values are expressed as means±SEM. Data were analyzed with 
a two-way repeated measures ANOVA with time and treatment as within subject factors. No differences 
were observed between treatments or between basal and postprandial FSR. 
Discussion 
In the present study, intrinsically L-[1-
13
C]phenylalanine-labeled beef was ingested, 
in combination with continuous intravenous infusion of L-[ring-
2
H5]-phenylalanine 
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and L-[ring-
2
H2]tyrosine, to assess postprandial protein kinetics after minced beef 
or beef steak consumption in older males. 
Meat texture plays a major role in chewing efficiency and bolus formation during 
mastication (15). In agreement, it took our subjects more time to consume the beef 
steak than it did to consume the minced beef (14.4±2.6 and 5.1±0.4 min, respec-
tively). The postprandial measuring period was started after complete consumption 
of the meat meal, and may explain why the postprandial increases in plasma insulin 
(Figure 1) and EAA (Figure 2) concentrations after beef consumption did not differ 
substantially between treatments. However, as we applied intrinsically L-[1-
13
C]phenylalanine-enriched meat, we were able to assess the specific release of 
meat-derived phenylalanine into the circulation. In accordance, we observed a 
rapid rise in plasma L-[1-
13
C]phenylalanine enrichment after meat ingestion (Figure 
3A). The average plasma L-[1-
13
C]phenylalanine enrichment showed a greater 
increase after consumption of minced beef when compared with beef steak. In 
agreement, subsequent calculation of meat-derived phenylalanine appearance 
rates showed a more rapid digestion and absorption of meat protein after con-
sumption of minced beef when compared with beef steak (Figure 4B). The latter 
clearly shows that meat texture can modulate postprandial protein digestion and 
absorption kinetics in older males. 
It has previously been suggested that consumption of more rapidly digestible 
protein results in a greater stimulation of postprandial protein retention in older 
adults when compared with the consumption of more slowly digestible protein (12, 
13, 28, 29). This concept had been developed by assessing the digestion and ab-
sorption kinetics of whey (fast) vs casein (slow) protein (30). However, as these 
proteins differ in both digestion and absorption kinetics as well as in amino acid 
composition, we revisited this concept by establishing differences in digestion and 
absorption kinetics and postprandial muscle protein synthesis after the ingestion of 
intact casein vs hydrolysed casein (9, 14). In line with our previous work, we ob-
served more rapid protein digestion and absorption after ingestion of minced beef 
vs beef steak, as evidenced by a more rapid postprandial rise in circulating exoge-
nous phenylalanine (Figure 4B). Furthermore, it also resulted in differences in 
digestion and absorption efficiency between minced beef and beef steak. As we 
applied the use of intrinsically L-[1-
13
C]phenylalanine-labeled beef combined with 
continuous intravenous infusion of L-[ring-
2
H5]phenylalanine and L-[ring-
2
H2]-
tyrosine, we were able to determine the fraction of meat-derived phenylalanine 
that appeared in the circulation during the postprandial period (Equation 4). As a 
result, we show that more meat-derived phenylalanine became available after 
minced beef compared with beef steak consumption (61±3 compared with 49±3%, 
respectively) during the 6-h postprandial period. Such a difference could be of 
substantial relevance for the stimulation of postprandial protein retention in the 
older adult. 
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It has been well established that the consumption of a meal-like amount of dietary 
protein increases protein synthesis and inhibits protein breakdown, thereby result-
ing in a (more) positive net protein balance during the postprandial phase (11). In 
agreement, consumption of 135 g beef was shown to do the same (Figure 5). How-
ever, the postprandial protein balance was more positive after the consumption of 
minced beef when compared with beef steak. This finding seems to be the result of 
small, but consistent differences in whole-body protein synthesis and breakdown 
rates between treatments and are likely attributed to the more rapid digestion and 
absorption kinetics and subsequent greater plasma availability of minced beef-
derived amino acids. In support, previous work has shown that meat protein utiliza-
tion for protein synthesis is reduced when chewing efficiency is impaired in elderly 
subjects (31). Taken together, we conclude that minced beef consumption is more 
effective when compared with beef steak consumption to augment postprandial 
protein retention in elderly men. 
Skeletal muscle protein synthesis is highly responsive to food intake (6). However, 
the muscle protein synthetic response to food intake has been shown to be im-
paired in the older population (2-4). This anabolic resistance of aging is now be-
lieved to contribute to the progressive loss of muscle mass with aging. In the pre-
sent study, we did not observe a significant increase in muscle protein FSR above 
baseline values during the 6 h period after consuming 135 g beef (~26 g protein) in 
our elderly subjects (Table 1). Therefore, the texture of the meat consumed seems 
irrelevant from the perspective of stimulating muscle protein synthesis in older 
adults. However, as postprandial muscle protein synthesis rates generally peak at 
1-2 h after food intake (32), it is possible that a small, temporary rise in muscle 
protein synthesis rates remained undetected in the present study. In retrospect, a 
lack of meal-stimulated muscle FSR may not be surprising considering the fact that 
the postprandial rise in circulating plasma leucine concentrations plays a key-role in 
the regulation of muscle protein synthesis (9, 33, 34). We observed an attenuated 
rise in plasma leucine concentration after beef consumption (Figure 2B) when 
compared to responses reported after the ingestion of similar amounts of casein or 
whey protein (7, 9, 14). After beef consumption, it took approximately 2 hours for 
plasma leucine concentrations to reach 234±14 μmol·L
-1
. This is considerably less 
than peak plasma leucine concentrations that tend to exceed 500 μmol·L
-1
 within 
60 min after ingesting 35 g whey protein (~4 g leucine) (7) or a leucine-enriched 
EAA supplement (~3 g leucine) (35). Based on the absence of a significant increase 
in muscle protein synthesis rates after the ingestion of 10 and 20 g as opposed to 
35 g whey protein in elderly men (7), we speculate that ingestion of 135 g minced 
beef or beef steak (~2 g leucine) simply does not allow a sufficient rise in plasma 
leucine concentration to increase postprandial muscle protein synthesis rates 
above basal levels. Consequently, beef could be considered a less optimal protein 
source from the perspective of optimizing postprandial muscle protein synthesis. 
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Additional dietary protein sources are needed or a greater amount of (minced) 
beef should be ingested in a single meal to effectively augment postprandial mus-
cle protein synthesis rates in the older adult. The latter, however, seems less prac-
tical as elderly individuals would have to consume close to 200 g of beef in a single 
meal. 
We conclude that consumption of minced beef is followed by more rapid protein 
digestion and amino acid absorption when compared with the consumption of beef 
steak, resulting in increased amino acid availability and greater postprandial pro-
tein retention in older men. These data are the first to apply intrinsically labeled 
beef to show that meat texture can modulate postprandial protein kinetics. Future 
clinical trials are warranted to evaluate the clinical relevance of food texture and 
mastication in muscle mass maintenance for the older population. 
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ging is accompanied by a progressive decline in skeletal muscle mass, 
termed sarcopenia. A possible key-factor in the etiology of sarcopenia is an 
impaired muscle protein synthetic response to food intake with older age. 
In the present thesis, we describe a series of dietary interventions that were aimed 
to effectively increase the muscle protein synthetic response to dietary protein 
ingestion in older adults. In this final chapter, the implications of our findings will 
be discussed in a broader perspective and specific areas on which future research 
should focus will be identified. 
Anabolic resistance 
It has been well established that muscle protein synthesis and breakdown rates are 
highly responsive to food intake. Ingestion of protein and/or amino acids strongly 
stimulates muscle protein synthesis and inhibits protein breakdown rates, resulting 
in a positive net protein balance in both the young and the elderly (1). Interestingly, 
data from recent studies suggest that the muscle protein synthetic response to 
smaller, meal-like amounts of amino acids is attenuated in older subjects when 
compared with young controls (2, 3). This impaired muscle protein synthetic re-
sponse to food intake has been proposed to represent one of the key-factors re-
sponsible in the development of sarcopenia. In Chapter 2, however, we did not 
observe an impaired muscle protein synthetic response to protein ingestion in the 
elderly when compared with the young. As such, our findings seem to be in con-
trast with the studies that did report ‘anabolic resistance’ to food intake in the 
elderly. Within these studies, postprandial muscle protein synthesis rates were 
assessed while plasma insulin levels were kept constant (using an insulin-clamp). In 
contrast, we assessed the muscle protein synthetic response under normal living 
conditions, i.e. following the ingestion of a single meal-like amount of protein. 
Ingestion of a single protein bolus results in a rapid increase in plasma amino acid 
availability that is accompanied by a rapid, but short-lived, postprandial peak in 
circulating insulin. The latter is relevant to facilitate postprandial nutritive blood 
flow which supports muscle protein synthesis by increasing amino acid delivery to 
the muscle (4). Therefore, our data suggest that there are no substantial differ-
ences in postprandial muscle protein synthesis rates between the young and the 
old under normal living conditions. However, it cannot be ignored that even minor 
changes (<5%) in postprandial muscle protein synthesis rates with a more advanced 
age will become of great clinical relevance over the course of many years. In fact, 
such minor differences seem consistent with the natural progression of sarcopenia 
that develops over several decades (5). Presently, the detection of such small, but 
physiologically relevant, differences is limited due to the large inter-subject vari-
ance in muscle protein synthesis rates and the sensitivity of the measurement (6). 
Typically, a sample size of 8-12 subjects per group is required to detect a 15-20% 
difference in muscle protein synthesis rates (Figure 1). 
A
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Figure 1. Mixed muscle protein fractional synthetic rates (FSR) in young (age, 22±1 yrs; n=22; black bar) 
and older (age, 70±1 yrs; n=22; white bar) men after ingesting 20-35 g of dairy protein (7, 8). Ingestion 
of intrinsically L-[1-
13
C]phenylalanine-labeled protein using the plasma free pool to calculate FSR 
(P=0.16). 
 
Although we can only speculate on whether postprandial muscle protein synthesis 
is truly impaired with aging, it seems of more clinical relevance to determine 
whether we can augment the muscle protein synthetic response to food intake. To 
allow this we need to assess the impact of various key-factors that drive postpran-
dial muscle protein synthesis, e.g. physical activity, protein digestion and absorp-
tion kinetics, the amino acid composition and the amount of the protein consumed. 
Physical activity 
Besides food intake, physical activity is considered the main anabolic stimulus for 
muscle mass preservation (9). A single bout of physical activity stimulates muscle 
protein synthesis as well as muscle protein breakdown rates, albeit the latter to a 
lesser extent (10, 11). These changes result in an improved net muscle protein 
balance (11). Although a single bout of physical activity stimulates muscle protein 
synthesis to a greater extent than protein breakdown, net muscle protein balance 
remains negative in the absence of food intake (11). Consequently, food intake 
following physical activity is required to obtain a net positive protein balance, 
allowing muscle hypertrophy to occur. 
Because some level of physical activity generally precedes food intake in normal 
daily life, it seemed evident that the concept of anabolic resistance should be 
studied in a postprandial state both at rest and following physical activity. In Chap-
ter 2, we show that more of the dietary protein-derived amino acids were used for 
de novo muscle protein synthesis when physical activity preceded protein inges-
tion. These findings indicate that exercised muscle becomes more sensitive to 
amino acid availability. This enhanced amino acid sensitivity of muscle protein 
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synthesis has been reported to persist for up to 16 h in trained (12) and 24-48 h in 
untrained individuals (11-13) following a single bout of physical activity. For this 
reason, subjects are always asked to refrain from (exhaustive) physical activity in 
the 48 h prior to an experiment. This restriction, however, does not compensate for 
obvious differences in habitual physical activity levels between young and elderly 
subjects and their subsequent impact on muscle protein synthesis rates assessed in 
the laboratory. As such, it could be speculated that a more sedentary lifestyle is 
responsible for the proposed anabolic resistance to food intake in the elderly. In 
agreement, it has been shown that muscle disuse also results in a reduced sensitivi-
ty of skeletal muscle tissue to anabolic stimuli such as food intake (14) and physical 
activity (15). With older people experiencing more frequent periods of bed rest due 
to illness or hospitalization it is clear that muscle disuse also contributes to the loss 
of muscle mass and strength at a more advanced age (16). 
In conclusion, habitual physical activity is an important factor modulating the 
muscle protein synthetic response to food intake. Increasing the duration and 
intensity of habitual physical activity, therefore, may represent an effective strate-
gy to preserve muscle mass.  
Protein digestion and absorption kinetics 
Following protein ingestion, the kinetics of protein digestion and absorption de-
termine at which rate the dietary protein-derived amino acids become available in 
the circulation (17). This rate has been proposed to represent a key-factor regulat-
ing postprandial muscle protein synthesis (18). However, protein digestion and 
amino acid absorption kinetics seem to affect postprandial muscle protein reten-
tion differently at a more advanced age (19). Whereas young adults show a more 
positive whole-body protein balance following ingestion of a slow digestible pro-
tein, older adults show a more positive whole-body protein balance following a 
faster digestible protein (20). In Chapter 3, we extended on these findings by show-
ing that the ingestion of faster digestible protein sources results in greater muscle 
protein synthesis rates when compared with the ingestion of more slowly digesti-
ble protein.  
Recent work suggests that peak muscle protein synthesis rates are reached within 
45 - 90 min following protein ingestion after which they return to baseline values. 
The latter would occur even under conditions where increased plasma amino acid 
availability is maintained (21). Consequently, many other studies have used 2-3 h 
timeframes to assess (peak) postprandial muscle protein synthesis rates in young 
and older subjects. In contrast to examining such ‘peak’ postprandial muscle pro-
tein synthesis rates, we were more interested in an aggregated response to assess 
how much of the dietary protein was used for de novo muscle protein synthesis. In 
our experiments we observed that amino acids derived from slowly digestible 
protein were still being released from the gut 6 h after protein ingestion (Chapter 
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3). Therefore, when comparing the impact of slow versus more rapidly digestible 
proteins, it may be of more relevance to assess the aggregated muscle protein 
synthetic response over an extended postprandial period. Whether assessing an 
aggregated response is more (or less) relevant than assessing ‘peak’ values of 
muscle protein synthesis following protein ingestion remains to be established. 
Interestingly, however, is the observation that the peak muscle protein synthetic 
response to food intake may be delayed in the elderly compared with the young 
(22).  
In a habitual diet, we hardly ever consume only ‘fast’ or ‘slow’ protein sources. In 
fact, most meals consist of different protein sources and combine protein with 
other macronutrients (23). Therefore, meal composition might be an important 
factor that affects digestion and absorption kinetics of dietary protein and its 
subsequent effect on muscle protein synthesis. For example, co-ingestion of other 
macronutrients has been reported to affect gastric emptying (24) and modulate 
splanchnic extraction of dietary protein (25). Besides the composition of a meal, 
the matrix of the food and its mastication are likely important factors that drive 
protein digestion and absorption kinetics. Normally, chewing is the first transfor-
mation process of consumed food on its way to the gut. Aging has been associated 
with decreased chewing efficiency, leading to a lower disruption of swallowed food 
(26). Chewing efficiency is even more compromised in subjects with impaired 
mastication such as those wearing dentures (27). So far, most studies have used 
(milk) protein drinks to study postprandial muscle protein synthesis. As such, the 
impact of food matrix and proper mastication has not received much attention. To 
provide more insight in the effect of chewing and texture on postprandial protein 
metabolism, we used intrinsically labeled meat that was produced by infusing a 
cow with large quantities of labeled phenylalanine (Chapter 5). In Chapter 6, we 
show that minced beef is more rapidly digested and absorbed when compared with 
beef steak and increases subsequent postprandial protein retention more effec-
tively in the elderly. Whether differences in heat treatment during the preparation 
of meat (i.e. cooking) have a similar effect on protein digestion and absorption 
kinetics remains to be established. Interestingly, however, are results from previ-
ous work with labeled egg protein showing that the digestibility of cooked egg 
protein was far greater than of raw egg protein (28). Taken together, the afore-
mentioned examples show that a more holistic view is required to increase our 
understanding of the relevance of food composition, matrix, mastication, and 
processing on protein digestion and absorption kinetics and subsequent postpran-
dial muscle protein synthesis. 
Amino acid composition 
An increase in essential amino acid (EAA) availability represents the main anabolic 
signal responsible for stimulating postprandial muscle protein synthesis rates (29). 
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Therefore, besides digestion and absorption kinetics, also the amino acid composi-
tion of a dietary protein source determines its anabolic properties. In Chapter 3, we 
compared postprandial protein synthesis rates following ingestion of whey, casein 
and casein hydrolysate in older men. In these experiments, a significant positive 
correlation was observed between the delta peak increase in EAA concentrations 
and the overall postprandial muscle protein synthetic response. Interestingly, the 
strongest correlation was observed for leucine. The latter likely explains, at least 
partly, the greater muscle protein synthetic response observed following ingestion 
of whey versus casein or casein hydrolysate. These findings seem to be in line with 
earlier work reporting that increasing the leucine content of a meal could compen-
sate for the level of anabolic resistance by increasing the postprandial muscle 
protein synthetic response to food intake in the elderly (30, 31). However, more 
recent long-term intervention trials were unable to confirm that leucine co-
ingestion with each main meal increases net muscle mass gain in an elderly popula-
tion (32, 33). These trials suggest that effective dietary interventions to combat 
sarcopenia will take more than just increasing the leucine content of a meal. In 
accordance, in Chapter 3, we also report significant positive correlations between 
the overall postprandial muscle protein synthetic response and the delta peak 
increase in concentration of 5 other EAAs. As such, more research is warranted to 
underpin the specific interactions between leucine and other (essential) amino 
acids that may drive the anabolic response to food intake.  
The amount of protein  
The muscle protein synthetic response to food intake is dependent on both the 
quality as well as the quantity of dietary protein ingested (34, 35). In Chapter 4, we 
show that the postprandial muscle protein synthetic response to whey protein 
ingestion is dose-dependent in elderly men. However, it should be noted that this 
dose-dependency is likely specific for fast digestible protein sources. Comparing 
work from our lab on dietary protein digestion and absorption kinetics following 
ingestion of intact casein by older adults, we observed that the ingestion of 35 g 
(36) versus 20 g (37) intact casein did not result in higher peak values of dietary 
protein-derived phenylalanine absorption from the gut. In contrast, when similar 
amounts of fast digestible casein hydrolysate were consumed, large differences in 
peak values were observed between 35 g and 20 g protein (Figure 2). 
In our experiments, we observed that approximately 50-60% of the dietary protein-
derived phenylalanine became available in the circulation during the 6 h postpran-
dial assessment period. Consequently, a large amount of dietary amino acids did 
not appear in the circulation following food intake. The metabolic fate of these 
amino acids remains to be elucidated. Apart from some non-absorption and oxida-
tion, it is likely that most of these amino acids are retained in the gut and are used 
for de novo protein synthesis in the splanchnic tissues (e.g. liver, gut, intestine) (38, 
39). 
 
Figure 2. Rate of appearance of dietary protein
following ingestion of 20 g and 35 g intact casein (CAS) and hyd
Combined results of Koopman et al. (36) and Pennings 
 
Previous work in humans (40) and pigs (41) has shown that the splanchnic area 
extracts ~50% of the ingested amino acids to sustain its functional mass
nitude of splanchnic extraction is not surprising considering the mass and high 
protein turnover rates of the various organs (1). In
will also be used for de novo synthesis of plasma proteins (38, 42). Following me
consumption, plasma albumin synthesis was shown to be a significant contributor 
to whole-body protein synthesis (43, 44). Interestingly, it was suggested that the 
stimulation of albumin synthesis observed during feeding prevents irreversible 
oxidative losses of a significant fraction of ingested EAAs and may serve as a vehicle 
to capture excess dietary amino acids and transport them to peripheral
sustain local protein synthesis (43). Whether the latter also
contributor to muscle protein synthesis following meal consumption remains to be 
determined. Therefore, further evaluation of the metabolic fate of dietary amino 
acids extracted by the splanchnic tissues will be instrumental to provide greater 
insight in postprandial protein metabolism.
General conclusions and future research
In the present thesis, a series of dietary interventions were tested to
increase the muscle protein synthetic response to food intake in older adults. The 
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-derived phenylalanine from the gut into the circulation 
rolyzed casein (CASH) by elderly men. 
et al. (37). 
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uniqueness of the experiments that were performed is the use of intrinsically 
labeled dietary protein of which the production was described in Chapter 5. Intrin-
sically labeled milk and meat protein were used to assess in vivo protein digestion 
and absorption kinetics and subsequent (muscle) protein synthesis rates following 
consumption of a single bolus of dietary protein. 
The first experiments indicated that exercised muscle is more sensitive to the 
availability of amino acids and that this responsiveness to physical activity is pre-
served at an advanced age. This makes physical activity and/or exercise an im-
portant factor in muscle mass preservation. The following series of experiments 
focused on quality and quantity of dietary protein and showed that the ingestion of 
faster digestible protein sources augments postprandial muscle protein synthesis 
rates more effectively than slower digestible protein sources in older adults. In 
addition, it was also shown that the amino acid composition of dietary protein (e.g. 
high in leucine) is an important factor that drives the muscle protein synthetic 
response to food intake. Whey protein seems to represent a more effective dietary 
component in the diet of older adults. However, the amount of whey protein that 
should be ingested in a single meal to maximize postprandial muscle protein syn-
thesis was observed to be at least 35 g. 
The performed experiments have increased our knowledge on postprandial protein 
metabolism. Nonetheless, there are many questions that remain because a normal, 
healthy diet generally provides many different protein sources in combination with 
other food components. Therefore, future research is required to combine all data 
and define more practical dietary recommendations to stimulate muscle mass 
preservation during aging. Questions that should be addressed in such future 
research include: 
 
• How will the intensity of physical activity affect protein digestion and ab-
sorption kinetics? Will this be different between young and older individu-
als? 
 
• Are potential differences in postprandial (peak) muscle protein synthesis 
rates between young and older subjects detected at 1-2 h after food in-
gestion more (or less) relevant than responses determined over an aggre-
gated time interval (e.g. 0-6 h)? 
 
• Does co-ingestion of dietary carbohydrate and/or fat affect protein diges-
tion and absorption kinetics and subsequent muscle protein synthesis 
rates? Is such an effect also age-dependent? 
 
• Does heat treatment of dietary protein affect protein digestion and ab-
sorption kinetics and subsequent muscle protein synthesis rates in older 
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adults? How does food processing and/or preparation modulate the post-
prandial muscle protein synthetic response? 
 
• Should the plasma concentrations of other (essential) amino acids be in-
creased (or decreased) together with leucine to allow for a greater muscle 
protein synthetic response to food intake? 
 
• What is the metabolic fate of dietary amino acids extracted by the 
splanchnic tissues following ingestion of a single meal?  
 
• How relevant is the postprandial inhibition of muscle protein breakdown 
for muscle mass preservation? Are there age-related differences in the 
postprandial muscle protein breakdown response to food intake? 
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ging is accompanied by a progressive decline in skeletal muscle mass, 
termed sarcopenia, which is associated with functional impairments in daily 
living activities, the loss of independence, and an increased risk of develop-
ing chronic metabolic disease. A possible key-factor in the etiology of sarcopenia is 
an impaired muscle protein synthetic response to food intake at a more advanced 
age. In the present thesis, a series of dietary interventions were tested to effective-
ly increase the muscle protein synthetic response to food intake in older adults. 
The uniqueness of the experiments that were performed is the use of intrinsically 
labeled milk and meat protein which allows the in vivo assessment of dietary pro-
tein digestion and absorption kinetics as well as subsequent (muscle) protein syn-
thesis rates following consumption of a single bolus of protein. 
In Chapter 2, we first compared dietary protein digestion and absorption kinetics 
and subsequent postprandial muscle protein synthesis rates following ingestion of 
a meal-like amount of protein between young and older adults. Because some level 
of physical activity generally precedes food intake in normal daily life, we assessed 
the postprandial muscle protein synthetic response both at rest and following 
physical activity. These experiments indicated that exercised muscle is more sensi-
tive to the availability of amino acids and that this responsiveness to physical activi-
ty is preserved at an advanced age. This makes physical activity or exercise an 
important factor in muscle mass preservation.  
The following series of experiments focused on quality (Chapter 3) and quantity 
(Chapter 4) of dietary protein and show that ingestion of more rapidly digestible 
protein sources increases postprandial muscle protein synthesis rates more effec-
tively than slower digestible protein sources in older adults. In addition, it is also 
shown that the amino acid composition of dietary protein (e.g. high in leucine) 
represents an important factor driving the postprandial muscle protein synthetic 
response. Whey protein seems to represent a dietary protein source with the 
greater muscle protein synthetic response when ingested by older adults. The 
amount of whey protein that should be ingested in a single meal to maximize the 
muscle protein synthetic response was observed to be at least 35 g.  
In Chapter 5, we describe the production of intrinsically labeled milk protein with 
an enrichment level that allows us to assess dietary protein digestion and absorp-
tion kinetics as well as subsequent de novo muscle protein accretion. Furthermore, 
we show the feasibility of producing intrinsically labeled meat protein that allows 
the in vivo assessment of protein digestion and absorption kinetics following beef 
consumption in humans. We extended on the latter in Chapter 6 by determining 
the effect of meat texture on digestion and absorption kinetics and subsequent 
postprandial protein retention in older adults. Therefore, older men were randomly 
assigned to a cross-over experiment in which they consumed intrinsically L-[1-
13
C]phenylalanine-labeled beef, provided as a steak or as minced beef. As a result, 
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we report that minced beef is more rapidly digested and absorbed when compared 
with beef steak, resulting in greater postprandial protein retention in older men. 
In, Chapter 7 the implications of our findings are discussed in a broader perspective 
and specific areas on which future research should focus are identified. There are 
many questions that remain to be addressed because a normal, healthy diet gener-
ally provides many different protein sources in combination with other food com-
ponents. Future research is required to combine all data and define more practical 
dietary recommendations to support muscle mass preservation during aging. 
 
 
 137 
Samenvatting 
 
SAMENVATTING 
138 
uderdom gaat gepaard met een progressieve afname van de hoeveelheid 
skeletspiermassa. Dit proces wordt ook wel sarcopenie genoemd en gaat 
veelal gepaard met fysieke beperkingen bij het uitvoeren van de dagelijkse 
activiteiten, het verlies van de eigen onafhankelijkheid, en een verhoogd risico op 
het ontwikkelen van chronisch metabole ziekten. Een mogelijk belangrijke factor in 
het ontstaan van sarcopenie is een verminderde opbouw van spiereiwit in oudere 
personen na de maaltijd. In dit proefschrift zijn een serie voedingsinterventies 
getest om de opbouw van spiereiwit in oudere personen effectief te verhogen. Het 
bijzondere aan deze testen is het gebruik van intrinsiek gelabelde eiwitten uit melk 
en vlees, waarvan de productie staat beschreven in hoofdstuk 5. Met behulp van 
deze eiwitten kan zowel de snelheid van eiwitvertering en –opname als ook de 
opbouw van skeletspiereiwit worden bepaald na een maaltijd. 
In hoofdstuk 2 testten we eerst de snelheid van eiwitvertering en –opname als ook 
de opbouw van skeletspiereiwit in jonge en oudere volwassenen na de inname van 
een melkeiwitdrankje We hebben dit zowel in rust als ook na fysieke inspanning 
getest aangezien, in het dagelijks leven, een bepaalde mate van fysieke inspanning 
vaak vooraf gaat aan de maaltijd Deze experimenten hebben aangetoond dat de 
skeletspieren na fysieke inspanning gevoeliger zijn voor de beschikbaarheid van 
eiwitten uit de voeding en dat deze gevoeligheid behouden blijft op hogere leeftijd. 
Dit maakt fysieke inspanning of sporten tot een belangrijke factor bij het behoud 
van de skeletspiermassa. 
De volgende serie experimenten waren gericht op de kwaliteit (hoofdstuk 3) en 
kwantiteit (hoofdstuk 4) van eiwitten in de maaltijd. Deze experimenten toonden 
aan dat snel verteerbare eiwitten effectiever zijn in het verhogen van de opbouw 
van skeletspiereiwit dan langzaam verteerbare eiwitten in oudere personen. Ver-
der toonden deze experimenten aan dat ook de aminozuursamenstelling van 
eiwitten in de maaltijd (o.a. veel leucine) een belangrijke factor is in het verhogen 
van de opbouw van skeletspiereiwit na de maaltijd. De consumptie van wei-eiwit, 
dat snel verteerbaar is en veel leucine bevat, bleek bijzonder effectief te zijn in het 
verhogen van de opbouw van skeletspiereiwit in oudere personen. De hoeveelheid 
wei-eiwit die in een enkele maaltijd moet worden geconsumeerd om de opbouw 
van skeletspiereiwit maximaal te verhogen bedraagt tenminste 35 g. 
In hoofdstuk 5 beschrijven we de productie van intrinsiek gelabeld melkeiwit met 
een dermate hoge labeling waarmee zowel de snelheid van eiwitvertering en –
opname als ook de opbouw van skeletspiereiwit kan worden bepaald na een maal-
tijd. Daarnaast tonen we aan dat het ook mogelijk is om intrinsiek gelabeld vlees te 
maken waarmee de snelheid van eiwitvertering en –opname in mensen kan wor-
den bepaald na vleesconsumptie. 
In hoofdstuk 6 testten we het effect van vleesstructuur, intact (biefstuk) of gema-
len (tartaar) rundvlees, op zowel de snelheid van eiwitvertering en –opname als 
ook de opbouw van lichaamseiwit in oudere personen na de maaltijd. Deze expe-
O
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rimenten toonden aan dat de eiwitten uit tartaar sneller worden verteerd en opge-
nomen dan de eiwitten uit biefstuk, wat vervolgens resulteerde in een hogere 
eiwitretentie. 
In hoofdstuk 7 worden de resultaten van onze experimenten in een bredere con-
text geplaatst en worden specieke richtingen voor toekomstig onderzoek geïdenti-
ficeerd. Er blijven nog vele vragen onbeantwoord aangezien een normaal, gezond 
dieet vele verschillende eiwitbronnen bevat in combinatie met andere voedings-
componenten. Daarom is vervolgonderzoek, op basis van de in dit proefschrift 
beschreven resultaten, noodzakelijk om meer praktisch voedingsadvies te kunnen 
geven voor het beter behouden van de skeletspiermassa gedurende het ouder 
worden. 
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